20133657	Androgens	McPherson SJ	Estrogen receptor-beta activated apoptosis in benign hyperplasia and cancer of the prostate is androgen independent and TNFalpha mediated.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
21499299	Androgens	Jeter CR	NANOG promotes cancer stem cell characteristics and prostate cancer resistance to androgen deprivation.	Oncogene	2011	110
22108827	Androgens	Sun Y	Androgen deprivation causes epithelial-mesenchymal transition in the prostate: implications for androgen-deprivation therapy.	Cancer research	2012	94
22438320	Androgens	Germann M	Stem-like cells with luminal progenitor phenotype survive castration in human prostate cancer.	Stem cells	2012	35
22831834	Androgens	Lee SO	New therapy targeting differential androgen receptor signaling in prostate cancer stem/progenitor vs. non-stem/progenitor cells.	Journal of molecular cell biology	2013	33
23426182	Androgens	Cai C	ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer.	The Journal of clinical investigation	2013	44
25535248	Androgens	Chen Z	Agonist and antagonist switch DNA motifs recognized by human androgen receptor in prostate cancer.	The EMBO journal	2015	17
8405201	Estrogens	Pike MC	Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.	Epidemiologic reviews	1993	171
15223047	Estrogens	Dontu G	Breast cancer, stem/progenitor cells and the estrogen receptor.	Trends in endocrinology and metabolism	2004	95
15617686	Estrogens	Clarke RB	A putative human breast stem cell population is enriched for steroid receptor-positive cells.	Developmental biology	2005	89
16849684	Estrogens	Asselin-Labat ML	Steroid hormone receptor status of mouse mammary stem cells.	Journal of the National Cancer Institute	2006	98
17586727	Estrogens	Sasser AK	Interleukin-6 is a potent growth factor for ER-alpha-positive human breast cancer.	FASEB journal 	2007	70
17761946	Estrogens	Dhasarathy A	The transcription factor snail mediates epithelial to mesenchymal transitions by repression of estrogen receptor-alpha.	Molecular endocrinology	2007	79
17981598	Estrogens	Komori T	Regulation of bone development and maintenance by Runx2.	Frontiers in bioscience 	2008	55
18230721	Estrogens	Liu S	BRCA1 regulates human mammary stem/progenitor cell fate.	Proceedings of the National Academy of Sciences of the United States of America	2008	157
18339859	Estrogens	Cheng AS	Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome.	Cancer research	2008	54
18443585	Estrogens	Ben-Porath I	An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.	Nature genetics	2008	811
18559090	Estrogens	Honeth G	The CD44+/CD24- phenotype is enriched in basal-like breast tumors.	Breast cancer research 	2008	186
18687985	Estrogens	Pinzone JJ	The role of Dickkopf-1 in bone development, homeostasis, and disease.	Blood	2009	85
18806226	Estrogens	Dumont N	Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers.	Proceedings of the National Academy of Sciences of the United States of America	2008	81
18841463	Estrogens	Tan AR	Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?	Breast cancer research and treatment	2009	48
19385968	Estrogens	Morimoto K	Stem cell marker aldehyde dehydrogenase 1-positive breast cancers are characterized by negative estrogen receptor, positive human epidermal growth factor receptor type 2, and high Ki67 expression.	Cancer science	2009	59
19451693	Estrogens	Bierie B	Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer.	The Journal of clinical investigation	2009	46
19664291	Estrogens	Fehm T	Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.	Breast cancer research 	2009	61
19911270	Estrogens	Resetkova E	Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment.	Breast cancer research and treatment	2010	60
20509143	Estrogens	Storci G	TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype.	Journal of cellular physiology	2010	41
20679727	Estrogens	Jiang Z	Rb deletion in mouse mammary progenitors induces luminal-B or basal-like/EMT tumor subtypes depending on p53 status.	The Journal of clinical investigation	2010	58
21098263	Estrogens	Fillmore CM	Estrogen expands breast cancer stem-like cells through paracrine FGF/Tbx3 signaling.	Proceedings of the National Academy of Sciences of the United States of America	2010	94
21193018	Estrogens	Guo S	Role of Notch and its oncogenic signaling crosstalk in breast cancer.	Biochimica et biophysica acta	2011	73
21553120	Estrogens	Guttilla IK	Prolonged mammosphere culture of MCF-7 cells induces an EMT and repression of the estrogen receptor by microRNAs.	Breast cancer research and treatment	2012	38
21920899	Estrogens	Elangovan S	SIRT1 is essential for oncogenic signaling by estrogen/estrogen receptor α in breast cancer.	Cancer research	2011	37
22257677	Estrogens	Guttilla IK	ERα, microRNAs, and the epithelial-mesenchymal transition in breast cancer.	Trends in endocrinology and metabolism	2012	31
22261811	Estrogens	Azim HA Jr	Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling.	Clinical cancer research 	2012	57
22496457	Estrogens	Palafox M	RANK induces epithelial-mesenchymal transition and stemness in human mammary epithelial cells and promotes tumorigenesis and metastasis.	Cancer research	2012	44
22692575	Estrogens	Leth-Larsen R	Functional heterogeneity within the CD44 high human breast cancer stem cell-like compartment reveals a gene signature predictive of distant metastasis.	Molecular medicine	2012	36
22821401	Estrogens	Kabos P	Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.	Breast cancer research and treatment	2012	40
23060440	Estrogens	Zhang Y	Estrogen receptor α signaling regulates breast tumor-initiating cells by down-regulating miR-140 which targets the transcription factor SOX2.	The Journal of biological chemistry	2012	34
23088371	Estrogens	Shehata M	Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland.	Breast cancer research 	2012	88
23334326	Estrogens	D'Assoro AB	The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.	Oncogene	2014	38
23442322	Estrogens	Ithimakin S	HER2 drives luminal breast cancer stem cells in the absence of HER2 amplification: implications for efficacy of adjuvant trastuzumab.	Cancer research	2013	62
23532539	Estrogens	Dethlefsen C	The role of intratumoral and systemic IL-6 in breast cancer.	Breast cancer research and treatment	2013	67
23711559	Estrogens	Feng S	Role of aryl hydrocarbon receptor in cancer.	Biochimica et biophysica acta	2013	35
23861811	Estrogens	Lamb R	Wnt pathway activity in breast cancer sub-types and stem-like cells.	PloS one	2013	41
24101509	Estrogens	Zhang X	Regulation of estrogen receptor α by histone methyltransferase SMYD2-mediated protein methylation.	Proceedings of the National Academy of Sciences of the United States of America	2013	33
24412361	Estrogens	Klein BJ	The histone-H3K4-specific demethylase KDM5B binds to its substrate and product through distinct PHD fingers.	Cell reports	2014	30
24469049	Estrogens	Cyr AR	TFAP2C governs the luminal epithelial phenotype in mammary development and carcinogenesis.	Oncogene	2015	22
24889938	Estrogens	Sun Y	Estrogen promotes stemness and invasiveness of ER-positive breast cancer cells through Gli1 activation.	Molecular cancer	2014	35
25006803	Estrogens	Askarian-Amiri ME	Emerging role of long non-coding RNA SOX2OT in SOX2 regulation in breast cancer.	PloS one	2014	31
25038752	Estrogens	Lim WK	Exome sequencing identifies highly recurrent MED12 somatic mutations in breast fibroadenoma.	Nature genetics	2014	37
26257067	Estrogens	Merino D	Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer.	Oncogene	2016	14
26286584	Estrogens	Strong AL	Leptin produced by obese adipose stromal/stem cells enhances proliferation and metastasis of estrogen receptor positive breast cancers.	Breast cancer research 	2015	20
26311719	Estrogens	Deng L	MicroRNA-143 Activation Regulates Smooth Muscle and Endothelial Cell Crosstalk in Pulmonary Arterial Hypertension.	Circulation research	2015	26
26487756	Estrogens	Chen X	Estrogen Metabolite 16α-Hydroxyestrone Exacerbates Bone Morphogenetic Protein Receptor Type II-Associated Pulmonary Arterial Hypertension Through MicroRNA-29-Mediated Modulation of Cellular Metabolism.	Circulation	2016	21
26899533	Estrogens	Masuda T	Clinical and biological significance of circulating tumor cells in cancer.	Molecular oncology	2016	14
26987290	Estrogens	Sun X	Let-7c blocks estrogen-activated Wnt signaling in induction of self-renewal of breast cancer stem cells.	Cancer gene therapy	2016	10
27935867	Estrogens	Vázquez R	The bromodomain inhibitor OTX015 (MK-8628) exerts anti-tumor activity in triple-negative breast cancer models as single agent and in combination with everolimus.	Oncotarget	2017	5
27966906	Estrogens	Zhang Y	Overcoming Tamoxifen Resistance of Human Breast Cancer by Targeted Gene Silencing Using Multifunctional pRNA Nanoparticles.	ACS nano	2017	9
17426693	Insulin	Jiang W	In vitro derivation of functional insulin-producing cells from human embryonic stem cells.	Cell research	2007	89
17615265	Insulin	Karnieli O	Generation of insulin-producing cells from human bone marrow mesenchymal stem cells by genetic manipulation.	Stem cells	2007	73
18197261	Insulin	Chao KC	Islet-like clusters derived from mesenchymal stem cells in Wharton's Jelly of the human umbilical cord for transplantation to control type 1 diabetes.	PloS one	2008	70
19742322	Insulin	Kuroda A	Insulin gene expression is regulated by DNA methylation.	PloS one	2009	69
20697088	Insulin	Hursting SD	Energy balance, host-related factors, and cancer progression.	Journal of clinical oncology 	2010	80
21362568	Insulin	Smukler SR	The adult mouse and human pancreas contain rare multipotent stem cells that express insulin.	Cell stem cell	2011	62
21494607	Insulin	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	129
22056147	Insulin	Kunisada Y	Small molecules induce efficient differentiation into insulin-producing cells from human induced pluripotent stem cells.	Stem cell research	2012	51
22278418	Insulin	Chen G	Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents.	The Journal of clinical endocrinology and metabolism	2012	37
22455973	Insulin	Cantaluppi V	Microvesicles derived from endothelial progenitor cells enhance neoangiogenesis of human pancreatic islets.	Cell transplantation	2012	42
22740171	Insulin	Rezania A	Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice.	Diabetes	2012	112
23183535	Insulin	Thatava T	Intrapatient variations in type 1 diabetes-specific iPS cell differentiation into insulin-producing cells.	Molecular therapy 	2013	29
23382704	Insulin	Schaffer AE	Nkx6.1 controls a gene regulatory network required for establishing and maintaining pancreatic Beta cell identity.	PLoS genetics	2013	57
24613355	Insulin	Chen YJ	De novo formation of insulin-producing "neo-β cell islets" from intestinal crypts.	Cell reports	2014	33
25303535	Insulin	Pagliuca FW	Generation of functional human pancreatic β cells in vitro.	Cell	2014	241
25866088	Insulin	Sharples AP	Longevity and skeletal muscle mass: the role of IGF signalling, the sirtuins, dietary restriction and protein intake.	Aging cell	2015	22
25999530	Insulin	Stewart AF	Human β-cell proliferation and intracellular signaling: part 3.	Diabetes	2015	26
26304037	Insulin	Agulnick AD	Insulin-Producing Endocrine Cells Differentiated In Vitro From Human Embryonic Stem Cells Function in Macroencapsulation Devices In Vivo.	Stem cells translational medicine	2015	24
26389675	Insulin	Sharma RB	Insulin demand regulates β cell number via the unfolded protein response.	The Journal of clinical investigation	2015	35
9143690	Peptides	Constant SL	Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches.	Annual review of immunology	1997	262
15205345	Peptides	Liang Z	Inhibition of breast cancer metastasis by selective synthetic polypeptide against CXCR4.	Cancer research	2004	91
19560813	Peptides	Lin CC	Functional PEG-peptide hydrogels to modulate local inflammation induced by the pro-inflammatory cytokine TNFalpha.	Biomaterials	2009	46
19802382	Peptides	Jaiswal S	Dengue virus infection and virus-specific HLA-A2 restricted immune responses in humanized NOD-scid IL2rgammanull mice.	PloS one	2009	60
19933311	Peptides	Meng Y	Characterization of integrin engagement during defined human embryonic stem cell culture.	FASEB journal 	2010	40
20103780	Peptides	Moosmann A	Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells.	Blood	2010	51
20133666	Peptides	Shah RN	Supramolecular design of self-assembling nanofibers for cartilage regeneration.	Proceedings of the National Academy of Sciences of the United States of America	2010	85
21857646	Peptides	Schraivogel D	CAMTA1 is a novel tumour suppressor regulated by miR-9/9* in glioblastoma stem cells.	The EMBO journal	2011	48
21886175	Peptides	Ratajczak MZ	A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients.	Leukemia	2012	45
23770775	Peptides	Linette GP	Cardiovascular toxicity and titin cross-reactivity of affinity-enhanced T cells in myeloma and melanoma.	Blood	2013	195
23817469	Peptides	Wang W	Loss of Apelin exacerbates myocardial infarction adverse remodeling and ischemia-reperfusion injury: therapeutic potential of synthetic Apelin analogues.	Journal of the American Heart Association	2013	31
24726536	Peptides	Shekaran A	Bone regeneration using an alpha 2 beta 1 integrin-specific hydrogel as a BMP-2 delivery vehicle.	Biomaterials	2014	28
11171994	Glucose	Haase VH	Vascular tumors in livers with targeted inactivation of the von Hippel-Lindau tumor suppressor.	Proceedings of the National Academy of Sciences of the United States of America	2001	167
12808457	Glucose	Mootha VK	PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes.	Nature genetics	2003	1829
16109759	Glucose	Sotiropoulou PA	Characterization of the optimal culture conditions for clinical scale production of human mesenchymal stem cells.	Stem cells	2006	115
16110338	Glucose	Corbo JC	A hybrid photoreceptor expressing both rod and cone genes in a mouse model of enhanced S-cone syndrome.	PLoS genetics	2005	66
16622416	Glucose	Mao X	APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function.	Nature cell biology	2006	168
16873530	Glucose	Chung S	Preadipocytes mediate lipopolysaccharide-induced inflammation and insulin resistance in primary cultures of newly differentiated human adipocytes.	Endocrinology	2006	61
17389326	Glucose	Chen YH	High glucose impairs early and late endothelial progenitor cells by modifying nitric oxide-related but not oxidative stress-mediated mechanisms.	Diabetes	2007	78
18184747	Glucose	Narala SR	SIRT1 acts as a nutrient-sensitive growth suppressor and its loss is associated with increased AMPK and telomerase activity.	Molecular biology of the cell	2008	50
18212116	Glucose	Aguiari P	High glucose induces adipogenic differentiation of muscle-derived stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2008	67
18288110	Glucose	Kroon E	Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo.	Nature biotechnology	2008	510
18782754	Glucose	Tateishi K	Generation of insulin-secreting islet-like clusters from human skin fibroblasts.	The Journal of biological chemistry	2008	104
19075268	Glucose	Koschmieder S	Dysregulation of the C/EBPalpha differentiation pathway in human cancer.	Journal of clinical oncology 	2009	51
19421146	Glucose	Kelber JA	Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways.	Oncogene	2009	48
19697348	Glucose	Elabd C	Human multipotent adipose-derived stem cells differentiate into functional brown adipocytes.	Stem cells	2009	67
20140248	Glucose	Xin H	Increasing tPA activity in astrocytes induced by multipotent mesenchymal stromal cells facilitate neurite outgrowth after stroke in the mouse.	PloS one	2010	42
20182580	Glucose	Liao Y	Physiological regulation of Akt activity and stability.	American journal of translational research	2010	103
20460169	Glucose	Smolková K	Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells.	The international journal of biochemistry & cell biology	2011	43
20497976	Glucose	Widyantoro B	Endothelial cell-derived endothelin-1 promotes cardiac fibrosis in diabetic hearts through stimulation of endothelial-to-mesenchymal transition.	Circulation	2010	85
20844768	Glucose	Chen JL	Lactic acidosis triggers starvation response with paradoxical induction of TXNIP through MondoA.	PLoS genetics	2010	44
21719305	Glucose	Hang Y	MafA and MafB activity in pancreatic β cells.	Trends in endocrinology and metabolism	2011	49
21792913	Glucose	Pattappa G	The metabolism of human mesenchymal stem cells during proliferation and differentiation.	Journal of cellular physiology	2011	47
21809358	Glucose	Cardinale V	Multipotent stem/progenitor cells in human biliary tree give rise to hepatocytes, cholangiocytes, and pancreatic islets.	Hepatology	2011	75
22293754	Glucose	Tamada M	Modulation of glucose metabolism by CD44 contributes to antioxidant status and drug resistance in cancer cells.	Cancer research	2012	50
22340904	Glucose	Elliott B	The central role of myostatin in skeletal muscle and whole body homeostasis.	Acta physiologica	2012	30
22371083	Glucose	Blum B	Functional beta-cell maturation is marked by an increased glucose threshold and by expression of urocortin 3.	Nature biotechnology	2012	76
22510571	Glucose	Valcourt JR	Staying alive: metabolic adaptations to quiescence.	Cell cycle	2012	47
22784697	Glucose	Thornton JE	How does Lin28 let-7 control development and disease?	Trends in cell biology	2012	100
22809961	Glucose	Menendez JA	Metformin is synthetically lethal with glucose withdrawal in cancer cells.	Cell cycle	2012	46
22850421	Glucose	Fiaschi T	Reciprocal metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay.	Cancer research	2012	100
23144172	Glucose	Mocharla P	AngiomiR-126 expression and secretion from circulating CD34(+) and CD14(+) PBMCs: role for proangiogenic effects and alterations in type 2 diabetics.	Blood	2013	37
23197693	Glucose	Sato A	Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.	Stem cells translational medicine	2012	40
23388637	Glucose	Qian SW	BMP4-mediated brown fat-like changes in white adipose tissue alter glucose and energy homeostasis.	Proceedings of the National Academy of Sciences of the United States of America	2013	59
23453623	Glucose	Dong C	Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer.	Cancer cell	2013	149
23562747	Glucose	Newman G	Leptin-cytokine crosstalk in breast cancer.	Molecular and cellular endocrinology	2014	32
23852538	Glucose	Yao Y	A role for the endothelium in vascular calcification.	Circulation research	2013	44
23897760	Glucose	Rezania A	Enrichment of human embryonic stem cell-derived NKX6.1-expressing pancreatic progenitor cells accelerates the maturation of insulin-secreting cells in vivo.	Stem cells	2013	48
23995067	Glucose	Flavahan WA	Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake.	Nature neuroscience	2013	83
24096870	Glucose	Liu PP	Metabolic regulation of cancer cell side population by glucose through activation of the Akt pathway.	Cell death and differentiation	2014	48
24141775	Glucose	Chen WT	GRP78 as a regulator of liver steatosis and cancer progression mediated by loss of the tumor suppressor PTEN.	Oncogene	2014	24
24395786	Glucose	Vozza A	UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation.	Proceedings of the National Academy of Sciences of the United States of America	2014	64
24953180	Glucose	Oburoglu L	Glucose and glutamine metabolism regulate human hematopoietic stem cell lineage specification.	Cell stem cell	2014	31
25105579	Glucose	Sancho R	Loss of Fbw7 reprograms adult pancreatic ductal cells into α, δ, and β cells.	Cell stem cell	2014	26
25119025	Glucose	Faehnle CR	Mechanism of Dis3l2 substrate recognition in the Lin28-let-7 pathway.	Nature	2014	31
25204974	Glucose	Carlsson PO	Preserved β-cell function in type 1 diabetes by mesenchymal stromal cells.	Diabetes	2015	22
25211370	Glucose	Rezania A	Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells.	Nature biotechnology	2014	165
25215489	Glucose	Wang YH	Cell-state-specific metabolic dependency in hematopoiesis and leukemogenesis.	Cell	2014	51
25281430	Glucose	Murahovschi V	WISP1 is a novel adipokine linked to inflammation in obesity.	Diabetes	2015	16
25304371	Glucose	Chen B	miR-22 as a prognostic factor targets glucose transporter protein type 1 in breast cancer.	Cancer letters	2015	21
25399420	Glucose	Gao Y	The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells.	Nucleic acids research	2014	42
25528771	Glucose	Shibuya K	Targeting the facilitative glucose transporter GLUT1 inhibits the self-renewal and tumor-initiating capacity of cancer stem cells.	Oncotarget	2015	28
25644265	Glucose	Kamphorst JJ	Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein.	Cancer research	2015	89
25732824	Glucose	Zhang D	Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation.	Cell reports	2015	27
25826432	Glucose	Peake JM	Cytokine expression and secretion by skeletal muscle cells: regulatory mechanisms and exercise effects.	Exercise immunology review	2015	37
26098213	Glucose	Dhawan S	DNA methylation directs functional maturation of pancreatic β cells.	The Journal of clinical investigation	2015	22
26122028	Glucose	Togliatto G	Obesity reduces the pro-angiogenic potential of adipose tissue stem cell-derived extracellular vesicles (EVs) by impairing miR-126 content: impact on clinical applications.	International journal of obesity	2016	11
26386558	Glucose	Ti D	LPS-preconditioned mesenchymal stromal cells modify macrophage polarization for resolution of chronic inflammation via exosome-shuttled let-7b.	Journal of translational medicine	2015	22
26626483	Glucose	Chang C	AMPK-Dependent Phosphorylation of GAPDH Triggers Sirt1 Activation and Is Necessary for Autophagy upon Glucose Starvation.	Molecular cell	2015	19
26743041	Glucose	Akhtar MW	Elevated glucose and oligomeric β-amyloid disrupt synapses via a common pathway of aberrant protein S-nitrosylation.	Nature communications	2016	15
26859576	Glucose	Paolicchi E	Targeting hypoxic response for cancer therapy.	Oncotarget	2016	20
26950362	Glucose	Helman A	p16(Ink4a)-induced senescence of pancreatic beta cells enhances insulin secretion.	Nature medicine	2016	30
27063289	Glucose	Saxena P	A programmable synthetic lineage-control network that differentiates human IPSCs into glucose-sensitive insulin-secreting beta-like cells.	Nature communications	2016	10
27076077	Glucose	Yoshihara E	ERRγ Is Required for the Metabolic Maturation of Therapeutically Functional Glucose-Responsive β Cells.	Cell metabolism	2016	14
27399229	Glucose	Dorrell C	Human islets contain four distinct subtypes of β cells.	Nature communications	2016	39
27557514	Glucose	Zou ZW	LncRNA ANRIL is up-regulated in nasopharyngeal carcinoma and promotes the cancer progression via increasing proliferation, reprograming cell glucose metabolism and inducing side-population stem-like cancer cells.	Oncotarget	2016	17
7871435	Zinc	Schoenherr CJ	The neuron-restrictive silencer factor (NRSF): a coordinate repressor of multiple neuron-specific genes.	Science	1995	260
9819405	Zinc	Gelmetti V	Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.	Molecular and cellular biology	1998	123
12576332	Zinc	Elagib KE	RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation.	Blood	2003	92
16406505	Zinc	Kasper M	GLI transcription factors: mediators of oncogenic Hedgehog signalling.	European journal of cancer	2006	122
16763212	Zinc	Ma Y	SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice.	Blood	2006	73
18522731	Zinc	Sharov AA	Identification of Pou5f1, Sox2, and Nanog downstream target genes with statistical confidence by applying a novel algorithm to time course microarray and genome-wide chromatin immunoprecipitation data.	BMC genomics	2008	76
18604447	Zinc	Evans PM	Roles of Krüpel-like factor 4 in normal homeostasis, cancer and stem cells.	Acta biochimica et biophysica Sinica	2008	68
19270682	Zinc	Wolf D	Embryonic stem cells use ZFP809 to silence retroviral DNAs.	Nature	2009	123
19544444	Zinc	Kong D	miR-200 regulates PDGF-D-mediated epithelial-mesenchymal transition, adhesion, and invasion of prostate cancer cells.	Stem cells	2009	123
19549848	Zinc	Brunet E	Chromosomal translocations induced at specified loci in human stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	73
19680244	Zinc	Hockemeyer D	Efficient targeting of expressed and silent genes in human ESCs and iPSCs using zinc-finger nucleases.	Nature biotechnology	2009	383
20706219	Zinc	Brabletz S	The ZEB/miR-200 feedback loop--a motor of cellular plasticity in development and cancer?	EMBO reports	2010	247
21156846	Zinc	Wilber A	Therapeutic levels of fetal hemoglobin in erythroid progeny of β-thalassemic CD34+ cells after lentiviral vector-mediated gene transfer.	Blood	2011	36
21665887	Zinc	Shih JY	The EMT regulator slug and lung carcinogenesis.	Carcinogenesis	2011	80
21801010	Zinc	Hui CC	Gli proteins in development and disease.	Annual review of cell and developmental biology	2011	184
21857672	Zinc	Lombardo A	Site-specific integration and tailoring of cassette design for sustainable gene transfer.	Nature methods	2011	88
21890822	Zinc	Ohashi S	A NOTCH3-mediated squamous cell differentiation program limits expansion of EMT-competent cells that express the ZEB transcription factors.	Cancer research	2011	47
21993621	Zinc	Yusa K	Targeted gene correction of α1-antitrypsin deficiency in induced pluripotent stem cells.	Nature	2011	192
22575959	Zinc	Hao HX	ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner.	Nature	2012	161
22898984	Zinc	Thornton JE	Lin28-mediated control of let-7 microRNA expression by alternative TUTases Zcchc11 (TUT4) and Zcchc6 (TUT7).	RNA	2012	67
22967807	Zinc	Wang Y	Genome editing of human embryonic stem cells and induced pluripotent stem cells with zinc finger nucleases for cellular imaging.	Circulation research	2012	33
23002118	Zinc	Chang CJ	Zinc-finger nuclease-mediated correction of α-thalassemia in iPS cells.	Blood	2012	32
23293284	Zinc	Rowe HM	De novo DNA methylation of endogenous retroviruses is shaped by KRAB-ZFPs/KAP1 and ESET.	Development	2013	44
23568838	Zinc	Piganeau M	Cancer translocations in human cells induced by zinc finger and TALE nucleases.	Genome research	2013	45
23587921	Zinc	Li L	Genomic editing of the HIV-1 coreceptor CCR5 in adult hematopoietic stem and progenitor cells using zinc finger nucleases.	Molecular therapy 	2013	63
23741009	Zinc	Torikai H	Toward eliminating HLA class I expression to generate universal cells from allogeneic donors.	Blood	2013	43
23840100	Zinc	Chen Q	Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling.	Mediators of inflammation	2013	53
23863942	Zinc	Jiang J	Translating dosage compensation to trisomy 21.	Nature	2013	73
24168186	Zinc	Wang Y	The Role of Snail in EMT and Tumorigenesis.	Current cancer drug targets	2013	85
24332369	Zinc	Stankic M	TGF-β-Id1 signaling opposes Twist1 and promotes metastatic colonization via a mesenchymal-to-epithelial transition.	Cell reports	2013	54
24556840	Zinc	Lamouille S	Molecular mechanisms of epithelial-mesenchymal transition.	Nature reviews. Molecular cell biology	2014	974
24623306	Zinc	Serra RW	A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype.	eLife	2014	32
24626089	Zinc	Nakaya T	KLF5 regulates the integrity and oncogenicity of intestinal stem cells.	Cancer research	2014	24
24879559	Zinc	Turelli P	Interplay of TRIM28 and DNA methylation in controlling human endogenous retroelements.	Genome research	2014	34
24939876	Zinc	Castro-Diaz N	Evolutionally dynamic L1 regulation in embryonic stem cells.	Genes & development	2014	49
24952462	Zinc	Whissell G	The transcription factor GATA6 enables self-renewal of colon adenoma stem cells by repressing BMP gene expression.	Nature cell biology	2014	25
25084828	Zinc	Kaufhold S	Central role of Snail1 in the regulation of EMT and resistance in cancer: a target for therapeutic intervention.	Journal of experimental & clinical cancer research 	2014	54
25086746	Zinc	Zhang P	ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.	Nature cell biology	2014	56
25148023	Zinc	Tindemans I	GATA-3 function in innate and adaptive immunity.	Immunity	2014	35
25296715	Zinc	Ren D	Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells.	Cell and tissue research	2014	33
25421577	Zinc	Addison JB	KAP1 promotes proliferation and metastatic progression of breast cancer cells.	Cancer research	2015	16
25492562	Zinc	Ousterout DG	Correction of dystrophin expression in cells from Duchenne muscular dystrophy patients through genomic excision of exon 51 by zinc finger nucleases.	Molecular therapy 	2015	33
25531323	Zinc	Weber CE	Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.	Oncogene	2015	30
25607528	Zinc	Zhang P	ZEB1: at the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance.	Cell cycle	2015	65
25702619	Zinc	Huang X	Production of Gene-Corrected Adult Beta Globin Protein in Human Erythrocytes Differentiated from Patient iPSCs After Genome Editing of the Sickle Point Mutation.	Stem cells	2015	42
25733580	Zinc	Hoban MD	Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells.	Blood	2015	67
25772471	Zinc	Crane AM	Targeted correction and restored function of the CFTR gene in cystic fibrosis induced pluripotent stem cells.	Stem cell reports	2015	34
25892221	Zinc	Soufi A	Pioneer transcription factors target partial DNA motifs on nucleosomes to initiate reprogramming.	Cell	2015	79
26023187	Zinc	Koo BK	Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia.	Proceedings of the National Academy of Sciences of the United States of America	2015	16
26025256	Zinc	Strogantsev R	Allele-specific binding of ZFP57 in the epigenetic regulation of imprinted and non-imprinted monoallelic expression.	Genome biology	2015	22
26551060	Zinc	Wang J	Homology-driven genome editing in hematopoietic stem and progenitor cells using ZFN mRNA and AAV6 donors.	Nature biotechnology	2015	48
27003935	Zinc	Ecco G	Transposable Elements and Their KRAB-ZFP Controllers Regulate Gene Expression in Adult Tissues.	Developmental cell	2016	17
27162353	Zinc	Madan B	USP6 oncogene promotes Wnt signaling by deubiquitylating Frizzleds.	Proceedings of the National Academy of Sciences of the United States of America	2016	14
28209719	Zinc	Schlums H	Adaptive NK cells can persist in patients with GATA2 mutation depleted of stem and progenitor cells.	Blood	2017	10
28273063	Zinc	Imbeault M	KRAB zinc-finger proteins contribute to the evolution of gene regulatory networks.	Nature	2017	19
28344999	Zinc	Chang KH	Long-Term Engraftment and Fetal Globin Induction upon BCL11A Gene Editing in Bone-Marrow-Derived CD34+ Hematopoietic Stem and Progenitor Cells.	Molecular therapy. Methods & clinical development	2017	6
10748521	Iron	Lewin M	Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells.	Nature biotechnology	2000	262
12676779	Iron	Hinds KA	Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells.	Blood	2003	81
15831703	Iron	Cooperman SS	Microcytic anemia, erythropoietic protoporphyria, and neurodegeneration in mice with targeted deletion of iron-regulatory protein 2.	Blood	2005	69
19416716	Iron	Zhang DL	A ferroportin transcript that lacks an iron-responsive element enables duodenal and erythroid precursor cells to evade translational repression.	Cell metabolism	2009	75
19621348	Iron	Tsiftsoglou AS	Erythropoiesis: model systems, molecular regulators, and developmental programs.	IUBMB life	2009	61
23136396	Iron	Hick A	Neurons and cardiomyocytes derived from induced pluripotent stem cells as a model for mitochondrial defects in Friedreich's ataxia.	Disease models & mechanisms	2013	43
25394715	Iron	Bulycheva E	Myelodysplasia is in the niche: novel concepts and emerging therapies.	Leukemia	2015	15
25428262	Iron	Dolatshad H	Disruption of SF3B1 results in deregulated expression and splicing of key genes and pathways in myelodysplastic syndrome hematopoietic stem and progenitor cells.	Leukemia	2015	20
26461092	Iron	Schonberg DL	Preferential Iron Trafficking Characterizes Glioblastoma Stem-like Cells.	Cancer cell	2015	35
28319068	Iron	Basuli D	Iron addiction: a novel therapeutic target in ovarian cancer.	Oncogene	2017	5
15499022	Adenosine Triphosphate	Pighin JA	Plant cuticular lipid export requires an ABC transporter.	Science	2004	121
15559249	Adenosine Triphosphate	Meijer L	Pharmacological inhibitors of glycogen synthase kinase 3.	Trends in pharmacological sciences	2004	136
15625123	Adenosine Triphosphate	de Paiva CS	ABCG2 transporter identifies a population of clonogenic human limbal epithelial cells.	Stem cells	2005	75
15894266	Adenosine Triphosphate	Plescia J	Rational design of shepherdin, a novel anticancer agent.	Cancer cell	2005	67
16402910	Adenosine Triphosphate	Krishnamurthy P	Role of ABCG2/BCRP in biology and medicine.	Annual review of pharmacology and toxicology	2006	82
16543131	Adenosine Triphosphate	Ishibashi T	Astrocytes promote myelination in response to electrical impulses.	Neuron	2006	179
16880519	Adenosine Triphosphate	Griswold IJ	Kinase domain mutants of Bcr-Abl exhibit altered transformation potency, kinase activity, and substrate utilization, irrespective of sensitivity to imatinib.	Molecular and cellular biology	2006	62
17322922	Adenosine Triphosphate	Lou H	Targeted therapy for cancer stem cells: the patched pathway and ABC transporters.	Oncogene	2007	62
17350577	Adenosine Triphosphate	Qu X	Autophagy gene-dependent clearance of apoptotic cells during embryonic development.	Cell	2007	209
17572300	Adenosine Triphosphate	Gillet JP	Chemotherapy-induced resistance by ATP-binding cassette transporter genes.	Biochimica et biophysica acta	2007	61
17911267	Adenosine Triphosphate	Zhou J	Activation of the PTEN/mTOR/STAT3 pathway in breast cancer stem-like cells is required for viability and maintenance.	Proceedings of the National Academy of Sciences of the United States of America	2007	193
18393293	Adenosine Triphosphate	Komuta M	Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin.	Hepatology	2008	74
19251738	Adenosine Triphosphate	Schnetz MP	Genomic distribution of CHD7 on chromatin tracks H3K4 methylation patterns.	Genome research	2009	87
19258498	Adenosine Triphosphate	Samudio I	Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism.	Cancer research	2009	73
19561591	Adenosine Triphosphate	Yoo AS	MicroRNA-mediated switching of chromatin-remodelling complexes in neural development.	Nature	2009	207
19711346	Adenosine Triphosphate	Zhu Z	Cancer stem/progenitor cells are highly enriched in CD133+CD44+ population in hepatocellular carcinoma.	International journal of cancer	2010	106
19887595	Adenosine Triphosphate	Costford SR	Skeletal muscle NAMPT is induced by exercise in humans.	American journal of physiology. Endocrinology and metabolism	2010	49
19892975	Adenosine Triphosphate	Cartier N	Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy.	Science	2009	382
20038799	Adenosine Triphosphate	Samudio I	Pharmacologic inhibition of fatty acid oxidation sensitizes human leukemia cells to apoptosis induction.	The Journal of clinical investigation	2010	138
20087650	Adenosine Triphosphate	Martin FT	Potential role of mesenchymal stem cells (MSCs) in the breast tumour microenvironment: stimulation of epithelial to mesenchymal transition (EMT).	Breast cancer research and treatment	2010	59
20130577	Adenosine Triphosphate	Bajpai R	CHD7 cooperates with PBAF to control multipotent neural crest formation.	Nature	2010	162
20159023	Adenosine Triphosphate	Ding XW	ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.	Life sciences	2010	80
20201066	Adenosine Triphosphate	Prigione A	The senescence-related mitochondrial/oxidative stress pathway is repressed in human induced pluripotent stem cells.	Stem cells	2010	164
20413686	Adenosine Triphosphate	Rawat R	Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.	The American journal of pathology	2010	45
20442200	Adenosine Triphosphate	Yang XR	High expression levels of putative hepatic stem/progenitor cell biomarkers related to tumour angiogenesis and poor prognosis of hepatocellular carcinoma.	Gut	2010	73
20562527	Adenosine Triphosphate	Migneco G	Glycolytic cancer associated fibroblasts promote breast cancer tumor growth, without a measurable increase in angiogenesis: evidence for stromal-epithelial metabolic coupling.	Cell cycle	2010	58
20683952	Adenosine Triphosphate	Wang XQ	Octamer 4 (Oct4) mediates chemotherapeutic drug resistance in liver cancer cells through a potential Oct4-AKT-ATP-binding cassette G2 pathway.	Hepatology	2010	56
21196229	Adenosine Triphosphate	Richard D	Brown fat biology and thermogenesis.	Frontiers in bioscience	2011	60
21212411	Adenosine Triphosphate	Frank NY	VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.	Cancer research	2011	51
21240260	Adenosine Triphosphate	Itzhaki I	Modelling the long QT syndrome with induced pluripotent stem cells.	Nature	2011	294
21242311	Adenosine Triphosphate	Birket MJ	A reduction in ATP demand and mitochondrial activity with neural differentiation of human embryonic stem cells.	Journal of cell science	2011	47
21249425	Adenosine Triphosphate	Kepp O	Molecular determinants of immunogenic cell death elicited by anticancer chemotherapy.	Cancer metastasis reviews	2011	70
21357396	Adenosine Triphosphate	Nakatsu MN	Wnt/β-catenin signaling regulates proliferation of human cornea epithelial stem/progenitor cells.	Investigative ophthalmology & visual science	2011	37
21390132	Adenosine Triphosphate	Simsek D	Crucial role for DNA ligase III in mitochondria but not in Xrcc1-dependent repair.	Nature	2011	77
21480217	Adenosine Triphosphate	Kryczek I	Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells.	International journal of cancer	2012	78
21531766	Adenosine Triphosphate	Jeon HM	ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2.	Cancer research	2011	54
21576264	Adenosine Triphosphate	Zaugg K	Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress.	Genes & development	2011	123
21622723	Adenosine Triphosphate	Maugeri-Saccà M	Cancer stem cells and chemosensitivity.	Clinical cancer research 	2011	45
21698063	Adenosine Triphosphate	Varum S	Energy metabolism in human pluripotent stem cells and their differentiated counterparts.	PloS one	2011	166
21709020	Adenosine Triphosphate	Avivar-Valderas A	PERK integrates autophagy and oxidative stress responses to promote survival during extracellular matrix detachment.	Molecular and cellular biology	2011	71
21900605	Adenosine Triphosphate	Vlashi E	Metabolic state of glioma stem cells and nontumorigenic cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	113
22075915	Adenosine Triphosphate	Basford CL	The functional and molecular characterisation of human embryonic stem cell-derived insulin-positive cells compared with adult pancreatic beta cells.	Diabetologia	2012	41
22085932	Adenosine Triphosphate	Zhang J	UCP2 regulates energy metabolism and differentiation potential of human pluripotent stem cells.	The EMBO journal	2011	135
22098950	Adenosine Triphosphate	Nakanishi T	Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression.	Chinese journal of cancer	2012	49
22194014	Adenosine Triphosphate	Wu JI	Diverse functions of ATP-dependent chromatin remodeling complexes in development and cancer.	Acta biochimica et biophysica Sinica	2012	35
22509477	Adenosine Triphosphate	Mo W	Human ABCG2: structure, function, and its role in multidrug resistance.	International journal of biochemistry and molecular biology	2012	37
22525272	Adenosine Triphosphate	Galavotti S	The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.	Oncogene	2013	55
22750882	Adenosine Triphosphate	Chambers SM	Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors.	Nature biotechnology	2012	103
23175232	Adenosine Triphosphate	Oikawa T	Sal-like protein 4 (SALL4), a stem cell biomarker in liver cancers.	Hepatology	2013	51
23371930	Adenosine Triphosphate	Xiong Q	Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.	Circulation	2013	32
23460667	Adenosine Triphosphate	Golebiewska A	Side population in human glioblastoma is non-tumorigenic and characterizes brain endothelial cells.	Brain 	2013	28
23477399	Adenosine Triphosphate	Lai RC	Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.	Regenerative medicine	2013	28
23651857	Adenosine Triphosphate	Hubert CG	Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A.	Genes & development	2013	36
23785148	Adenosine Triphosphate	Staahl BT	Kinetic analysis of npBAF to nBAF switching reveals exchange of SS18 with CREST and integration with neural developmental pathways.	The Journal of neuroscience 	2013	28
23945235	Adenosine Triphosphate	Byers DE	Long-term IL-33-producing epithelial progenitor cells in chronic obstructive lung disease.	The Journal of clinical investigation	2013	57
24332968	Adenosine Triphosphate	Tornovsky-Babeay S	Type 2 diabetes and congenital hyperinsulinism cause DNA double-strand breaks and p53 activity in β cells.	Cell metabolism	2014	32
24385509	Adenosine Triphosphate	Westerterp M	ATP-binding cassette transporters, atherosclerosis, and inflammation.	Circulation research	2014	55
24669934	Adenosine Triphosphate	Lindoso RS	Extracellular vesicles released from mesenchymal stromal cells modulate miRNA in renal tubular cells and inhibit ATP depletion injury.	Stem cells and development	2014	24
24777293	Adenosine Triphosphate	Shi L	miR-145 inhibits migration and invasion of glioma stem cells by targeting ABCG2.	Neuromolecular medicine	2014	24
25030174	Adenosine Triphosphate	Ksander BR	ABCB5 is a limbal stem cell gene required for corneal development and repair.	Nature	2014	48
25195934	Adenosine Triphosphate	Son EY	The role of BAF (mSWI/SNF) complexes in mammalian neural development.	American journal of medical genetics. Part C, Seminars in medical genetics	2014	27
25262208	Adenosine Triphosphate	Miranda-Lorenzo I	Intracellular autofluorescence: a biomarker for epithelial cancer stem cells.	Nature methods	2014	36
25277190	Adenosine Triphosphate	Bonuccelli G	Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells.	Oncotarget	2014	23
25801706	Adenosine Triphosphate	Israelson A	Macrophage migration inhibitory factor as a chaperone inhibiting accumulation of misfolded SOD1.	Neuron	2015	19
26067592	Adenosine Triphosphate	Monsel A	Therapeutic Effects of Human Mesenchymal Stem Cell-derived Microvesicles in Severe Pneumonia in Mice.	American journal of respiratory and critical care medicine	2015	35
26253027	Adenosine Triphosphate	Lee SR	Target Discrimination in Nonsense-Mediated mRNA Decay Requires Upf1 ATPase Activity.	Molecular cell	2015	22
26327810	Adenosine Triphosphate	Zhang W	Insights into Chemoresistance of Prostate Cancer.	International journal of biological sciences	2015	16
26553936	Adenosine Triphosphate	Harikumar A	Chromatin remodeling and bivalent histone modifications in embryonic stem cells.	EMBO reports	2015	18
26649310	Adenosine Triphosphate	Moitra K	Overcoming Multidrug Resistance in Cancer Stem Cells.	BioMed research international	2015	16
26814966	Adenosine Triphosphate	de Dieuleveult M	Genome-wide nucleosome specificity and function of chromatin remodellers in ES cells.	Nature	2016	25
27050306	Adenosine Triphosphate	Tohyama S	Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells.	Cell metabolism	2016	11
27693323	Adenosine Triphosphate	Shouval DS	Interleukin 1β Mediates Intestinal Inflammation in Mice and Patients With Interleukin 10 Receptor Deficiency.	Gastroenterology	2016	10
28165338	Adenosine Triphosphate	Whittaker DE	The chromatin remodeling factor CHD7 controls cerebellar development by regulating reelin expression.	The Journal of clinical investigation	2017	8
28337542	Adenosine Triphosphate	Paillusson S	α-Synuclein binds to the ER-mitochondria tethering protein VAPB to disrupt Ca2+ homeostasis and mitochondrial ATP production.	Acta neuropathologica	2017	9
15310843	Dopamine	Perrier AL	Derivation of midbrain dopamine neurons from human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2004	250
15502868	Dopamine	Martinat C	Sensitivity to oxidative stress in DJ-1-deficient dopamine neurons: an ES- derived cell model of primary Parkinsonism.	PLoS biology	2004	81
15536184	Dopamine	Zeng X	Dopaminergic differentiation of human embryonic stem cells.	Stem cells	2004	82
15917474	Dopamine	Yan Y	Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells.	Stem cells	2005	130
17038668	Dopamine	Sonntag KC	Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.	Stem cells	2007	71
17586681	Dopamine	Redmond DE Jr	Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	103
17761882	Dopamine	Kim J	A MicroRNA feedback circuit in midbrain dopamine neurons.	Science	2007	367
19433789	Dopamine	O'Keeffe GC	Dopamine-induced proliferation of adult neural precursor cells in the mammalian subventricular zone is mediated through EGF.	Proceedings of the National Academy of Sciences of the United States of America	2009	53
20592420	Dopamine	Politis M	Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.	Science translational medicine	2010	60
21576821	Dopamine	Rhee YH	Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease.	The Journal of clinical investigation	2011	80
21624813	Dopamine	Kim H	miR-371-3 expression predicts neural differentiation propensity in human pluripotent stem cells.	Cell stem cell	2011	47
21877920	Dopamine	Sánchez-Danés A	Efficient generation of A9 midbrain dopaminergic neurons by lentiviral delivery of LMX1A in human embryonic stem cells and induced pluripotent stem cells.	Human gene therapy	2012	34
22407749	Dopamine	Sánchez-Danés A	Disease-specific phenotypes in dopamine neurons from human iPS-based models of genetic and sporadic Parkinson's disease.	EMBO molecular medicine	2012	117
23732879	Dopamine	Robicsek O	Abnormal neuronal differentiation and mitochondrial dysfunction in hair follicle-derived induced pluripotent stem cells of schizophrenia patients.	Molecular psychiatry	2013	50
24315443	Dopamine	Miller JD	Human iPSC-based modeling of late-onset disease via progerin-induced aging.	Cell stem cell	2013	146
24736453	Dopamine	Cebrián C	MHC-I expression renders catecholaminergic neurons susceptible to T-cell-mediated degeneration.	Nature communications	2014	37
25127144	Dopamine	Panman L	Sox6 and Otx2 control the specification of substantia nigra and ventral tegmental area dopamine neurons.	Cell reports	2014	20
25403878	Dopamine	Le Grand JN	Neural stem cells in Parkinson's disease: a role for neurogenesis defects in onset and progression.	Cellular and molecular life sciences 	2015	17
25456120	Dopamine	Woodard CM	iPSC-derived dopamine neurons reveal differences between monozygotic twins discordant for Parkinson's disease.	Cell reports	2014	35
25788518	Dopamine	Anastasaki C	Elucidating the impact of neurofibromatosis-1 germline mutations on neurofibromin function and dopamine-based learning.	Human molecular genetics	2015	18
26839413	Dopamine	Mazzulli JR	α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.	Proceedings of the National Academy of Sciences of the United States of America	2016	25
26905200	Dopamine	Fernandes HJ	ER Stress and Autophagic Perturbations Lead to Elevated Extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-Derived Dopamine Neurons.	Stem cell reports	2016	27
27300435	Dopamine	Dolma S	Inhibition of Dopamine Receptor D4 Impedes Autophagic Flux, Proliferation, and Survival of Glioblastoma Stem Cells.	Cancer cell	2016	18
27514754	Dopamine	Würth R	Phenotypical and Pharmacological Characterization of Stem-Like Cells in Human Pituitary Adenomas.	Molecular neurobiology	2017	5
28398344	Dopamine	Rivetti di Val Cervo P	Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson's disease model.	Nature biotechnology	2017	11
9809557	Bromodeoxyuridine	Eriksson PS	Neurogenesis in the adult human hippocampus.	Nature medicine	1998	1036
10751442	Bromodeoxyuridine	Aberg MA	Peripheral infusion of IGF-I selectively induces neurogenesis in the adult rat hippocampus.	The Journal of neuroscience 	2000	144
15161630	Bromodeoxyuridine	Galiano RD	Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells.	The American journal of pathology	2004	144
15381728	Bromodeoxyuridine	Rivino L	Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells.	The Journal of experimental medicine	2004	93
15473967	Bromodeoxyuridine	Feng Y	Mitotic spindle regulation by Nde1 controls cerebral cortical size.	Neuron	2004	142
16105882	Bromodeoxyuridine	Woodward WA	On mammary stem cells.	Journal of cell science	2005	81
16449977	Bromodeoxyuridine	Patrawala L	Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells.	Oncogene	2006	302
16972248	Bromodeoxyuridine	Becker KA	Self-renewal of human embryonic stem cells is supported by a shortened G1 cell cycle phase.	Journal of cellular physiology	2006	142
17287398	Bromodeoxyuridine	Christov C	Muscle satellite cells and endothelial cells: close neighbors and privileged partners.	Molecular biology of the cell	2007	119
17615543	Bromodeoxyuridine	Seigel GM	Human embryonic and neuronal stem cell markers in retinoblastoma.	Molecular vision	2007	56
18366788	Bromodeoxyuridine	Fillmore CM	Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy.	Breast cancer research 	2008	368
19072981	Bromodeoxyuridine	Chu P	Characterization of a subpopulation of colon cancer cells with stem cell-like properties.	International journal of cancer	2009	51
19213953	Bromodeoxyuridine	Zhang J	Functional cardiomyocytes derived from human induced pluripotent stem cells.	Circulation research	2009	366
19956666	Bromodeoxyuridine	Bhanja P	Protective role of R-spondin1, an intestinal stem cell growth factor, against radiation-induced gastrointestinal syndrome in mice.	PloS one	2009	49
23257984	Bromodeoxyuridine	Lian X	Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.	Nature protocols	2013	205
24284627	Bromodeoxyuridine	Li Q	Oncogenic Nras has bimodal effects on stem cells that sustainably increase competitiveness.	Nature	2013	32
8033210	Cysteine	Warren AJ	The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development.	Cell	1994	157
17673662	Cysteine	Johnson CP	Forced unfolding of proteins within cells.	Science	2007	130
19648934	Cysteine	Dansen TB	Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity.	Nature chemical biology	2009	61
21536738	Cysteine	Shochat C	Gain-of-function mutations in interleukin-7 receptor-α (IL7R) in childhood acute lymphoblastic leukemias.	The Journal of experimental medicine	2011	98
21844361	Cysteine	Qu J	S-Nitrosylation activates Cdk5 and contributes to synaptic spine loss induced by beta-amyloid peptide.	Proceedings of the National Academy of Sciences of the United States of America	2011	45
22710668	Cysteine	Kypta RM	Wnt/β-catenin signalling in prostate cancer.	Nature reviews. Urology	2012	63
23016862	Cysteine	Voronkov A	Wnt/beta-catenin signaling and small molecule inhibitors.	Current pharmaceutical design	2013	55
23881612	Cysteine	Hong KJ	RECK inhibits stemness gene expression and tumorigenicity of gastric cancer cells by suppressing ADAM-mediated Notch1 activation.	Journal of cellular physiology	2014	24
25172549	Cysteine	Le PN	Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28.	Pharmacology & therapeutics	2015	34
25326800	Cysteine	Zhang Z	Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.	Nature medicine	2014	47
25823923	Cysteine	Qin L	WNT5A promotes stemness characteristics in nasopharyngeal carcinoma cells leading to metastasis and tumorigenesis.	Oncotarget	2015	23
27540856	Cysteine	Hourihan JM	Cysteine Sulfenylation Directs IRE-1 to Activate the SKN-1/Nrf2 Antioxidant Response.	Molecular cell	2016	14
28498362	Cysteine	Julien O	Caspases and their substrates.	Cell death and differentiation	2017	12
9875932	Proteoglycans	Yoo JU	The chondrogenic potential of human bone-marrow-derived mesenchymal progenitor cells.	The Journal of bone and joint surgery. American volume	1998	144
10964946	Proteoglycans	Chang A	NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions.	The Journal of neuroscience 	2000	147
12382974	Proteoglycans	Nöth U	Multilineage mesenchymal differentiation potential of human trabecular bone-derived cells.	Journal of orthopaedic research 	2002	87
15521064	Proteoglycans	Solchaga LA	FGF-2 enhances the mitotic and chondrogenic potentials of human adult bone marrow-derived mesenchymal stem cells.	Journal of cellular physiology	2005	112
16682644	Proteoglycans	Ligon KL	Development of NG2 neural progenitor cells requires Olig gene function.	Proceedings of the National Academy of Sciences of the United States of America	2006	76
17229976	Proteoglycans	Nishiyama A	Polydendrocytes: NG2 cells with many roles in development and repair of the CNS.	The Neuroscientist 	2007	61
20043946	Proteoglycans	Trotter J	NG2 cells: Properties, progeny and origin.	Brain research reviews	2010	65
21907924	Proteoglycans	Sugiarto S	Asymmetry-defective oligodendrocyte progenitors are glioma precursors.	Cancer cell	2011	72
22058056	Proteoglycans	Krüger JP	Human platelet-rich plasma stimulates migration and chondrogenic differentiation of human subchondral progenitor cells.	Journal of orthopaedic research 	2012	38
22882758	Proteoglycans	Crisan M	Perivascular cells for regenerative medicine.	Journal of cellular and molecular medicine	2012	48
25947161	Proteoglycans	Krencik R	Dysregulation of astrocyte extracellular signaling in Costello syndrome.	Science translational medicine	2015	19
11478845	Glycosaminoglycans	Barry F	Chondrogenic differentiation of mesenchymal stem cells from bone marrow: differentiation-dependent gene expression of matrix components.	Experimental cell research	2001	151
16691412	Glycosaminoglycans	Mauck RL	Regulation of cartilaginous ECM gene transcription by chondrocytes and MSCs in 3D culture in response to dynamic loading.	Biomechanics and modeling in mechanobiology	2007	55
18295878	Glycosaminoglycans	Salinas CN	The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities.	Biomaterials	2008	66
19878627	Glycosaminoglycans	Markway BD	Enhanced chondrogenic differentiation of human bone marrow-derived mesenchymal stem cells in low oxygen environment micropellet cultures.	Cell transplantation	2010	41
23005914	Glycosaminoglycans	Musah S	Glycosaminoglycan-binding hydrogels enable mechanical control of human pluripotent stem cell self-renewal.	ACS nano	2012	32
15070674	Hyaluronic Acid	Avigdor A	CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrow.	Blood	2004	132
17208295	Hyaluronic Acid	Kim J	Bone regeneration using hyaluronic acid-based hydrogel with bone morphogenic protein-2 and human mesenchymal stem cells.	Biomaterials	2007	67
18441325	Hyaluronic Acid	Bourguignon LY	Hyaluronan-CD44 interaction activates stem cell marker Nanog, Stat-3-mediated MDR1 gene expression, and ankyrin-regulated multidrug efflux in breast and ovarian tumor cells.	The Journal of biological chemistry	2008	122
18490190	Hyaluronic Acid	Toole BP	Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance.	Drug resistance updates 	2008	55
18534864	Hyaluronic Acid	Toole BP	Hyaluronan: a constitutive regulator of chemoresistance and malignancy in cancer cells.	Seminars in cancer biology	2008	53
19193129	Hyaluronic Acid	Chung C	Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis.	Tissue engineering. Part A	2009	95
19633292	Hyaluronic Acid	Bourguignon LY	Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells.	The Journal of biological chemistry	2009	106
20008845	Hyaluronic Acid	Toole BP	Hyaluronan-CD44 Interactions in Cancer: Paradoxes and Possibilities.	Clinical cancer research 	2009	90
20197461	Hyaluronic Acid	Xu Y	CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma.	Cancer research	2010	59
20303742	Hyaluronic Acid	Orian-Rousseau V	CD44, a therapeutic target for metastasising tumours.	European journal of cancer	2010	116
20534434	Hyaluronic Acid	Sloane JA	Hyaluronan blocks oligodendrocyte progenitor maturation and remyelination through TLR2.	Proceedings of the National Academy of Sciences of the United States of America	2010	76
21248167	Hyaluronic Acid	Jiang D	Hyaluronan as an immune regulator in human diseases.	Physiological reviews	2011	178
21685938	Hyaluronic Acid	Bourguignon LY	Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells.	Oncogene	2012	72
23410679	Hyaluronic Acid	Ganesh S	Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.	Biomaterials	2013	40
23463525	Hyaluronic Acid	Preston M	Digestion products of the PH20 hyaluronidase inhibit remyelination.	Annals of neurology	2013	26
23939298	Hyaluronic Acid	Mercer SE	A dynamic spatiotemporal extracellular matrix facilitates epicardial-mediated vertebrate heart regeneration.	Developmental biology	2013	29
24145190	Hyaluronic Acid	Ju SY	Maintenance of the stemness in CD44(+) HCT-15 and HCT-116 human colon cancer cells requires miR-203 suppression.	Stem cell research	2014	21
25081533	Hyaluronic Acid	Bourguignon LY	Hyaluronan-CD44 interaction promotes oncogenic signaling, microRNA functions, chemoresistance, and radiation resistance in cancer stem cells leading to tumor progression.	Advances in cancer research	2014	24
27694932	Hyaluronic Acid	Liang J	Hyaluronan and TLR4 promote surfactant-protein-C-positive alveolar progenitor cell renewal and prevent severe pulmonary fibrosis in mice.	Nature medicine	2016	20
15870183	Cytarabine	Tallman MS	Drug therapy for acute myeloid leukemia.	Blood	2005	146
21175313	Cytarabine	Preudhomme C	Imatinib plus peginterferon alfa-2a in chronic myeloid leukemia.	The New England journal of medicine	2010	61
21937694	Cytarabine	Wey S	Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.	Blood	2012	31
23249862	Cytarabine	Herrmann H	Small-molecule inhibition of BRD4 as a new potent approach to eliminate leukemic stem- and progenitor cells in acute myeloid leukemia AML.	Oncotarget	2012	45
24708856	Cytarabine	Palma CA	MicroRNA-155 as an inducer of apoptosis and cell differentiation in Acute Myeloid Leukaemia.	Molecular cancer	2014	27
27367478	Cytarabine	De Kouchkovsky I	'Acute myeloid leukemia: a comprehensive review and 2016 update'.	Blood cancer journal	2016	24
28416471	Cytarabine	Farge T	Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism.	Cancer discovery	2017	7
11104786	Cyclophosphamide	Ponomaryov T	Induction of the chemokine stromal-derived factor-1 following DNA damage improves human stem cell function.	The Journal of clinical investigation	2000	138
12225788	Cyclophosphamide	Lapidot T	Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.	Experimental hematology	2002	143
16337237	Cyclophosphamide	Jung Y	Regulation of SDF-1 (CXCL12) production by osteoblasts; a possible mechanism for stem cell homing.	Bone	2006	84
19961944	Cyclophosphamide	Symons HJ	Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation.	Biology of blood and marrow transplantation 	2010	41
20631380	Cyclophosphamide	Campbell KJ	Elevated Mcl-1 perturbs lymphopoiesis, promotes transformation of hematopoietic stem/progenitor cells, and enhances drug resistance.	Blood	2010	44
20660290	Cyclophosphamide	Schmitz N	Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.	Blood	2010	55
25687405	Cyclophosphamide	Acharya MM	Stem cell transplantation reverses chemotherapy-induced cognitive dysfunction.	Cancer research	2015	16
9831867	Doxorubicin	Ross JS	The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy.	Stem cells	1998	110
15899824	Doxorubicin	Frank NY	ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.	Cancer research	2005	139
18645006	Doxorubicin	Sullivan R	Hypoxia-induced resistance to anticancer drugs is associated with decreased senescence and requires hypoxia-inducible factor-1 activity.	Molecular cancer therapeutics	2008	53
19092120	Doxorubicin	Ronconi E	Regeneration of glomerular podocytes by human renal progenitors.	Journal of the American Society of Nephrology 	2009	155
19156211	Doxorubicin	Mahller YY	Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.	PloS one	2009	52
20038740	Doxorubicin	De Angelis A	Anthracycline cardiomyopathy is mediated by depletion of the cardiac stem cell pool and is rescued by restoration of progenitor cell function.	Circulation	2010	70
20224986	Doxorubicin	Liu T	Establishment and characterization of multi-drug resistant, prostate carcinoma-initiating stem-like cells from human prostate cancer cell lines 22RV1.	Molecular and cellular biochemistry	2010	43
20442777	Doxorubicin	Bandyopadhyay A	Doxorubicin in combination with a small TGFbeta inhibitor: a potential novel therapy for metastatic breast cancer in mouse models.	PloS one	2010	50
20460510	Doxorubicin	Adhikari AS	CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance.	Cancer research	2010	80
20668064	Doxorubicin	Zhang X	Oncogenic Wip1 phosphatase is inhibited by miR-16 in the DNA damage signaling pathway.	Cancer research	2010	48
20682318	Doxorubicin	Cheung ST	Granulin-epithelin precursor and ATP-dependent binding cassette (ABC)B5 regulate liver cancer cell chemoresistance.	Gastroenterology	2011	40
20935265	Doxorubicin	Calcagno AM	Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.	Journal of the National Cancer Institute	2010	76
21953503	Doxorubicin	Zhu Y	Reduced miR-128 in breast tumor-initiating cells induces chemotherapeutic resistance via Bmi-1 and ABCC5.	Clinical cancer research 	2011	54
21996747	Doxorubicin	Lo PK	CD49f and CD61 identify Her2/neu-induced mammary tumor-initiating cells that are potentially derived from luminal progenitors and maintained by the integrin-TGFβ signaling.	Oncogene	2012	53
22308459	Doxorubicin	Meirelles K	Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance.	Proceedings of the National Academy of Sciences of the United States of America	2012	39
23277563	Doxorubicin	Hirsch HA	Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth.	Proceedings of the National Academy of Sciences of the United States of America	2013	106
23411815	Doxorubicin	Piegari E	Doxorubicin induces senescence and impairs function of human cardiac progenitor cells.	Basic research in cardiology	2013	30
24078252	Doxorubicin	Akdemir KC	Genome-wide profiling reveals stimulus-specific functions of p53 during differentiation and DNA damage of human embryonic stem cells.	Nucleic acids research	2014	30
25292190	Doxorubicin	Xu M	miR-382 inhibits osteosarcoma metastasis and relapse by targeting Y box-binding protein 1.	Molecular therapy 	2015	18
25330770	Doxorubicin	Liu JC	Combined deletion of Pten and p53 in mammary epithelium accelerates triple-negative breast cancer with dependency on eEF2K.	EMBO molecular medicine	2014	25
25368020	Doxorubicin	Park EY	Targeting of miR34a-NOTCH1 axis reduced breast cancer stemness and chemoresistance.	Cancer research	2014	38
25823028	Doxorubicin	Xi G	CD133 and DNA-PK regulate MDR1 via the PI3K- or Akt-NF-κB pathway in multidrug-resistant glioblastoma cells in vitro.	Oncogene	2016	15
26004286	Doxorubicin	Rao W	Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells.	ACS nano	2015	22
26057572	Doxorubicin	Zhang Y	Potent Paracrine Effects of human induced Pluripotent Stem Cell-derived Mesenchymal Stem Cells Attenuate Doxorubicin-induced Cardiomyopathy.	Scientific reports	2015	19
26876203	Doxorubicin	Zhang ZM	Pygo2 activates MDR1 expression and mediates chemoresistance in breast cancer via the Wnt/β-catenin pathway.	Oncogene	2016	11
8600162	Dexamethasone	Haynesworth SE	Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha.	Journal of cellular physiology	1996	122
9916173	Dexamethasone	Mackay AM	Chondrogenic differentiation of cultured human mesenchymal stem cells from marrow.	Tissue engineering	1998	242
11805321	Dexamethasone	Kang DC	mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties.	Proceedings of the National Academy of Sciences of the United States of America	2002	166
11917104	Dexamethasone	Sekiya I	In vitro cartilage formation by human adult stem cells from bone marrow stroma defines the sequence of cellular and molecular events during chondrogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2002	136
15100091	Dexamethasone	Sacheck JM	IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1.	American journal of physiology. Endocrinology and metabolism	2004	122
15985292	Dexamethasone	Wang Y	In vitro cartilage tissue engineering with 3D porous aqueous-derived silk scaffolds and mesenchymal stem cells.	Biomaterials	2005	83
16572454	Dexamethasone	Estes BT	Potent induction of chondrocytic differentiation of human adipose-derived adult stem cells by bone morphogenetic protein 6.	Arthritis and rheumatism	2006	63
17469183	Dexamethasone	Siddappa R	Donor variation and loss of multipotency during in vitro expansion of human mesenchymal stem cells for bone tissue engineering.	Journal of orthopaedic research 	2007	66
17593024	Dexamethasone	Barlogie B	Incorporating bortezomib into upfront treatment for multiple myeloma: early results of total therapy 3.	British journal of haematology	2007	82
18438858	Dexamethasone	Mueller MB	Functional characterization of hypertrophy in chondrogenesis of human mesenchymal stem cells.	Arthritis and rheumatism	2008	86
19026649	Dexamethasone	Basma H	Differentiation and transplantation of human embryonic stem cell-derived hepatocytes.	Gastroenterology	2009	148
19843692	Dexamethasone	Hamidouche Z	Priming integrin alpha5 promotes human mesenchymal stromal cell osteoblast differentiation and osteogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2009	51
19902470	Dexamethasone	Vuk-Pavlović S	Immunosuppressive CD14+HLA-DRlow/- monocytes in prostate cancer.	The Prostate	2010	80
20196646	Dexamethasone	Puetzer JL	Comparative review of growth factors for induction of three-dimensional in vitro chondrogenesis in human mesenchymal stem cells isolated from bone marrow and adipose tissue.	Tissue engineering. Part B, Reviews	2010	50
20237346	Dexamethasone	Greenberger S	Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells.	The New England journal of medicine	2010	40
21127173	Dexamethasone	England SJ	Immature erythroblasts with extensive ex vivo self-renewal capacity emerge from the early mammalian fetus.	Blood	2011	45
22536411	Dexamethasone	Hoch AI	Differentiation-dependent secretion of proangiogenic factors by mesenchymal stem cells.	PloS one	2012	38
23303060	Dexamethasone	Anacker C	Glucocorticoid-related molecular signaling pathways regulating hippocampal neurogenesis.	Neuropsychopharmacology 	2013	38
9426049	Thymidine	Grignani F	High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein.	Cancer research	1998	106
16282341	Thymidine	Berger C	Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation.	Blood	2006	93
19345145	Thymidine	Ciceri F	Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study.	The Lancet. Oncology	2009	131
22269649	Thymidine	Cheng F	Protecting against wayward human induced pluripotent stem cells with a suicide gene.	Biomaterials	2012	31
23431204	Thymidine	Ponti G	Cell cycle and lineage progression of neural progenitors in the ventricular-subventricular zones of adult mice.	Proceedings of the National Academy of Sciences of the United States of America	2013	57
10446993	Antineoplastic Agents	Chang BD	A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.	Cancer research	1999	119
15523088	Antineoplastic Agents	Studeny M	Mesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents.	Journal of the National Cancer Institute	2004	237
16146333	Antineoplastic Agents	Mao Q	Role of the breast cancer resistance protein (ABCG2) in drug transport.	The AAPS journal	2005	86
17854227	Antineoplastic Agents	Bagalkot V	Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer.	Nano letters	2007	126
20215516	Antineoplastic Agents	Jin Y	Antineoplastic mechanisms of niclosamide in acute myelogenous leukemia stem cells: inactivation of the NF-kappaB pathway and generation of reactive oxygen species.	Cancer research	2010	92
23349734	Antineoplastic Agents	Godugu C	AlgiMatrix™ based 3D cell culture system as an in-vitro tumor model for anticancer studies.	PloS one	2013	33
24732808	Antineoplastic Agents	Li Y	Multi-targeted therapy of cancer by niclosamide: A new application for an old drug.	Cancer letters	2014	36
25712124	Antineoplastic Agents	Prabhu VV	Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.	Cancer research	2015	30
10224280	Fluorouracil	Li S	The P190, P210, and P230 forms of the BCR/ABL oncogene induce a similar chronic myeloid leukemia-like syndrome in mice but have different lymphoid leukemogenic activity.	The Journal of experimental medicine	1999	131
19244128	Fluorouracil	Dallas NA	Chemoresistant colorectal cancer cells, the cancer stem cell phenotype, and increased sensitivity to insulin-like growth factor-I receptor inhibition.	Cancer research	2009	149
19417905	Fluorouracil	Sung JH	A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs.	Lab on a chip	2009	64
19734943	Fluorouracil	Song B	Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.	Oncogene	2009	125
20697159	Fluorouracil	Haraguchi N	CD13 is a therapeutic target in human liver cancer stem cells.	The Journal of clinical investigation	2010	135
22993328	Fluorouracil	Izumiya M	Chemoresistance is associated with cancer stem cell-like properties and epithelial-to-mesenchymal transition in pancreatic cancer cells.	Anticancer research	2012	33
23684942	Fluorouracil	Lei Z	Identification of molecular subtypes of gastric cancer with different responses to PI3-kinase inhibitors and 5-fluorouracil.	Gastroenterology	2013	62
24009080	Fluorouracil	Siemens H	Repression of c-Kit by p53 is mediated by miR-34 and is associated with reduced chemoresistance, migration and stemness.	Oncotarget	2013	51
24275137	Fluorouracil	Deng J	Targeting miR-21 enhances the sensitivity of human colon cancer HT-29 cells to chemoradiotherapy in vitro.	Biochemical and biophysical research communications	2014	26
24323901	Fluorouracil	Touil Y	Colon cancer cells escape 5FU chemotherapy-induced cell death by entering stemness and quiescence associated with the c-Yes/YAP axis.	Clinical cancer research 	2014	40
24446491	Fluorouracil	Shin JY	High c-Kit expression identifies hematopoietic stem cells with impaired self-renewal and megakaryocytic bias.	The Journal of experimental medicine	2014	38
24859412	Fluorouracil	Honjo S	Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer.	International journal of oncology	2014	24
25820415	Fluorouracil	Kawai T	Keratin 19, a Cancer Stem Cell Marker in Human Hepatocellular Carcinoma.	Clinical cancer research 	2015	23
27119506	Fluorouracil	Vishnubalaji R	MicroRNA-320 suppresses colorectal cancer by targeting SOX4, FOXM1, and FOXQ1.	Oncotarget	2016	14
27145382	Fluorouracil	Otvos B	Cancer Stem Cell-Secreted Macrophage Migration Inhibitory Factor Stimulates Myeloid Derived Suppressor Cell Function and Facilitates Glioblastoma Immune Evasion.	Stem cells	2016	18
27840990	Fluorouracil	Liu N	MicroRNA-302a enhances 5-fluorouracil-induced cell death in human colon cancer cells.	Oncology reports	2017	6
16357177	Cisplatin	Nawrocki ST	Bortezomib sensitizes pancreatic cancer cells to endoplasmic reticulum stress-mediated apoptosis.	Cancer research	2005	95
18519691	Cisplatin	Zhang S	Identification and characterization of ovarian cancer-initiating cells from primary human tumors.	Cancer research	2008	391
18612434	Cisplatin	Chen YC	Oct-4 expression maintained cancer stem-like properties in lung cancer-derived CD133-positive cells.	PloS one	2008	141
18728788	Cisplatin	Levina V	Drug-selected human lung cancer stem cells: cytokine network, tumorigenic and metastatic properties.	PloS one	2008	140
19074899	Cisplatin	Yang N	MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.	Cancer research	2008	113
19805294	Cisplatin	Bertolini G	Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment.	Proceedings of the National Academy of Sciences of the United States of America	2009	248
20028869	Cisplatin	Levina V	Elimination of human lung cancer stem cells through targeting of the stem cell factor-c-kit autocrine signaling loop.	Cancer research	2010	40
20049901	Cisplatin	Morigi M	Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury.	Stem cells	2010	51
20074550	Cisplatin	Teng Y	Wnt/beta-catenin signaling regulates cancer stem cells in lung cancer A549 cells.	Biochemical and biophysical research communications	2010	67
21124918	Cisplatin	Leung EL	Non-small cell lung cancer cells expressing CD44 are enriched for stem cell-like properties.	PloS one	2010	115
21225626	Cisplatin	Sun S	Head neck squamous cell carcinoma c-Met⁺ cells display cancer stem cell properties and are responsible for cisplatin-resistance and metastasis.	International journal of cancer	2011	37
21248297	Cisplatin	Hamano R	Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway.	Clinical cancer research 	2011	56
21342274	Cisplatin	Tsai LL	Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.	Journal of oral pathology & medicine 	2011	50
21442631	Cisplatin	Schrader J	Matrix stiffness modulates proliferation, chemotherapeutic response, and dormancy in hepatocellular carcinoma cells.	Hepatology	2011	81
21726833	Cisplatin	Lee TK	CD24(+) liver tumor-initiating cells drive self-renewal and tumor initiation through STAT3-mediated NANOG regulation.	Cell stem cell	2011	148
22142828	Cisplatin	Steg AD	Stem cell pathways contribute to clinical chemoresistance in ovarian cancer.	Clinical cancer research 	2012	92
22431999	Cisplatin	Bruno S	Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury.	PloS one	2012	135
22797058	Cisplatin	Chau WK	c-Kit mediates chemoresistance and tumor-initiating capacity of ovarian cancer cells through activation of Wnt/β-catenin-ATP-binding cassette G2 signaling.	Oncogene	2013	53
22847005	Cisplatin	Bourguignon LY	Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.	The Journal of biological chemistry	2012	64
22928012	Cisplatin	Lohberger B	Aldehyde dehydrogenase 1, a potential marker for cancer stem cells in human sarcoma.	PloS one	2012	31
23019585	Cisplatin	McAuliffe SM	Targeting Notch, a key pathway for ovarian cancer stem cells, sensitizes tumors to platinum therapy.	Proceedings of the National Academy of Sciences of the United States of America	2012	87
23082760	Cisplatin	Tomasoni S	Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells.	Stem cells and development	2013	74
23135908	Cisplatin	Liu YP	Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling.	Cancer research	2013	44
23349823	Cisplatin	Barr MP	Generation and characterisation of cisplatin-resistant non-small cell lung cancer cell lines displaying a stem-like signature.	PloS one	2013	52
23524583	Cisplatin	Zhang S	Generation of cancer stem-like cells through the formation of polyploid giant cancer cells.	Oncogene	2014	58
23542177	Cisplatin	Mao B	SIRT1 regulates YAP2-mediated cell proliferation and chemoresistance in hepatocellular carcinoma.	Oncogene	2014	30
23610451	Cisplatin	Listerman I	The major reverse transcriptase-incompetent splice variant of the human telomerase protein inhibits telomerase activity but protects from apoptosis.	Cancer research	2013	32
23618405	Cisplatin	Zhou Y	Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.	Stem cell research & therapy	2013	95
23967051	Cisplatin	Yasuda K	Ovarian cancer stem cells are enriched in side population and aldehyde dehydrogenase bright overlapping population.	PloS one	2013	29
24318570	Cisplatin	Liu SY	High aldehyde dehydrogenase activity identifies cancer stem cells in human cervical cancer.	Oncotarget	2013	29
24333218	Cisplatin	Wang H	Acquisition of epithelial-mesenchymal transition phenotype and cancer stem cell-like properties in cisplatin-resistant lung cancer cells through AKT/β-catenin/Snail signaling pathway.	European journal of pharmacology	2014	29
24709421	Cisplatin	Nör C	Cisplatin induces Bmi-1 and enhances the stem cell fraction in head and neck cancer.	Neoplasia	2014	37
24848258	Cisplatin	Shapiro IM	Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.	Science translational medicine	2014	44
25537512	Cisplatin	Chiu WT	FOXM1 confers to epithelial-mesenchymal transition, stemness and chemoresistance in epithelial ovarian carcinoma cells.	Oncotarget	2015	35
25658419	Cisplatin	Xu J	β-Catenin is required for the tumorigenic behavior of triple-negative breast cancer cells.	PloS one	2015	18
25831546	Cisplatin	Srivastava AK	Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	30
25995442	Cisplatin	Liu G	Augmentation of response to chemotherapy by microRNA-506 through regulation of RAD51 in serous ovarian cancers.	Journal of the National Cancer Institute	2015	24
26020117	Cisplatin	Cioffi M	Identification of a distinct population of CD133(+)CXCR4(+) cancer stem cells in ovarian cancer.	Scientific reports	2015	22
26224861	Cisplatin	Kuo BR	In Vivo Cochlear Hair Cell Generation and Survival by Coactivation of β-Catenin and Atoh1.	The Journal of neuroscience 	2015	17
26654944	Cisplatin	Choi EJ	FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells.	Oncotarget	2016	12
27013395	Cisplatin	Morrow CJ	Tumourigenic non-small-cell lung cancer mesenchymal circulating tumour cells: a clinical case study.	Annals of oncology 	2016	14
27803105	Cisplatin	Yokoyama Y	BET Inhibitors Suppress ALDH Activity by Targeting ALDH1A1 Super-Enhancer in Ovarian Cancer.	Cancer research	2016	13
28027578	Cisplatin	Li D	Long noncoding RNA HULC modulates the phosphorylation of YB-1 through serving as a scaffold of extracellular signal-regulated kinase and YB-1 to enhance hepatocarcinogenesis.	Hepatology	2017	17
28164431	Cisplatin	Ragni E	Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication.	Stem cells	2017	6
28285905	Cisplatin	Chen D	Targeting BMI1+ Cancer Stem Cells Overcomes Chemoresistance and Inhibits Metastases in Squamous Cell Carcinoma.	Cell stem cell	2017	10
28406482	Cisplatin	Wang L	Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity.	Cell death & disease	2017	6
12011461	Oxygen	Jögi A	Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype.	Proceedings of the National Academy of Sciences of the United States of America	2002	104
12663857	Oxygen	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	88
12840067	Oxygen	Danet GH	Expansion of human SCID-repopulating cells under hypoxic conditions.	The Journal of clinical investigation	2003	81
14519683	Oxygen	Winokur ST	Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation.	Human molecular genetics	2003	90
14645546	Oxygen	Hu CJ	Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.	Molecular and cellular biology	2003	356
15173316	Oxygen	D'Ippolito G	Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential.	Journal of cell science	2004	138
16331674	Oxygen	Grayson WL	Effects of hypoxia on human mesenchymal stem cell expansion and plasticity in 3D constructs.	Journal of cellular physiology	2006	96
16616713	Oxygen	D'Ippolito G	Low oxygen tension inhibits osteogenic differentiation and enhances stemness of human MIAMI cells.	Bone	2006	94
17045587	Oxygen	Diez H	Hypoxia-mediated activation of Dll4-Notch-Hey2 signaling in endothelial progenitor cells and adoption of arterial cell fate.	Experimental cell research	2007	63
17084552	Oxygen	Blazek ER	Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD133- cells, and the CD133+ sector is enlarged by hypoxia.	International journal of radiation oncology, biology, physics	2007	60
17276151	Oxygen	Potier E	Hypoxia affects mesenchymal stromal cell osteogenic differentiation and angiogenic factor expression.	Bone	2007	64
17476338	Oxygen	Hung SC	Short-term exposure of multipotent stromal cells to low oxygen increases their expression of CX3CR1 and CXCR4 and their engraftment in vivo.	PloS one	2007	92
17482542	Oxygen	Keith B	Hypoxia-inducible factors, stem cells, and cancer.	Cell	2007	333
17521616	Oxygen	Grayson WL	Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells.	Biochemical and biophysical research communications	2007	128
17932421	Oxygen	Raffaghello L	Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche.	Stem cells	2008	89
18511601	Oxygen	Rosová I	Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells.	Stem cells	2008	168
18535813	Oxygen	Bidlingmaier S	The utility and limitations of glycosylated human CD133 epitopes in defining cancer stem cells.	Journal of molecular medicine	2008	83
18713948	Oxygen	Lu SJ	Biologic properties and enucleation of red blood cells from human embryonic stem cells.	Blood	2008	83
18767184	Oxygen	Niebruegge S	Generation of human embryonic stem cell-derived mesoderm and cardiac cells using size-specified aggregates in an oxygen-controlled bioreactor.	Biotechnology and bioengineering	2009	65
19372578	Oxygen	McCord AM	Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.	Molecular cancer research 	2009	70
19441077	Oxygen	Panchision DM	The role of oxygen in regulating neural stem cells in development and disease.	Journal of cellular physiology	2009	78
19698058	Oxygen	Das R	The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches.	Tissue engineering. Part B, Reviews	2010	81
19711453	Oxygen	Kawamoto A	Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I/IIa, multicenter, single-blinded, dose-escalation clinical trial.	Stem cells	2009	51
19718046	Oxygen	Soeda A	Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha.	Oncogene	2009	169
19755485	Oxygen	Forristal CE	Hypoxia inducible factors regulate pluripotency and proliferation in human embryonic stem cells cultured at reduced oxygen tensions.	Reproduction	2010	95
20052410	Oxygen	Santilli G	Mild hypoxia enhances proliferation and multipotency of human neural stem cells.	PloS one	2010	52
20109207	Oxygen	Holzwarth C	Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells.	BMC cell biology	2010	64
20164424	Oxygen	Denny MF	A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.	Journal of immunology	2010	125
20517715	Oxygen	Imtiyaz HZ	Hypoxia-inducible factors as essential regulators of inflammation.	Current topics in microbiology and immunology	2010	75
20962028	Oxygen	Lu X	Hypoxia and hypoxia-inducible factors: master regulators of metastasis.	Clinical cancer research 	2010	161
21127501	Oxygen	Hjelmeland AB	Acidic stress promotes a glioma stem cell phenotype.	Cell death and differentiation	2011	92
21450070	Oxygen	Basciano L	Long term culture of mesenchymal stem cells in hypoxia promotes a genetic program maintaining their undifferentiated and multipotent status.	BMC cell biology	2011	46
21512133	Oxygen	Koh MY	The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion.	Cancer research	2011	65
21809383	Oxygen	Hung SP	Hypoxia promotes proliferation and osteogenic differentiation potentials of human mesenchymal stem cells.	Journal of orthopaedic research 	2012	36
21836617	Oxygen	Heddleston JM	Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential.	Cell death and differentiation	2012	41
21885599	Oxygen	Giarratana MC	Proof of principle for transfusion of in vitro-generated red blood cells.	Blood	2011	80
21900452	Oxygen	Bussolati B	Hypoxia modulates the undifferentiated phenotype of human renal inner medullary CD133+ progenitors through Oct4/miR-145 balance.	American journal of physiology. Renal physiology	2012	30
22225988	Oxygen	Schwab LP	Hypoxia-inducible factor 1α promotes primary tumor growth and tumor-initiating cell activity in breast cancer.	Breast cancer research 	2012	48
22385573	Oxygen	Adesida AB	Hypoxia mediated isolation and expansion enhances the chondrogenic capacity of bone marrow mesenchymal stromal cells.	Stem cell research & therapy	2012	51
22431396	Oxygen	Kim KM	miR-182 is a negative regulator of osteoblast proliferation, differentiation, and skeletogenesis through targeting FoxO1.	Journal of bone and mineral research 	2012	40
22642602	Oxygen	Liang D	The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells.	BMC cancer	2012	36
22770242	Oxygen	Anguera MC	Molecular signatures of human induced pluripotent stem cells highlight sex differences and cancer genes.	Cell stem cell	2012	41
22818162	Oxygen	Koh MY	Passing the baton: the HIF switch.	Trends in biochemical sciences	2012	65
22899010	Oxygen	Janiszewska M	Imp2 controls oxidative phosphorylation and is crucial for preserving glioblastoma cancer stem cells.	Genes & development	2012	68
22962263	Oxygen	Noman MZ	Hypoxia-inducible miR-210 regulates the susceptibility of tumor cells to lysis by cytotoxic T cells.	Cancer research	2012	38
23071357	Oxygen	Tamada M	Pyruvate kinase M2: multiple faces for conferring benefits on cancer cells.	Clinical cancer research 	2012	47
23174192	Oxygen	Hasselbalch HC	Chronic inflammation as a promotor of mutagenesis in essential thrombocythemia, polycythemia vera and myelofibrosis. A human inflammation model for cancer development?	Leukemia research	2013	40
23301832	Oxygen	Mimeault M	Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells.	Journal of cellular and molecular medicine	2013	60
23318445	Oxygen	Kumari U	Evidence of mitochondrial dysfunction and impaired ROS detoxifying machinery in Fanconi anemia cells.	Oncogene	2014	26
23391506	Oxygen	Li H	Stress response of glioblastoma cells mediated by miR-17-5p targeting PTEN and the passenger strand miR-17-3p targeting MDM2.	Oncotarget	2012	42
23505143	Oxygen	Liu L	Hypoxia preconditioned human adipose derived mesenchymal stem cells enhance angiogenic potential via secretion of increased VEGF and bFGF.	Cell biology international	2013	25
23553816	Oxygen	Folmes CD	Disease-causing mitochondrial heteroplasmy segregated within induced pluripotent stem cell clones derived from a patient with MELAS.	Stem cells	2013	33
23579275	Oxygen	Kim JH	Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2.	Cell death & disease	2013	36
23744828	Oxygen	Palomäki S	HIF-1α is upregulated in human mesenchymal stem cells.	Stem cells	2013	31
23755141	Oxygen	Heneidi S	Awakened by cellular stress: isolation and characterization of a novel population of pluripotent stem cells derived from human adipose tissue.	PloS one	2013	28
23765801	Oxygen	Mathieu J	Hypoxia induces re-entry of committed cells into pluripotency.	Stem cells	2013	36
23792436	Oxygen	Dudek J	Cardiolipin deficiency affects respiratory chain function and organization in an induced pluripotent stem cell model of Barth syndrome.	Stem cell research	2013	29
23807220	Oxygen	Estrada JC	Human mesenchymal stem cell-replicative senescence and oxidative stress are closely linked to aneuploidy.	Cell death & disease	2013	42
23861904	Oxygen	Salomon C	Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis.	PloS one	2013	59
23882269	Oxygen	Roemeling-van Rhijn M	Effects of Hypoxia on the Immunomodulatory Properties of Adipose Tissue-Derived Mesenchymal Stem cells.	Frontiers in immunology	2013	29
24204740	Oxygen	Zhang Y	Mitochondrial respiration regulates adipogenic differentiation of human mesenchymal stem cells.	PloS one	2013	32
24438903	Oxygen	Bura A	Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.	Cytotherapy	2014	47
24687582	Oxygen	Fry CS	Fibre type-specific satellite cell response to aerobic training in sedentary adults.	The Journal of physiology	2014	25
24776803	Oxygen	van Galen P	The unfolded protein response governs integrity of the haematopoietic stem-cell pool during stress.	Nature	2014	58
24889884	Oxygen	Catalano MG	Extracorporeal shockwaves (ESWs) enhance the osteogenic medium-induced differentiation of adipose-derived stem cells into osteoblast-like cells.	Journal of tissue engineering and regenerative medicine	2017	5
25288370	Oxygen	Merling RK	An AAVS1-targeted minigene platform for correction of iPSCs from all five types of chronic granulomatous disease.	Molecular therapy 	2015	17
25351418	Oxygen	van den Beucken T	Hypoxia promotes stem cell phenotypes and poor prognosis through epigenetic regulation of DICER.	Nature communications	2014	43
25383540	Oxygen	Zuo W	p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration.	Nature	2015	78
25517294	Oxygen	Song B	Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.	Stem cells and development	2015	28
25583481	Oxygen	Bartesaghi S	Inhibition of oxidative metabolism leads to p53 genetic inactivation and transformation in neural stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	15
25771792	Oxygen	Rieber N	Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells.	Cell host & microbe	2015	21
26073944	Oxygen	Mantel CR	Enhancing Hematopoietic Stem Cell Transplantation Efficacy by Mitigating Oxygen Shock.	Cell	2015	32
26119783	Oxygen	Murakami S	Roles of Nrf2 in cell proliferation and differentiation.	Free radical biology & medicine	2015	26
26501191	Oxygen	Huang L	Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell- and patient-derived tumor organoids.	Nature medicine	2015	39
26568842	Oxygen	Watson AS	Autophagy limits proliferation and glycolytic metabolism in acute myeloid leukemia.	Cell death discovery	2015	22
26735018	Oxygen	Lee SB	An ID2-dependent mechanism for VHL inactivation in cancer.	Nature	2016	18
26796754	Oxygen	Arentson-Lantz EJ	Fourteen days of bed rest induces a decline in satellite cell content and robust atrophy of skeletal muscle fibers in middle-aged adults.	Journal of applied physiology	2016	15
27686535	Oxygen	Ansari A	Function of the SIRT3 mitochondrial deacetylase in cellular physiology, cancer, and neurodegenerative disease.	Aging cell	2017	11
27967234	Oxygen	Yee M	Alternative Progenitor Lineages Regenerate the Adult Lung Depleted of Alveolar Epithelial Type 2 Cells.	American journal of respiratory cell and molecular biology	2017	5
28137309	Oxygen	Lee SY	Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.	Molecular cancer	2017	11
8349823	Cholesterol	Ishibashi S	Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.	The Journal of clinical investigation	1993	348
9218423	Cholesterol	Sullivan PM	Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis.	The Journal of biological chemistry	1997	145
10760292	Cholesterol	McNeish J	High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1.	Proceedings of the National Academy of Sciences of the United States of America	2000	93
11440984	Cholesterol	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	431
15066264	Cholesterol	Guirland C	Lipid rafts mediate chemotropic guidance of nerve growth cones.	Neuron	2004	70
15328152	Cholesterol	Wysoczynski M	Incorporation of CXCR4 into membrane lipid rafts primes homing-related responses of hematopoietic stem/progenitor cells to an SDF-1 gradient.	Blood	2005	68
18067118	Cholesterol	Mizrak D	CD133: molecule of the moment.	The Journal of pathology	2008	152
20138817	Cholesterol	Lai RC	Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury.	Stem cell research	2010	295
20739751	Cholesterol	Rashid ST	Modeling inherited metabolic disorders of the liver using human induced pluripotent stem cells.	The Journal of clinical investigation	2010	173
23547842	Cholesterol	Wei X	Hyaluronic acid-based nanogel-drug conjugates with enhanced anticancer activity designed for the targeting of CD44-positive and drug-resistant tumors.	Bioconjugate chemistry	2013	25
23663738	Cholesterol	Nagareddy PR	Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis.	Cell metabolism	2013	71
23954590	Cholesterol	Myers BR	Hedgehog pathway modulation by multiple lipid binding sites on the smoothened effector of signal response.	Developmental cell	2013	42
24936472	Cholesterol	Maetzel D	Genetic and chemical correction of cholesterol accumulation and impaired autophagy in hepatic and neural cells derived from Niemann-Pick Type C patient-specific iPS cells.	Stem cell reports	2014	45
25904599	Cholesterol	Zhang H	Functional analysis and transcriptomic profiling of iPSC-derived macrophages and their application in modeling Mendelian disease.	Circulation research	2015	18
25919570	Cholesterol	Lin Y	MicroRNA-33b Inhibits Breast Cancer Metastasis by Targeting HMGA2, SALL4 and Twist1.	Scientific reports	2015	33
26199412	Cholesterol	Kang J	Simultaneous deletion of the methylcytosine oxidases Tet1 and Tet3 increases transcriptome variability in early embryogenesis.	Proceedings of the National Academy of Sciences of the United States of America	2015	18
27705744	Cholesterol	Luchetti G	Cholesterol activates the G-protein coupled receptor Smoothened to promote Hedgehog signaling.	eLife	2016	15
28330937	Cholesterol	Kinoshita M	Raft-based sphingomyelin interactions revealed by new fluorescent sphingomyelin analogs.	The Journal of cell biology	2017	5
21186346	Hydrogen Peroxide	Dickinson BC	Nox2 redox signaling maintains essential cell populations in the brain.	Nature chemical biology	2011	72
21834525	Hydrogen Peroxide	Lippert AR	Boronate oxidation as a bioorthogonal reaction approach for studying the chemistry of hydrogen peroxide in living systems.	Accounts of chemical research	2011	70
21896730	Hydrogen Peroxide	Sun QA	Oxygen-coupled redox regulation of the skeletal muscle ryanodine receptor-Ca2+ release channel by NADPH oxidase 4.	Proceedings of the National Academy of Sciences of the United States of America	2011	39
22129993	Hydrogen Peroxide	Balliet RM	Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection.	Cell cycle	2011	41
22313602	Hydrogen Peroxide	Witkiewicz AK	Using the "reverse Warburg effect" to identify high-risk breast cancer patients: stromal MCT4 predicts poor clinical outcome in triple-negative breast cancers.	Cell cycle	2012	70
23326372	Hydrogen Peroxide	Singhapol C	Mitochondrial telomerase protects cancer cells from nuclear DNA damage and apoptosis.	PloS one	2013	30
28223550	Hydrogen Peroxide	Bonuccelli G	NADH autofluorescence, a new metabolic biomarker for cancer stem cells: Identification of Vitamin C and CAPE as natural products targeting "stemness".	Oncotarget	2017	8
28224980	Hydrogen Peroxide	Menges S	Alpha-synuclein prevents the formation of spherical mitochondria and apoptosis under oxidative stress.	Scientific reports	2017	6
26352815	Melphalan	Garfall AL	Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma.	The New England journal of medicine	2015	85
15670778	Dimethyl Sulfoxide	Seo MJ	Differentiation of human adipose stromal cells into hepatic lineage in vitro and in vivo.	Biochemical and biophysical research communications	2005	101
18238852	Dimethyl Sulfoxide	Hay DC	Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo.	Stem cells	2008	91
23584186	Dimethyl Sulfoxide	Chetty S	A simple tool to improve pluripotent stem cell differentiation.	Nature methods	2013	48
17426276	C-Peptide	Voltarelli JC	Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus.	JAMA	2007	111
19255591	C-Peptide	Zhang D	Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells.	Cell research	2009	145
21270052	C-Peptide	Nostro MC	Stage-specific signaling through TGFβ family members and WNT regulates patterning and pancreatic specification of human pluripotent stem cells.	Development	2011	121
22233865	C-Peptide	Zhao Y	Reversal of type 1 diabetes via islet β cell regeneration following immune modulation by cord blood-derived multipotent stem cells.	BMC medicine	2012	38
24257076	C-Peptide	Bruin JE	Characterization of polyhormonal insulin-producing cells derived in vitro from human embryonic stem cells.	Stem cell research	2014	27
26628416	C-Peptide	Cai J	Umbilical Cord Mesenchymal Stromal Cell With Autologous Bone Marrow Cell Transplantation in Established Type 1 Diabetes: A Pilot Randomized Controlled Open-Label Clinical Study to Assess Safety and Impact on Insulin Secretion.	Diabetes care	2016	11
17463394	Bleomycin	Xu J	Role of the SDF-1/CXCR4 axis in the pathogenesis of lung injury and fibrosis.	American journal of respiratory cell and molecular biology	2007	57
17569781	Bleomycin	Ortiz LA	Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury.	Proceedings of the National Academy of Sciences of the United States of America	2007	272
19497992	Bleomycin	Moodley Y	Human umbilical cord mesenchymal stem cells reduce fibrosis of bleomycin-induced lung injury.	The American journal of pathology	2009	85
25385603	Bleomycin	Lee RH	TSG-6 as a biomarker to predict efficacy of human mesenchymal stem/progenitor cells (hMSCs) in modulating sterile inflammation in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2014	39
25533958	Bleomycin	Vaughan AE	Lineage-negative progenitors mobilize to regenerate lung epithelium after major injury.	Nature	2015	88
18663354	Etoposide	Tagscherer KE	Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins.	Oncogene	2008	63
20625515	Etoposide	Song J	Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling.	PloS one	2010	45
18560594	irinotecan	Dylla SJ	Colorectal cancer stem cells are enriched in xenogeneic tumors following chemotherapy.	PloS one	2008	174
19664991	irinotecan	Hoey T	DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency.	Cell stem cell	2009	110
20332776	irinotecan	Fang DD	Expansion of CD133(+) colon cancer cultures retaining stem cell properties to enable cancer stem cell target discovery.	British journal of cancer	2010	41
20720216	irinotecan	Lam W	The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity.	Science translational medicine	2010	71
21948564	irinotecan	Bitarte N	MicroRNA-451 is involved in the self-renewal, tumorigenicity, and chemoresistance of colorectal cancer stem cells.	Stem cells	2011	70
23081779	irinotecan	Kobayashi S	LGR5-positive colon cancer stem cells interconvert with drug-resistant LGR5-negative cells and are capable of tumor reconstitution.	Stem cells	2012	38
23358684	irinotecan	Swindall AF	ST6Gal-I protein expression is upregulated in human epithelial tumors and correlates with stem cell markers in normal tissues and colon cancer cell lines.	Cancer research	2013	36
26294215	irinotecan	Zhang S	Small-Molecule NSC59984 Restores p53 Pathway Signaling and Antitumor Effects against Colorectal Cancer via p73 Activation and Degradation of Mutant p53.	Cancer research	2015	20
19544473	Paclitaxel	Kurrey NK	Snail and slug mediate radioresistance and chemoresistance by antagonizing p53-mediated apoptosis and acquiring a stem-like phenotype in ovarian cancer cells.	Stem cells	2009	191
19748175	Paclitaxel	Zhang Q	A subpopulation of CD133(+) cancer stem-like cells characterized in human oral squamous cell carcinoma confer resistance to chemotherapy.	Cancer letters	2010	56
20332234	Paclitaxel	To K	Y-box binding protein-1 induces the expression of CD44 and CD49f leading to enhanced self-renewal, mammosphere growth, and drug resistance.	Cancer research	2010	49
20624637	Paclitaxel	Li Z	MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.	Gynecologic oncology	2010	46
22768203	Paclitaxel	Singh S	Chemoresistance in prostate cancer cells is regulated by miRNAs and Hedgehog pathway.	PloS one	2012	35
23871962	Paclitaxel	Swaminathan SK	CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer.	Journal of controlled release 	2013	27
23943797	Paclitaxel	Cieply B	Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.	Cancer research	2013	39
25153722	Paclitaxel	Konno Y	MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells.	Oncotarget	2014	53
25154499	Paclitaxel	Wu T	Oxidative stress, mammospheres and Nrf2-new implication for breast cancer therapy?	Molecular carcinogenesis	2015	20
25689802	Paclitaxel	Wheeler HE	Modeling chemotherapeutic neurotoxicity with human induced pluripotent stem cell-derived neuronal cells.	PloS one	2015	23
26421710	Paclitaxel	Farnie G	High mitochondrial mass identifies a sub-population of stem-like cancer cells that are chemo-resistant.	Oncotarget	2015	30
26855150	Paclitaxel	Noll EM	CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma.	Nature medicine	2016	15
27887917	Paclitaxel	Jeong JY	MicroRNA-136 inhibits cancer stem cell activity and enhances the anti-tumor effect of paclitaxel against chemoresistant ovarian cancer cells by targeting Notch3.	Cancer letters	2017	9
28209618	Paclitaxel	Chen MW	The STAT3-miRNA-92-Wnt Signaling Pathway Regulates Spheroid Formation and Malignant Progression in Ovarian Cancer.	Cancer research	2017	7
10411913	Tamoxifen	Vasioukhin V	The magical touch: genome targeting in epidermal stem cells induced by tamoxifen application to mouse skin.	Proceedings of the National Academy of Sciences of the United States of America	1999	237
15703750	Tamoxifen	Laugwitz KL	Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages.	Nature	2005	345
20495363	Tamoxifen	Bonuccelli G	The reverse Warburg effect: glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts.	Cell cycle	2010	73
21768775	Tamoxifen	Martinez-Outschoorn UE	Understanding the metabolic basis of drug resistance: therapeutic induction of the Warburg effect kills cancer cells.	Cell cycle	2011	42
23589310	Tamoxifen	Khurana SS	The hyaluronic acid receptor CD44 coordinates normal and metaplastic gastric epithelial progenitor cell proliferation.	The Journal of biological chemistry	2013	32
24178749	Tamoxifen	Piva M	Sox2 promotes tamoxifen resistance in breast cancer cells.	EMBO molecular medicine	2014	54
25213081	Tamoxifen	Bergamaschi A	The forkhead transcription factor FOXM1 promotes endocrine resistance and invasiveness in estrogen receptor-positive breast cancer by expansion of stem-like cancer cells.	Breast cancer research 	2014	22
25580734	Tamoxifen	Zhou W	Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth.	Nature cell biology	2015	88
25968054	Tamoxifen	Chen H	Reinforcement of STAT3 activity reprogrammes human embryonic stem cells to naive-like pluripotency.	Nature communications	2015	28
26634606	Tamoxifen	Liu Q	Genetic lineage tracing identifies in situ Kit-expressing cardiomyocytes.	Cell research	2016	23
27593106	Tamoxifen	Raggi C	Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages.	Journal of hepatology	2017	16
28355176	Tamoxifen	Shimokawa M	Visualization and targeting of LGR5+ human colon cancer stem cells.	Nature	2017	23
28514441	Tamoxifen	Gordon SR	PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity.	Nature	2017	43
8690216	Nitric Oxide	Sanders KM	A case for interstitial cells of Cajal as pacemakers and mediators of neurotransmission in the gastrointestinal tract.	Gastroenterology	1996	198
10483914	Nitric Oxide	Fawcett JW	The glial scar and central nervous system repair.	Brain research bulletin	1999	287
14605020	Nitric Oxide	Gulati R	Diverse origin and function of cells with endothelial phenotype obtained from adult human blood.	Circulation research	2003	97
14699017	Nitric Oxide	Hur J	Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2004	212
14989423	Nitric Oxide	Dinarello CA	The IL-1 family and inflammatory diseases.	Clinical and experimental rheumatology	2002	126
15601578	Nitric Oxide	Hristov M	Endothelial progenitor cells: characterization, pathophysiology, and possible clinical relevance.	Journal of cellular and molecular medicine	2004	83
16380482	Nitric Oxide	Segal MS	Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes.	Diabetes	2006	69
17684157	Nitric Oxide	Chabannes D	A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells.	Blood	2007	81
18550634	Nitric Oxide	Urbich C	Role of microRNAs in vascular diseases, inflammation, and angiogenesis.	Cardiovascular research	2008	223
18661552	Nitric Oxide	Kim YJ	Neuroprotective effects of human mesenchymal stem cells on dopaminergic neurons through anti-inflammatory action.	Glia	2009	52
19231921	Nitric Oxide	DelaRosa O	Requirement of IFN-gamma-mediated indoleamine 2,3-dioxygenase expression in the modulation of lymphocyte proliferation by human adipose-derived stem cells.	Tissue engineering. Part A	2009	67
19411199	Nitric Oxide	Wilkins A	Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro.	Stem cell research	2009	60
19544427	Nitric Oxide	Ren G	Species variation in the mechanisms of mesenchymal stem cell-mediated immunosuppression.	Stem cells	2009	150
20144787	Nitric Oxide	Charles N	Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.	Cell stem cell	2010	140
20147544	Nitric Oxide	Tricoire L	Common origins of hippocampal Ivy and nitric oxide synthase expressing neurogliaform cells.	The Journal of neuroscience 	2010	53
20368733	Nitric Oxide	Shi Y	Mesenchymal stem cells: a new strategy for immunosuppression and tissue repair.	Cell research	2010	122
20431067	Nitric Oxide	Kane NM	Derivation of endothelial cells from human embryonic stem cells by directed differentiation: analysis of microRNA and angiogenesis in vitro and in vivo.	Arteriosclerosis, thrombosis, and vascular biology	2010	49
20664249	Nitric Oxide	Suciu L	Telocytes in human term placenta: morphology and phenotype.	Cells, tissues, organs	2010	65
20978357	Nitric Oxide	Glynn SA	Increased NOS2 predicts poor survival in estrogen receptor-negative breast cancer patients.	The Journal of clinical investigation	2010	63
21242993	Nitric Oxide	Meisel R	Human but not murine multipotent mesenchymal stromal cells exhibit broad-spectrum antimicrobial effector function mediated by indoleamine 2,3-dioxygenase.	Leukemia	2011	56
21352202	Nitric Oxide	Shi M	Immunomodulatory properties and therapeutic application of mesenchymal stem cells.	Clinical and experimental immunology	2011	71
21729780	Nitric Oxide	Eyler CE	Glioma stem cell proliferation and tumor growth are promoted by nitric oxide synthase-2.	Cell	2011	88
21951555	Nitric Oxide	Soleymaninejadian E	Immunomodulatory properties of mesenchymal stem cells: cytokines and factors.	American journal of reproductive immunology	2012	49
22008910	Nitric Oxide	Prockop DJ	Mesenchymal stem/stromal cells (MSCs): role as guardians of inflammation.	Molecular therapy 	2012	180
22167522	Nitric Oxide	Kietadisorn R	Tackling endothelial dysfunction by modulating NOS uncoupling: new insights into its pathogenesis and therapeutic possibilities.	American journal of physiology. Endocrinology and metabolism	2012	55
22421969	Nitric Oxide	Li W	Mesenchymal stem cells: a double-edged sword in regulating immune responses.	Cell death and differentiation	2012	60
22771777	Nitric Oxide	van Buul GM	Mesenchymal stem cells secrete factors that inhibit inflammatory processes in short-term osteoarthritic synovium and cartilage explant culture.	Osteoarthritis and cartilage	2012	33
24162664	Nitric Oxide	Su J	Phylogenetic distinction of iNOS and IDO function in mesenchymal stem cell-mediated immunosuppression in mammalian species.	Cell death and differentiation	2014	26
24452999	Nitric Oxide	Ling W	Mesenchymal stem cells use IDO to regulate immunity in tumor microenvironment.	Cancer research	2014	35
26137590	Nitric Oxide	Premer C	Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.	EBioMedicine	2015	23
26246868	Nitric Oxide	Kornicka K	The Effect of Age on Osteogenic and Adipogenic Differentiation Potential of Human Adipose Derived Stromal Stem Cells (hASCs) and the Impact of Stress Factors in the Course of the Differentiation Process.	Oxidative medicine and cellular longevity	2015	17
26439886	Nitric Oxide	Yiou R	Safety of Intracavernous Bone Marrow-Mononuclear Cells for Postradical Prostatectomy Erectile Dysfunction: An Open Dose-Escalation Pilot Study.	European urology	2016	12
27514990	Nitric Oxide	Balez R	Neuroprotective effects of apigenin against inflammation, neuronal excitability and apoptosis in an induced pluripotent stem cell model of Alzheimer's disease.	Scientific reports	2016	11
17363372	Oligonucleotides, Antisense	Zhu S	MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1).	The Journal of biological chemistry	2007	321
23380860	Oligonucleotides, Antisense	Lentz JJ	Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness.	Nature medicine	2013	41
24139042	Oligonucleotides, Antisense	Donnelly CJ	RNA toxicity from the ALS/FTD C9ORF72 expansion is mitigated by antisense intervention.	Neuron	2013	202
24154603	Oligonucleotides, Antisense	Sareen D	Targeting RNA foci in iPSC-derived motor neurons from ALS patients with a C9ORF72 repeat expansion.	Science translational medicine	2013	168
26308891	Oligonucleotides, Antisense	Zhang K	The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.	Nature	2015	146
27281208	Oligonucleotides, Antisense	Fox RG	Image-based detection and targeting of therapy resistance in pancreatic adenocarcinoma.	Nature	2016	16
10801416	Phosphatidylinositols	de Klein A	Targeted disruption of the cell-cycle checkpoint gene ATR leads to early embryonic lethality in mice.	Current biology 	2000	130
12124177	Phosphatidylinositols	Sattler M	Critical role for Gab2 in transformation by BCR/ABL.	Cancer cell	2002	93
15361852	Phosphatidylinositols	Portis T	Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.	Oncogene	2004	71
16478915	Phosphatidylinositols	Kakinuma T	Chemokines, chemokine receptors, and cancer metastasis.	Journal of leukocyte biology	2006	85
16738242	Phosphatidylinositols	Wang L	Matrix metalloproteinase 2 (MMP2) and MMP9 secreted by erythropoietin-activated endothelial cells promote neural progenitor cell migration.	The Journal of neuroscience 	2006	98
16880536	Phosphatidylinositols	Kasper M	Selective modulation of Hedgehog/GLI target gene expression by epidermal growth factor signaling in human keratinocytes.	Molecular and cellular biology	2006	71
18160036	Phosphatidylinositols	Takai H	Tel2 regulates the stability of PI3K-related protein kinases.	Cell	2007	80
18349857	Phosphatidylinositols	Turley EA	Mechanisms of disease: epithelial-mesenchymal transition--does cellular plasticity fuel neoplastic progression?	Nature clinical practice. Oncology	2008	93
18852283	Phosphatidylinositols	Shimizu T	Stabilized beta-catenin functions through TCF/LEF proteins and the Notch/RBP-Jkappa complex to promote proliferation and suppress differentiation of neural precursor cells.	Molecular and cellular biology	2008	59
19914164	Phosphatidylinositols	Genander M	Dissociation of EphB2 signaling pathways mediating progenitor cell proliferation and tumor suppression.	Cell	2009	59
20399811	Phosphatidylinositols	Martelli AM	The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis.	Biochimica et biophysica acta	2010	41
20668162	Phosphatidylinositols	Goodman CA	A phosphatidylinositol 3-kinase/protein kinase B-independent activation of mammalian target of rapamycin signaling is sufficient to induce skeletal muscle hypertrophy.	Molecular biology of the cell	2010	42
21628414	Phosphatidylinositols	Kuchenbauer F	Comprehensive analysis of mammalian miRNA* species and their role in myeloid cells.	Blood	2011	38
21818118	Phosphatidylinositols	Qiang L	HIF-1α is critical for hypoxia-mediated maintenance of glioblastoma stem cells by activating Notch signaling pathway.	Cell death and differentiation	2012	59
22473959	Phosphatidylinositols	Lee K	Vital roles of mTOR complex 2 in Notch-driven thymocyte differentiation and leukemia.	The Journal of experimental medicine	2012	43
22494966	Phosphatidylinositols	Torsvik A	Mesenchymal stem cell signaling in cancer progression.	Cancer treatment reviews	2013	27
24393708	Phosphatidylinositols	Francipane MG	mTOR pathway in colorectal cancer: an update.	Oncotarget	2014	31
24607406	Phosphatidylinositols	Todaro M	CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis.	Cell stem cell	2014	116
22457746	Y 27632	Liu Y	One-step derivation of mesenchymal stem cell (MSC)-like cells from human pluripotent stem cells on a fibrillar collagen coating.	PloS one	2012	33
23169653	Y 27632	Suprynowicz FA	Conditionally reprogrammed cells represent a stem-like state of adult epithelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2012	67
15550488	Sirolimus	Récher C	Antileukemic activity of rapamycin in acute myeloid leukemia.	Blood	2005	67
16763566	Sirolimus	Shahbazian D	The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity.	The EMBO journal	2006	127
16799564	Sirolimus	Androutsellis-Theotokis A	Notch signalling regulates stem cell numbers in vitro and in vivo.	Nature	2006	271
16962829	Sirolimus	Shiota C	Multiallelic disruption of the rictor gene in mice reveals that mTOR complex 2 is essential for fetal growth and viability.	Developmental cell	2006	169
17041628	Sirolimus	Easton JB	mTOR and cancer therapy.	Oncogene	2006	128
19416884	Sirolimus	Zhou J	mTOR supports long-term self-renewal and suppresses mesoderm and endoderm activities of human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2009	66
19458359	Sirolimus	Tamburini J	Protein synthesis is resistant to rapamycin and constitutes a promising therapeutic target in acute myeloid leukemia.	Blood	2009	54
19778506	Sirolimus	Kim JY	DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212.	Neuron	2009	128
20008787	Sirolimus	Kharas MG	Constitutively active AKT depletes hematopoietic stem cells and induces leukemia in mice.	Blood	2010	90
20563248	Sirolimus	Molina JR	Invasive glioblastoma cells acquire stemness and increased Akt activation.	Neoplasia	2010	62
20671809	Sirolimus	Martelli AM	The phosphatidylinositol 3-kinase/Akt/mTOR signaling network as a therapeutic target in acute myelogenous leukemia patients.	Oncotarget	2010	76
21212100	Sirolimus	Ricciardi S	Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model.	Human molecular genetics	2011	69
21289308	Sirolimus	Yoshimi A	Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.	Blood	2011	35
21415215	Sirolimus	Altman JK	Dual mTORC2/mTORC1 targeting results in potent suppressive effects on acute myeloid leukemia (AML) progenitors.	Clinical cancer research 	2011	37
21436840	Sirolimus	Martelli AM	Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway.	Leukemia	2011	52
21460795	Sirolimus	Galan-Moya EM	Secreted factors from brain endothelial cells maintain glioblastoma stem-like cell expansion through the mTOR pathway.	EMBO reports	2011	44
21898543	Sirolimus	Kim J	Erythropoietin mediated bone formation is regulated by mTOR signaling.	Journal of cellular biochemistry	2012	33
22025691	Sirolimus	Goto J	Regulable neural progenitor-specific Tsc1 loss yields giant cells with organellar dysfunction in a model of tuberous sclerosis complex.	Proceedings of the National Academy of Sciences of the United States of America	2011	61
22125056	Sirolimus	Weichhart T	Mammalian target of rapamycin: a signaling kinase for every aspect of cellular life.	Methods in molecular biology	2012	36
22473468	Sirolimus	Song MS	The functions and regulation of the PTEN tumour suppressor.	Nature reviews. Molecular cell biology	2012	494
22500797	Sirolimus	Laplante M	mTOR signaling in growth control and disease.	Cell	2012	2019
22698676	Sirolimus	Mercier I	Caveolin-1 and accelerated host aging in the breast tumor microenvironment: chemoprevention with rapamycin, an mTOR inhibitor and anti-aging drug.	The American journal of pathology	2012	68
22729283	Sirolimus	Xian L	Matrix IGF-1 maintains bone mass by activation of mTOR in mesenchymal stem cells.	Nature medicine	2012	106
22826565	Sirolimus	Zeng Z	Targeting of mTORC1/2 by the mTOR kinase inhibitor PP242 induces apoptosis in AML cells under conditions mimicking the bone marrow microenvironment.	Blood	2012	38
22958932	Sirolimus	Iglesias-Bartolome R	mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis.	Cell stem cell	2012	91
22980985	Sirolimus	Lu P	Long-distance growth and connectivity of neural stem cells after severe spinal cord injury.	Cell	2012	147
23081885	Sirolimus	Tsai V	Fetal brain mTOR signaling activation in tuberous sclerosis complex.	Cerebral cortex	2014	22
23152448	Sirolimus	Kaul A	Pediatric glioma-associated KIAA1549:BRAF expression regulates neuroglial cell growth in a cell type-specific and mTOR-dependent manner.	Genes & development	2012	33
23265840	Sirolimus	Maiese K	mTOR: on target for novel therapeutic strategies in the nervous system.	Trends in molecular medicine	2013	61
23454761	Sirolimus	Lamming DW	Rapalogs and mTOR inhibitors as anti-aging therapeutics.	The Journal of clinical investigation	2013	122
23710834	Sirolimus	Mercalli A	Rapamycin unbalances the polarization of human macrophages to M1.	Immunology	2013	36
23778311	Sirolimus	McCubrey JA	Multifaceted roles of GSK-3 and Wnt/β-catenin in hematopoiesis and leukemogenesis: opportunities for therapeutic intervention.	Leukemia	2014	41
24027431	Sirolimus	Kim JK	TBK1 regulates prostate cancer dormancy through mTOR inhibition.	Neoplasia	2013	26
24052624	Sirolimus	Wang Q	Targeting amino acid transport in metastatic castration-resistant prostate cancer: effects on cell cycle, cell growth, and tumor development.	Journal of the National Cancer Institute	2013	31
24185040	Sirolimus	Francipane MG	Selective targeting of human colon cancer stem-like cells by the mTOR inhibitor Torin-1.	Oncotarget	2013	29
24231729	Sirolimus	Matsubara S	mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions.	Scientific reports	2013	28
24311635	Sirolimus	Kahn J	The mTORC1/mTORC2 inhibitor AZD2014 enhances the radiosensitivity of glioblastoma stem-like cells.	Neuro-oncology	2014	23
24445654	Sirolimus	Chang L	Emerging roles of radioresistance in prostate cancer metastasis and radiation therapy.	Cancer metastasis reviews	2014	21
24954509	Sirolimus	Chou SD	HSF1 regulation of β-catenin in mammary cancer cells through control of HuR/elavL1 expression.	Oncogene	2015	21
25202833	Sirolimus	Hsueh AJ	Intraovarian control of early folliculogenesis.	Endocrine reviews	2015	25
25739910	Sirolimus	Mercado N	Accelerated ageing of the lung in COPD: new concepts.	Thorax	2015	33
25749036	Sirolimus	Yang H	FBXW7 suppresses epithelial-mesenchymal transition, stemness and metastatic potential of cholangiocarcinoma cells.	Oncotarget	2015	21
26147250	Sirolimus	Laberge RM	MTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation.	Nature cell biology	2015	103
26220978	Sirolimus	Awad O	Altered TFEB-mediated lysosomal biogenesis in Gaucher disease iPSC-derived neuronal cells.	Human molecular genetics	2015	22
26563133	Sirolimus	Brunstein CG	Umbilical cord blood-derived T regulatory cells to prevent GVHD: kinetics, toxicity profile, and clinical effect.	Blood	2016	46
26584640	Sirolimus	Yin Y	mTORC2 promotes type I insulin-like growth factor receptor and insulin receptor activation through the tyrosine kinase activity of mTOR.	Cell research	2016	12
27074878	Sirolimus	Scioli MG	Combined treatment with platelet-rich plasma and insulin favours chondrogenic and osteogenic differentiation of human adipose-derived stem cells in three-dimensional collagen scaffolds.	Journal of tissue engineering and regenerative medicine	2017	5
27558094	Sirolimus	Terzi MY	The cell fate: senescence or quiescence.	Molecular biology reports	2016	13
27578176	Sirolimus	Yu JS	Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.	Development	2016	21
28600802	Sirolimus	Linke M	mTORC1 and mTORC2 as regulators of cell metabolism in immunity.	FEBS letters	2017	6
17435755	Superoxides	Nagai M	Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons.	Nature neuroscience	2007	368
18334666	Superoxides	Kim DH	Heme oxygenase-mediated increases in adiponectin decrease fat content and inflammatory cytokines tumor necrosis factor-alpha and interleukin-6 in Zucker rats and reduce adipogenesis in human mesenchymal stem cells.	The Journal of pharmacology and experimental therapeutics	2008	52
18586098	Superoxides	Vercelli A	Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.	Neurobiology of disease	2008	57
19614919	Superoxides	Lee EY	Hypoxia-enhanced wound-healing function of adipose-derived stem cells: increase in stem cell proliferation and up-regulation of VEGF and bFGF.	Wound repair and regeneration 	2009	95
20458006	Superoxides	Giannotti G	Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction.	Hypertension	2010	41
21150282	Superoxides	Trimmer C	Caveolin-1 and mitochondrial SOD2 (MnSOD) function as tumor suppressors in the stromal microenvironment: a new genetically tractable model for human cancer associated fibroblasts.	Cancer biology & therapy	2011	47
21832997	Superoxides	Haidet-Phillips AM	Astrocytes from familial and sporadic ALS patients are toxic to motor neurons.	Nature biotechnology	2011	194
21969586	Superoxides	Papadeas ST	Astrocytes carrying the superoxide dismutase 1 (SOD1G93A) mutation induce wild-type motor neuron degeneration in vivo.	Proceedings of the National Academy of Sciences of the United States of America	2011	57
22416121	Superoxides	Guareschi S	An over-oxidized form of superoxide dismutase found in sporadic amyotrophic lateral sclerosis with bulbar onset shares a toxic mechanism with mutant SOD1.	Proceedings of the National Academy of Sciences of the United States of America	2012	58
24379375	Superoxides	Meyer K	Direct conversion of patient fibroblasts demonstrates non-cell autonomous toxicity of astrocytes to motor neurons in familial and sporadic ALS.	Proceedings of the National Academy of Sciences of the United States of America	2014	71
24397850	Superoxides	Choudhery MS	Donor age negatively impacts adipose tissue-derived mesenchymal stem cell expansion and differentiation.	Journal of translational medicine	2014	70
24497574	Superoxides	Yang J	Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines.	Human molecular genetics	2014	22
27001847	Superoxides	Zhang C	Hypoxia induces the breast cancer stem cell phenotype by HIF-dependent and ALKBH5-mediated m⁶A-demethylation of NANOG mRNA.	Proceedings of the National Academy of Sciences of the United States of America	2016	42
27688759	Superoxides	Ferraiuolo L	Oligodendrocytes contribute to motor neuron death in ALS via SOD1-dependent mechanism.	Proceedings of the National Academy of Sciences of the United States of America	2016	11
19071168	alginic acid	Wang X	Growth factor gradients via microsphere delivery in biopolymer scaffolds for osteochondral tissue engineering.	Journal of controlled release 	2009	73
19715387	alginic acid	Diekman BO	Chondrogenesis of adult stem cells from adipose tissue and bone marrow: induction by growth factors and cartilage-derived matrix.	Tissue engineering. Part A	2010	69
20570346	alginic acid	Zhao L	An injectable calcium phosphate-alginate hydrogel-umbilical cord mesenchymal stem cell paste for bone tissue engineering.	Biomaterials	2010	65
21652067	alginic acid	Bian L	Enhanced MSC chondrogenesis following delivery of TGF-β3 from alginate microspheres within hyaluronic acid hydrogels in vitro and in vivo.	Biomaterials	2011	63
21757229	alginic acid	Zhou H	The fast release of stem cells from alginate-fibrin microbeads in injectable scaffolds for bone tissue engineering.	Biomaterials	2011	37
22136718	alginic acid	Gaetani R	Cardiac tissue engineering using tissue printing technology and human cardiac progenitor cells.	Biomaterials	2012	37
22241609	alginic acid	Wei Y	Chondrogenic differentiation of induced pluripotent stem cells from osteoarthritic chondrocytes in alginate matrix.	European cells & materials	2012	31
16227573	Adenosine	Wu L	Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells.	Molecular and cellular biology	2005	104
19716791	Adenosine	Chen LL	Altered nuclear retention of mRNAs containing inverted repeats in human embryonic stem cells: functional role of a nuclear noncoding RNA.	Molecular cell	2009	192
21590734	Adenosine	Gharibi B	Adenosine receptor subtype expression and activation influence the differentiation of mesenchymal stem cells to osteoblasts and adipocytes.	Journal of bone and mineral research 	2011	36
22968453	Adenosine	Candotti F	Gene therapy for adenosine deaminase-deficient severe combined immune deficiency: clinical comparison of retroviral vectors and treatment plans.	Blood	2012	59
23275297	Adenosine	Jiang Q	ADAR1 promotes malignant progenitor reprogramming in chronic myeloid leukemia.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
23592612	Adenosine	Boison D	Adenosine kinase: exploitation for therapeutic gain.	Pharmacological reviews	2013	44
24395775	Adenosine	Shih YR	Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling.	Proceedings of the National Academy of Sciences of the United States of America	2014	34
25708366	Adenosine	Chen T	ADAR1 is required for differentiation and neural induction by regulating microRNA processing in a catalytically independent manner.	Cell research	2015	15
25860576	Adenosine	Cicalese MP	Clinical applications of gene therapy for primary immunodeficiencies.	Human gene therapy	2015	17
27129325	Adenosine	Cicalese MP	Update on the safety and efficacy of retroviral gene therapy for immunodeficiency due to adenosine deaminase deficiency.	Blood	2016	20
27595325	Adenosine	Stellos K	Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation.	Nature medicine	2016	18
16239320	gemcitabine	Haraguchi N	Characterization of a side population of cancer cells from human gastrointestinal system.	Stem cells	2006	170
17332349	gemcitabine	Feldmann G	Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers.	Cancer research	2007	242
17909916	gemcitabine	Shah AN	Development and characterization of gemcitabine-resistant pancreatic tumor cells.	Annals of surgical oncology	2007	152
19174553	gemcitabine	Jimeno A	A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.	Molecular cancer therapeutics	2009	104
19276344	gemcitabine	Wang Z	Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway.	Cancer research	2009	195
19501590	gemcitabine	Mueller MT	Combined targeted treatment to eliminate tumorigenic cancer stem cells in human pancreatic cancer.	Gastroenterology	2009	81
19598259	gemcitabine	Hong SP	CD44-positive cells are responsible for gemcitabine resistance in pancreatic cancer cells.	International journal of cancer	2009	80
21045835	gemcitabine	Singh S	CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy.	British journal of cancer	2010	59
21408027	gemcitabine	Bao B	Anti-tumor activity of a novel compound-CDF is mediated by regulating miR-21, miR-200, and PTEN in pancreatic cancer.	PloS one	2011	73
22056140	gemcitabine	Lonardo E	Nodal/Activin signaling drives self-renewal and tumorigenicity of pancreatic cancer stem cells and provides a target for combined drug therapy.	Cell stem cell	2011	102
22086681	gemcitabine	Bao B	Metformin inhibits cell proliferation, migration and invasion by attenuating CSC function mediated by deregulating miRNAs in pancreatic cancer cells.	Cancer prevention research	2012	101
22510406	gemcitabine	Hamada S	Pancreatic stellate cells enhance stem cell-like phenotypes in pancreatic cancer cells.	Biochemical and biophysical research communications	2012	46
23402814	gemcitabine	Yabuuchi S	Notch signaling pathway targeted therapy suppresses tumor progression and metastatic spread in pancreatic cancer.	Cancer letters	2013	41
23437065	gemcitabine	Proctor E	Bmi1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma.	PloS one	2013	32
23661005	gemcitabine	Hage C	The novel c-Met inhibitor cabozantinib overcomes gemcitabine resistance and stem cell signaling in pancreatic cancer.	Cell death & disease	2013	39
23849556	gemcitabine	Heinemann V	Tumour-stroma interactions in pancreatic ductal adenocarcinoma: rationale and current evidence for new therapeutic strategies.	Cancer treatment reviews	2014	30
24178759	gemcitabine	Maftouh M	Synergistic interaction of novel lactate dehydrogenase inhibitors with gemcitabine against pancreatic cancer cells in hypoxia.	British journal of cancer	2014	23
24216611	gemcitabine	Hamada S	MiR-365 induces gemcitabine resistance in pancreatic cancer cells by targeting the adaptor protein SHC1 and pro-apoptotic regulator BAX.	Cellular signalling	2014	25
25034785	gemcitabine	Zeuner A	Elimination of quiescent/slow-proliferating cancer stem cells by Bcl-XL inhibition in non-small cell lung cancer.	Cell death and differentiation	2014	27
25117811	gemcitabine	Hasegawa S	MicroRNA-1246 expression associated with CCNG2-mediated chemoresistance and stemness in pancreatic cancer.	British journal of cancer	2014	27
25278454	gemcitabine	Kim EJ	Pilot clinical trial of hedgehog pathway inhibitor GDC-0449 (vismodegib) in combination with gemcitabine in patients with metastatic pancreatic adenocarcinoma.	Clinical cancer research 	2014	36
25453096	gemcitabine	Samanta D	Hypoxia-inducible factors are required for chemotherapy resistance of breast cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	69
25473894	gemcitabine	Suzuki S	JNK suppression of chemotherapeutic agents-induced ROS confers chemoresistance on pancreatic cancer stem cells.	Oncotarget	2015	18
25717063	gemcitabine	Cioffi M	Inhibition of CD47 Effectively Targets Pancreatic Cancer Stem Cells via Dual Mechanisms.	Clinical cancer research 	2015	20
25887381	gemcitabine	Cioffi M	The miR-17-92 cluster counteracts quiescence and chemoresistance in a distinct subpopulation of pancreatic cancer stem cells.	Gut	2015	24
25934888	gemcitabine	Yen WC	Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.	Clinical cancer research 	2015	42
26458814	gemcitabine	Yang MC	Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine.	Molecular cancer	2015	25
26546043	gemcitabine	Tyagi N	p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling.	Cancer letters	2016	13
27216178	gemcitabine	Schultz MJ	The Tumor-Associated Glycosyltransferase ST6Gal-I Regulates Stem Cell Transcription Factors and Confers a Cancer Stem Cell Phenotype.	Cancer research	2016	12
27576197	gemcitabine	Zhang Z	Gemcitabine treatment promotes pancreatic cancer stemness through the Nox/ROS/NF-κB/STAT3 signaling cascade.	Cancer letters	2016	18
15161665	Reactive Oxygen Species	Dernbach E	Antioxidative stress-associated genes in circulating progenitor cells: evidence for enhanced resistance against oxidative stress.	Blood	2004	91
17179479	Reactive Oxygen Species	Phillips TM	The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation.	Journal of the National Cancer Institute	2006	416
19118493	Reactive Oxygen Species	Zhang H	Role of TNF-alpha in vascular dysfunction.	Clinical science	2009	108
19285945	Reactive Oxygen Species	Gandhi S	PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calcium-induced cell death.	Molecular cell	2009	170
19543237	Reactive Oxygen Species	Huang H	IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling.	Cell death and differentiation	2009	49
20073085	Reactive Oxygen Species	Armstrong L	Human induced pluripotent stem cell lines show stress defense mechanisms and mitochondrial regulation similar to those of human embryonic stem cells.	Stem cells	2010	89
20574517	Reactive Oxygen Species	Venkataraman S	MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence.	PloS one	2010	55
20618067	Reactive Oxygen Species	Storz P	Forkhead homeobox type O transcription factors in the responses to oxidative stress.	Antioxidants & redox signaling	2011	74
20861671	Reactive Oxygen Species	Lisanti MP	Understanding the "lethal" drivers of tumor-stroma co-evolution: emerging role(s) for hypoxia, oxidative stress and autophagy/mitophagy in the tumor micro-environment.	Cancer biology & therapy	2010	66
21211782	Reactive Oxygen Species	Le Belle JE	Proliferative neural stem cells have high endogenous ROS levels that regulate self-renewal and neurogenesis in a PI3K/Akt-dependant manner.	Cell stem cell	2011	168
21235356	Reactive Oxygen Species	Giannoni E	Cancer associated fibroblasts exploit reactive oxygen species through a proinflammatory signature leading to epithelial mesenchymal transition and stemness.	Antioxidants & redox signaling	2011	50
21411759	Reactive Oxygen Species	Zou J	Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting.	Blood	2011	91
21567162	Reactive Oxygen Species	Shao L	Reactive oxygen species and hematopoietic stem cell senescence.	International journal of hematology	2011	39
21878644	Reactive Oxygen Species	Achuthan S	Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species.	The Journal of biological chemistry	2011	47
22079466	Reactive Oxygen Species	Piao LS	CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma.	Cancer letters	2012	53
22411871	Reactive Oxygen Species	Nieborowska-Skorska M	Rac2-MRC-cIII-generated ROS cause genomic instability in chronic myeloid leukemia stem cells and primitive progenitors.	Blood	2012	32
22607099	Reactive Oxygen Species	Lee S	Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.	Antioxidants & redox signaling	2013	51
23025577	Reactive Oxygen Species	Higuchi M	Differentiation of human adipose-derived stem cells into fat involves reactive oxygen species and Forkhead box O1 mediated upregulation of antioxidant enzymes.	Stem cells and development	2013	33
23085514	Reactive Oxygen Species	Urao N	Redox regulation of stem/progenitor cells and bone marrow niche.	Free radical biology & medicine	2013	44
23117019	Reactive Oxygen Species	Maryanovich M	A ROS rheostat for cell fate regulation.	Trends in cell biology	2013	34
23333149	Reactive Oxygen Species	Lagadinou ED	BCL-2 inhibition targets oxidative phosphorylation and selectively eradicates quiescent human leukemia stem cells.	Cell stem cell	2013	142
23334333	Reactive Oxygen Species	Nagano O	Redox regulation in stem-like cancer cells by CD44 variant isoforms.	Oncogene	2013	62
23492768	Reactive Oxygen Species	Wang K	Redox homeostasis: the linchpin in stem cell self-renewal and differentiation.	Cell death & disease	2013	53
23954870	Reactive Oxygen Species	Zuo L	The impact of reactive oxygen species and genetic mitochondrial mutations in Parkinson's disease.	Gene	2013	40
24070090	Reactive Oxygen Species	Maugeri N	Oxidative stress elicits platelet/leukocyte inflammatory interactions via HMGB1: a candidate for microvessel injury in sytemic sclerosis.	Antioxidants & redox signaling	2014	22
24080946	Reactive Oxygen Species	Stankov MV	Histone deacetylase inhibitors induce apoptosis in myeloid leukemia by suppressing autophagy.	Leukemia	2014	21
24095676	Reactive Oxygen Species	Rouault-Pierre K	HIF-2α protects human hematopoietic stem/progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress.	Cell stem cell	2013	32
24121277	Reactive Oxygen Species	Venere M	Therapeutic targeting of constitutive PARP activation compromises stem cell phenotype and survival of glioblastoma-initiating cells.	Cell death and differentiation	2014	37
24133204	Reactive Oxygen Species	Kang T	MicroRNA-27 (miR-27) targets prohibitin and impairs adipocyte differentiation and mitochondrial function in human adipose-derived stem cells.	The Journal of biological chemistry	2013	33
24185179	Reactive Oxygen Species	Sato A	Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.	Stem cell research	2014	26
24659476	Reactive Oxygen Species	Gharibi B	Inhibition of Akt/mTOR attenuates age-related changes in mesenchymal stem cells.	Stem cells	2014	23
24675724	Reactive Oxygen Species	Tian FJ	Elevated microRNA-155 promotes foam cell formation by targeting HBP1 in atherogenesis.	Cardiovascular research	2014	24
24813252	Reactive Oxygen Species	Wang G	Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies.	Nature medicine	2014	139
24836575	Reactive Oxygen Species	Schwab L	Neutrophil granulocytes recruited upon translocation of intestinal bacteria enhance graft-versus-host disease via tissue damage.	Nature medicine	2014	30
25253673	Reactive Oxygen Species	Ebert AD	Characterization of the molecular mechanisms underlying increased ischemic damage in the aldehyde dehydrogenase 2 genetic polymorphism using a human induced pluripotent stem cell model system.	Science translational medicine	2014	27
25406339	Reactive Oxygen Species	Kawakami T	Deficient Autophagy Results in Mitochondrial Dysfunction and FSGS.	Journal of the American Society of Nephrology 	2015	27
25541259	Reactive Oxygen Species	Mizuno T	Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species.	Gynecologic oncology	2015	24
25603196	Reactive Oxygen Species	Atashi F	The role of reactive oxygen species in mesenchymal stem cell adipogenic and osteogenic differentiation: a review.	Stem cells and development	2015	46
26078812	Reactive Oxygen Species	Krstić J	Transforming Growth Factor-Beta and Oxidative Stress Interplay: Implications in Tumorigenesis and Cancer Progression.	Oxidative medicine and cellular longevity	2015	22
26319899	Reactive Oxygen Species	Xu X	Aldehyde dehydrogenases and cancer stem cells.	Cancer letters	2015	19
26627594	Reactive Oxygen Species	Qian P	The Dlk1-Gtl2 Locus Preserves LT-HSC Function by Inhibiting the PI3K-mTOR Pathway to Restrict Mitochondrial Metabolism.	Cell stem cell	2016	19
26682001	Reactive Oxygen Species	Ryoo IG	Redox Modulating NRF2: A Potential Mediator of Cancer Stem Cell Resistance.	Oxidative medicine and cellular longevity	2016	12
26904936	Reactive Oxygen Species	Hawkins KE	NRF2 Orchestrates the Metabolic Shift during Induced Pluripotent Stem Cell Reprogramming.	Cell reports	2016	17
27392575	Reactive Oxygen Species	Safiedeen Z	Temporal Cross Talk Between Endoplasmic Reticulum and Mitochondria Regulates Oxidative Stress and Mediates Microparticle-Induced Endothelial Dysfunction.	Antioxidants & redox signaling	2017	5
18371436	Doxycycline	Brambrink T	Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.	Cell stem cell	2008	256
18786420	Doxycycline	Maherali N	A high-efficiency system for the generation and study of human induced pluripotent stem cells.	Cell stem cell	2008	167
21098095	Doxycycline	Takayama N	Transient activation of c-MYC expression is critical for efficient platelet generation from human induced pluripotent stem cells.	The Journal of experimental medicine	2010	89
22615765	Doxycycline	Chen S	SOX2 gene regulates the transcriptional network of oncogenes and affects tumorigenesis of human lung cancer cells.	PloS one	2012	49
23080539	Doxycycline	Koch CM	Pluripotent stem cells escape from senescence-associated DNA methylation changes.	Genome research	2013	32
26087309	Doxycycline	Lamb R	Doxycycline down-regulates DNA-PK and radiosensitizes tumor initiating cells: Implications for more effective radiation therapy.	Oncotarget	2015	27
26091037	Doxycycline	Dow LE	Apc Restoration Promotes Cellular Differentiation and Reestablishes Crypt Homeostasis in Colorectal Cancer.	Cell	2015	80
28264028	Doxycycline	Xu P	Parvovirus B19 NS1 protein induces cell cycle arrest at G2-phase by activating the ATR-CDC25C-CDK1 pathway.	PLoS pathogens	2017	6
16458961	Durapatite	Li C	Electrospun silk-BMP-2 scaffolds for bone tissue engineering.	Biomaterials	2006	143
15130492	trichostatin A	Iezzi S	Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin.	Developmental cell	2004	71
17158926	trichostatin A	Grégoire S	Histone deacetylase 3 interacts with and deacetylates myocyte enhancer factor 2.	Molecular and cellular biology	2007	74
19700647	trichostatin A	Guo W	Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition.	American journal of physiology. Lung cellular and molecular physiology	2009	69
23085757	trichostatin A	Su SF	miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer.	Oncogene	2013	42
19689470	Histone Deacetylase Inhibitors	Lee S	Histone deacetylase inhibitors decrease proliferation potential and multilineage differentiation capability of human mesenchymal stem cells.	Cell proliferation	2009	46
20686575	Histone Deacetylase Inhibitors	Garcia-Perez JL	Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells.	Nature	2010	60
24623855	Histone Deacetylase Inhibitors	Ware CB	Derivation of naive human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	108
25159818	Histone Deacetylase Inhibitors	Soragni E	Epigenetic therapy for Friedreich ataxia.	Annals of neurology	2014	26
26977882	Histone Deacetylase Inhibitors	Pei Y	HDAC and PI3K Antagonists Cooperate to Inhibit Growth of MYC-Driven Medulloblastoma.	Cancer cell	2016	19
15743839	maxacalcitol	Kuroda T	Octamer and Sox elements are required for transcriptional cis regulation of Nanog gene expression.	Molecular and cellular biology	2005	143
15860457	maxacalcitol	Rodda DJ	Transcriptional regulation of nanog by OCT4 and SOX2.	The Journal of biological chemistry	2005	283
16153702	maxacalcitol	Boyer LA	Core transcriptional regulatory circuitry in human embryonic stem cells.	Cell	2005	1387
16228988	maxacalcitol	Ezeh UI	Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma.	Cancer	2005	115
18029452	maxacalcitol	Yu J	Induced pluripotent stem cell lines derived from human somatic cells.	Science	2007	2852
18056451	maxacalcitol	Eastham AM	Epithelial-mesenchymal transition events during human embryonic stem cell differentiation.	Cancer research	2007	81
18583537	maxacalcitol	Bar M	MicroRNA discovery and profiling in human embryonic stem cells by deep sequencing of small RNA libraries.	Stem cells	2008	133
18597617	maxacalcitol	Lin G	Defining stem and progenitor cells within adipose tissue.	Stem cells and development	2008	102
18682241	maxacalcitol	Xu RH	NANOG is a direct target of TGFbeta/activin-mediated SMAD signaling in human ESCs.	Cell stem cell	2008	154
18787205	maxacalcitol	Atlasi Y	OCT4 spliced variants are differentially expressed in human pluripotent and nonpluripotent cells.	Stem cells	2008	77
19480567	maxacalcitol	Kashyap V	Regulation of stem cell pluripotency and differentiation involves a mutual regulatory circuit of the NANOG, OCT4, and SOX2 pluripotency transcription factors with polycomb repressive complexes and stem cell microRNAs.	Stem cells and development	2009	115
19696409	maxacalcitol	Martinez-Fernandez A	iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.	Circulation research	2009	51
19770585	maxacalcitol	Heddleston JM	The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype.	Cell cycle	2009	220
20027182	maxacalcitol	Bhutani N	Reprogramming towards pluripotency requires AID-dependent DNA demethylation.	Nature	2010	263
21245162	maxacalcitol	Teo AK	Pluripotency factors regulate definitive endoderm specification through eomesodermin.	Genes & development	2011	93
21266967	maxacalcitol	Tsutsui H	An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells.	Nature communications	2011	54
21512136	maxacalcitol	King CE	LIN28B promotes colon cancer progression and metastasis.	Cancer research	2011	93
21712410	maxacalcitol	Mathieu J	HIF induces human embryonic stem cell markers in cancer cells.	Cancer research	2011	146
22869753	maxacalcitol	Margariti A	Direct reprogramming of fibroblasts into endothelial cells capable of angiogenesis and reendothelialization in tissue-engineered vessels.	Proceedings of the National Academy of Sciences of the United States of America	2012	73
9780338	fludarabine	Aversa F	Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype.	The New England journal of medicine	1998	127
12662126	fludarabine	Plosker GL	Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.	Drugs	2003	78
12791654	fludarabine	Maris MB	HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies.	Blood	2003	79
15753458	fludarabine	Aversa F	Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse.	Journal of clinical oncology 	2005	123
18411419	fludarabine	Khouri IF	Eight-year experience with allogeneic stem cell transplantation for relapsed follicular lymphoma after nonmyeloablative conditioning with fludarabine, cyclophosphamide, and rituximab.	Blood	2008	92
18950462	fludarabine	Shi J	Infusion of haplo-identical killer immunoglobulin-like receptor ligand mismatched NK cells for relapsed myeloma in the setting of autologous stem cell transplantation.	British journal of haematology	2008	52
21791425	fludarabine	Curti A	Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients.	Blood	2011	81
22343376	fludarabine	Kamani NR	Unrelated donor cord blood transplantation for children with severe sickle cell disease: results of one cohort from the phase II study from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN).	Biology of blood and marrow transplantation 	2012	31
22796535	fludarabine	Ciurea SO	Improved early outcomes using a T cell replete graft compared with T cell depleted haploidentical hematopoietic stem cell transplantation.	Biology of blood and marrow transplantation 	2012	36
23720127	fludarabine	Hallek M	Chronic lymphocytic leukemia: 2013 update on diagnosis, risk stratification and treatment.	American journal of hematology	2013	38
25319501	fludarabine	Lee DW	T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial.	Lancet	2015	367
26002963	fludarabine	Treon SP	How I treat Waldenström macroglobulinemia.	Blood	2015	15
26764356	fludarabine	Mielcarek M	Posttransplantation cyclophosphamide for prevention of graft-versus-host disease after HLA-matched mobilized blood cell transplantation.	Blood	2016	11
28291388	fludarabine	Kochenderfer JN	Lymphoma Remissions Caused by Anti-CD19 Chimeric Antigen Receptor T Cells Are Associated With High Serum Interleukin-15 Levels.	Journal of clinical oncology 	2017	13
22113611	polyglutamine	Koch P	Excitation-induced ataxin-3 aggregation in neurons from patients with Machado-Joseph disease.	Nature	2011	80
22613578	polyglutamine	Juopperi TA	Astrocytes generated from patient induced pluripotent stem cells recapitulate features of Huntington's disease patient cells.	Molecular brain	2012	72
22748967	polyglutamine	An MC	Genetic correction of Huntington's disease phenotypes in induced pluripotent stem cells.	Cell stem cell	2012	96
24584051	polyglutamine	Crotti A	Mutant Huntingtin promotes autonomous microglia activation via myeloid lineage-determining factors.	Nature neuroscience	2014	57
25108912	polyglutamine	Cortes CJ	Polyglutamine-expanded androgen receptor interferes with TFEB to elicit autophagy defects in SBMA.	Nature neuroscience	2014	27
20599449	arsenic trioxide	Essers MA	Targeting leukemic stem cells by breaking their dormancy.	Molecular oncology	2010	51
20624968	arsenic trioxide	Kim J	Arsenic antagonizes the Hedgehog pathway by preventing ciliary accumulation and reducing stability of the Gli2 transcriptional effector.	Proceedings of the National Academy of Sciences of the United States of America	2010	80
22041887	arsenic trioxide	Martinez-Outschoorn UE	Anti-estrogen resistance in breast cancer is induced by the tumor microenvironment and can be overcome by inhibiting mitochondrial function in epithelial cancer cells.	Cancer biology & therapy	2011	49
24859340	arsenic trioxide	Sweeney RT	Identification of recurrent SMO and BRAF mutations in ameloblastomas.	Nature genetics	2014	26
16192477	Antilymphocyte Serum	Lowsky R	Protective conditioning for acute graft-versus-host disease.	The New England journal of medicine	2005	87
22405058	Antilymphocyte Serum	Scandling JD	Tolerance and withdrawal of immunosuppressive drugs in patients given kidney and hematopoietic cell transplants.	American journal of transplantation 	2012	54
24419525	Antilymphocyte Serum	Baron F	Impact of in vivo T-cell depletion on outcome of AML patients in first CR given peripheral blood stem cells and reduced-intensity conditioning allo-SCT from a HLA-identical sibling donor: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.	Bone marrow transplantation	2014	23
12138111	Cytosine	Chen T	A novel Dnmt3a isoform produced from an alternative promoter localizes to euchromatin and its expression correlates with active de novo methylation.	The Journal of biological chemistry	2002	95
16253997	Cytosine	Lee JH	CpG-binding protein (CXXC finger protein 1) is a component of the mammalian Set1 histone H3-Lys4 methyltransferase complex, the analogue of the yeast Set1/COMPASS complex.	The Journal of biological chemistry	2005	114
18369324	Cytosine	Aboody KS	Stem and progenitor cell-mediated tumor selective gene therapy.	Gene therapy	2008	88
21347436	Cytosine	Koch CM	Specific age-associated DNA methylation changes in human dermal fibroblasts.	PloS one	2011	41
21925312	Cytosine	Bhutani N	DNA demethylation dynamics.	Cell	2011	184
22174693	Cytosine	Ziller MJ	Genomic distribution and inter-sample variation of non-CpG methylation across human cell types.	PLoS genetics	2011	124
22898819	Cytosine	Chen CC	The mammalian de novo DNA methyltransferases DNMT3A and DNMT3B are also DNA 5-hydroxymethylcytosine dehydroxymethylases.	The Journal of biological chemistry	2012	51
23871666	Cytosine	Hussain S	NSun2-mediated cytosine-5 methylation of vault noncoding RNA determines its processing into regulatory small RNAs.	Cell reports	2013	69
25893293	Cytosine	Fan H	Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.	Oncogene	2016	12
26436839	Cytosine	Okoye-Okafor UC	New IDH1 mutant inhibitors for treatment of acute myeloid leukemia.	Nature chemical biology	2015	25
27979915	Cytosine	Portnow J	Neural Stem Cell-Based Anticancer Gene Therapy: A First-in-Human Study in Recurrent High-Grade Glioma Patients.	Clinical cancer research 	2017	7
15229356	Azacitidine	Xu W	Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro.	Experimental biology and medicine	2004	71
15579650	Azacitidine	Wang HS	Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord.	Stem cells	2004	251
20810283	Azacitidine	De Carvalho DD	DNA methylation and cellular reprogramming.	Trends in cell biology	2010	62
21572997	Azacitidine	So AY	DNA methyltransferase controls stem cell aging by regulating BMI1 and EZH2 through microRNAs.	PloS one	2011	41
21886171	Azacitidine	Platzbecker U	Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.	Leukemia	2012	46
22069467	Azacitidine	Alonso MM	Genetic and epigenetic modifications of Sox2 contribute to the invasive phenotype of malignant gliomas.	PloS one	2011	54
22234690	Azacitidine	Goodyear OC	Azacitidine augments expansion of regulatory T cells after allogeneic stem cell transplantation in patients with acute myeloid leukemia (AML).	Blood	2012	44
22753872	Azacitidine	Will B	Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations.	Blood	2012	46
23391309	Azacitidine	Chong JJ	Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart.	Stem cells and development	2013	35
25336400	Azacitidine	Chen WC	Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity.	Stem cells	2015	28
25564399	Azacitidine	Locatelli F	How I treat juvenile myelomonocytic leukemia.	Blood	2015	22
26160102	Azacitidine	Haag S	NSUN6 is a human RNA methyltransferase that catalyzes formation of m5C72 in specific tRNAs.	RNA	2015	22
27197203	Azacitidine	Pathania R	Combined Inhibition of DNMT and HDAC Blocks the Tumorigenicity of Cancer Stem-like Cells and Attenuates Mammary Tumor Growth.	Cancer research	2016	13
21559013	docetaxel	Lee HE	An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancer.	British journal of cancer	2011	50
22387005	docetaxel	Shien K	Prognostic impact of cancer stem cell-related markers in non-small cell lung cancer patients treated with induction chemoradiotherapy.	Lung cancer	2012	33
22975379	docetaxel	Domingo-Domenech J	Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells.	Cancer cell	2012	120
23041061	docetaxel	Puhr M	Epithelial-to-mesenchymal transition leads to docetaxel resistance in prostate cancer and is mediated by reduced expression of miR-200c and miR-205.	The American journal of pathology	2012	68
23041621	docetaxel	Qiu M	Specific inhibition of Notch1 signaling enhances the antitumor efficacy of chemotherapy in triple negative breast cancer through reduction of cancer stem cells.	Cancer letters	2013	26
23340294	docetaxel	Schott AF	Preclinical and clinical studies of gamma secretase inhibitors with docetaxel on human breast tumors.	Clinical cancer research 	2013	44
23368632	docetaxel	Chen J	Evaluation of characteristics of CD44+CD117+ ovarian cancer stem cells in three dimensional basement membrane extract scaffold versus two dimensional monocultures.	BMC cell biology	2013	26
24008666	docetaxel	Liu P	Disulfiram targets cancer stem-like cells and reverses resistance and cross-resistance in acquired paclitaxel-resistant triple-negative breast cancer cells.	British journal of cancer	2013	26
24577057	docetaxel	Liu Y	Lack of correlation of stem cell markers in breast cancer stem cells.	British journal of cancer	2014	24
24659820	docetaxel	Marín-Aguilera M	Epithelial-to-mesenchymal transition mediates docetaxel resistance and high risk of relapse in prostate cancer.	Molecular cancer therapeutics	2014	27
24985346	docetaxel	Ono M	Exosomes from bone marrow mesenchymal stem cells contain a microRNA that promotes dormancy in metastatic breast cancer cells.	Science signaling	2014	105
9465086	Glycosylphosphatidylinositols	Reiter RE	Prostate stem cell antigen: a cell surface marker overexpressed in prostate cancer.	Proceedings of the National Academy of Sciences of the United States of America	1998	150
17989688	Glycosylphosphatidylinositols	Rother RP	Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria.	Nature biotechnology	2007	116
20501618	Glycosylphosphatidylinositols	Saeki N	Prostate stem cell antigen: a Jekyll and Hyde molecule?	Clinical cancer research 	2010	49
21482678	Glycosylphosphatidylinositols	Overdevest JB	CD24 offers a therapeutic target for control of bladder cancer metastasis based on a requirement for lung colonization.	Cancer research	2011	38
27903532	Glycosylphosphatidylinositols	Corat MA	Acquired somatic mutations in PNH reveal long-term maintenance of adaptive NK cells independent of HSPCs.	Blood	2017	6
19075754	Acetaldehyde	Moreb JS	Aldehyde dehydrogenase as a marker for stem cells.	Current stem cell research & therapy	2008	79
20010854	Acetaldehyde	Li T	ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome.	Laboratory investigation; a journal of technical methods and pathology	2010	111
24037726	Acetaldehyde	Hira A	Variant ALDH2 is associated with accelerated progression of bone marrow failure in Japanese Fanconi anemia patients.	Blood	2013	30
24907115	Acetaldehyde	Shao C	Essential role of aldehyde dehydrogenase 1A3 for the maintenance of non-small cell lung cancer stem cells is associated with the STAT3 pathway.	Clinical cancer research 	2014	34
25155611	Acetaldehyde	Oberbeck N	Maternal aldehyde elimination during pregnancy preserves the fetal genome.	Molecular cell	2014	21
25827713	Acetaldehyde	Thiagarajan PS	Development of a Fluorescent Reporter System to Delineate Cancer Stem Cells in Triple-Negative Breast Cancer.	Stem cells	2015	18
26184171	Acetaldehyde	Scarpa ES	Phytochemicals as Innovative Therapeutic Tools against Cancer Stem Cells.	International journal of molecular sciences	2015	16
26387544	Acetaldehyde	Meads MB	Targeting PYK2 mediates microenvironment-specific cell death in multiple myeloma.	Oncogene	2016	11
26783961	Acetaldehyde	Tomita H	Aldehyde dehydrogenase 1A1 in stem cells and cancer.	Oncotarget	2016	47
27270422	Acetaldehyde	Lu J	MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1.	Oncogene	2017	8
27634934	Acetaldehyde	Keysar SB	Regulation of Head and Neck Squamous Cancer Stem Cells by PI3K and SOX2.	Journal of the National Cancer Institute	2017	8
20357375	Metformin	Fadini GP	The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.	Diabetes care	2010	70
20458531	Metformin	Vazquez-Martin A	The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells.	Breast cancer research and treatment	2011	68
20668229	Metformin	Green AS	The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation.	Blood	2010	53
20890129	Metformin	Vazquez-Martin A	Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status.	Cell cycle	2010	75
21088486	Metformin	Cufí S	Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.	Cell cycle	2010	75
21220315	Metformin	Iliopoulos D	Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion.	Proceedings of the National Academy of Sciences of the United States of America	2011	186
21368581	Metformin	Oliveras-Ferraros C	Micro(mi)RNA expression profile of breast cancer epithelial cells treated with the anti-diabetic drug metformin: induction of the tumor suppressor miRNA let-7a and suppression of the TGFβ-induced oncomiR miRNA-181a.	Cell cycle	2011	41
22134189	Metformin	Whitaker-Menezes D	Hyperactivation of oxidative mitochondrial metabolism in epithelial cancer cells in situ: visualizing the therapeutic effects of metformin in tumor tissue.	Cell cycle	2011	79
22189713	Metformin	Deng XS	Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers.	Cell cycle	2012	51
22203527	Metformin	Del Barco S	Metformin: multi-faceted protection against cancer.	Oncotarget	2011	100
22500211	Metformin	Song CW	Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells.	Scientific reports	2012	70
22565037	Metformin	Cufi S	Metformin-induced preferential killing of breast cancer initiating CD44+CD24-/low cells is sufficient to overcome primary resistance to trastuzumab in HER2+ human breast cancer xenografts.	Oncotarget	2012	67
22770240	Metformin	Wang J	Metformin activates an atypical PKC-CBP pathway to promote neurogenesis and enhance spatial memory formation.	Cell stem cell	2012	75
23070475	Metformin	Salem AF	Mitochondrial biogenesis in epithelial cancer cells promotes breast cancer tumor growth and confers autophagy resistance.	Cell cycle	2012	35
23255107	Metformin	Würth R	Metformin selectively affects human glioblastoma tumor-initiating cell viability: A role for metformin-induced inhibition of Akt.	Cell cycle	2013	57
23287468	Metformin	Vazquez-Martin A	The mitochondrial H(+)-ATP synthase and the lipogenic switch: new core components of metabolic reprogramming in induced pluripotent stem (iPS) cells.	Cell cycle	2013	29
23667692	Metformin	Gou S	Low concentrations of metformin selectively inhibit CD133⁺ cell proliferation in pancreatic cancer and have anticancer action.	PloS one	2013	33
24204632	Metformin	Lonardo E	Metformin targets the metabolic achilles heel of human pancreatic cancer stem cells.	PloS one	2013	47
24322659	Metformin	Zhu P	Metformin selectively targets tumor-initiating cells in ErbB2-overexpressing breast cancer models.	Cancer prevention research	2014	24
24419232	Metformin	Dallaglio K	Paradoxic effects of metformin on endothelial cells and angiogenesis.	Carcinogenesis	2014	26
25002509	Metformin	Janzer A	Metformin and phenformin deplete tricarboxylic acid cycle and glycolytic intermediates during cell transformation and NTPs in cancer stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2014	57
25088204	Metformin	Yan L	Regulation of tumor cell migration and invasion by the H19/let-7 axis is antagonized by metformin-induced DNA methylation.	Oncogene	2015	53
25361004	Metformin	Gritti M	Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current.	Oncotarget	2014	33
26065921	Metformin	Takahashi RU	Loss of microRNA-27b contributes to breast cancer stem cell generation by activating ENPP1.	Nature communications	2015	19
26365176	Metformin	Sancho P	MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.	Cell metabolism	2015	64
27378194	Metformin	Gadducci A	Metformin use and gynecological cancers: A novel treatment option emerging from drug repositioning.	Critical reviews in oncology/hematology	2016	11
15128896	Busulfan	Staba SL	Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.	The New England journal of medicine	2004	83
17062750	Busulfan	Mostoslavsky G	Complete correction of murine Artemis immunodeficiency by lentiviral vector-mediated gene transfer.	Proceedings of the National Academy of Sciences of the United States of America	2006	61
17182671	Busulfan	Gorantla S	Human immunodeficiency virus type 1 pathobiology studied in humanized BALB/c-Rag2-/-gammac-/- mice.	Journal of virology	2007	71
17882221	Busulfan	Seandel M	Generation of functional multipotent adult stem cells from GPR125+ germline progenitors.	Nature	2007	123
21349855	Busulfan	Izadyar F	Identification and characterization of repopulating spermatogonial stem cells from the adult human testis.	Human reproduction	2011	37
25310256	Busulfan	Wilson EM	Extensive double humanization of both liver and hematopoiesis in FRGN mice.	Stem cell research	2014	31
27099176	Busulfan	De Ravin SS	Lentiviral hematopoietic stem cell gene therapy for X-linked severe combined immunodeficiency.	Science translational medicine	2016	18
27289174	Busulfan	Sessa M	Lentiviral haemopoietic stem-cell gene therapy in early-onset metachromatic leukodystrophy: an ad-hoc analysis of a non-randomised, open-label, phase 1/2 trial.	Lancet	2016	22
18568017	Valproic Acid	Huangfu D	Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds.	Nature biotechnology	2008	467
18849973	Valproic Acid	Huangfu D	Induction of pluripotent stem cells from primary human fibroblasts with only Oct4 and Sox2.	Nature biotechnology	2008	402
22760542	Valproic Acid	Moschidou D	Valproic acid confers functional pluripotency to human amniotic fluid stem cells in a transgene-free approach.	Molecular therapy 	2012	34
24105979	Valproic Acid	Paino F	Histone deacetylase inhibition with valproic acid downregulates osteocalcin gene expression in human dental pulp stem cells and osteoblasts: evidence for HDAC2 involvement.	Stem cells	2014	29
24381939	Valproic Acid	Marquez-Curtis LA	Enhancing the migration ability of mesenchymal stromal cells by targeting the SDF-1/CXCR4 axis.	BioMed research international	2013	43
25801509	Valproic Acid	Yoshida M	Modeling the early phenotype at the neuromuscular junction of spinal muscular atrophy using patient-derived iPSCs.	Stem cell reports	2015	18
26742529	Valproic Acid	Zhao Y	Brain REST/NRSF Is Not Only a Silent Repressor but Also an Active Protector.	Molecular neurobiology	2017	7
12242268	decitabine	Xu C	Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells.	Circulation research	2002	169
16645171	decitabine	Zorn E	IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo.	Blood	2006	189
18577749	decitabine	Fujita T	CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.	Journal of the National Cancer Institute	2008	62
19308264	decitabine	Garzia L	MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma.	PloS one	2009	79
20103663	decitabine	Di Tomaso T	Immunobiological characterization of cancer stem cells isolated from glioblastoma patients.	Clinical cancer research 	2010	63
20424188	decitabine	Choi J	In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia.	Blood	2010	69
21368160	decitabine	Sproul D	Transcriptionally repressed genes become aberrantly methylated and distinguish tumors of different lineages in breast cancer.	Proceedings of the National Academy of Sciences of the United States of America	2011	57
22387464	decitabine	Bultmann S	Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers.	Nucleic acids research	2012	70
23365201	decitabine	Dar AA	The role of miR-18b in MDM2-p53 pathway signaling and melanoma progression.	Journal of the National Cancer Institute	2013	30
23369223	decitabine	Karahoca M	Pharmacokinetic and pharmacodynamic analysis of 5-aza-2'-deoxycytidine (decitabine) in the design of its dose-schedule for cancer therapy.	Clinical epigenetics	2013	56
23526416	decitabine	Estey EH	Acute myeloid leukemia: 2013 update on risk-stratification and management.	American journal of hematology	2013	70
24077826	decitabine	Turcan S	Efficient induction of differentiation and growth inhibition in IDH1 mutant glioma cells by the DNMT Inhibitor Decitabine.	Oncotarget	2013	49
24270737	decitabine	Yang H	Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents.	Leukemia	2014	67
27259275	decitabine	Tagde A	MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.	Oncotarget	2016	12
9396603	bisbenzimide ethoxide trihydrochloride	Goodell MA	Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species.	Nature medicine	1997	192
10477735	bisbenzimide ethoxide trihydrochloride	Holyoake T	Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.	Blood	1999	106
11493466	bisbenzimide ethoxide trihydrochloride	Wulf GG	A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia.	Blood	2001	87
11781231	bisbenzimide ethoxide trihydrochloride	Scharenberg CW	The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors.	Blood	2002	159
11801536	bisbenzimide ethoxide trihydrochloride	Kim M	The multidrug resistance transporter ABCG2 (breast cancer resistance protein 1) effluxes Hoechst 33342 and is overexpressed in hematopoietic stem cells.	Clinical cancer research 	2002	95
15811951	bisbenzimide ethoxide trihydrochloride	Budak MT	Ocular surface epithelia contain ABCG2-dependent side population cells exhibiting features associated with stem cells.	Journal of cell science	2005	66
16849428	bisbenzimide ethoxide trihydrochloride	Szotek PP	Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness.	Proceedings of the National Academy of Sciences of the United States of America	2006	229
17510412	bisbenzimide ethoxide trihydrochloride	Ho MM	Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells.	Cancer research	2007	281
18680391	bisbenzimide ethoxide trihydrochloride	Huang D	Isolation and identification of cancer stem-like cells in esophageal carcinoma cell lines.	Stem cells and development	2009	48
19500336	bisbenzimide ethoxide trihydrochloride	Grogan SP	Mesenchymal progenitor cell markers in human articular cartilage: normal distribution and changes in osteoarthritis.	Arthritis research & therapy	2009	75
20019840	bisbenzimide ethoxide trihydrochloride	Vesuna F	Twist modulates breast cancer stem cells by transcriptional regulation of CD24 expression.	Neoplasia	2009	66
20354527	bisbenzimide ethoxide trihydrochloride	Hu L	Ovarian cancer stem-like side-population cells are tumourigenic and chemoresistant.	British journal of cancer	2010	82
21931300	bisbenzimide ethoxide trihydrochloride	Nakatsugawa M	SOX2 is overexpressed in stem-like cells of human lung adenocarcinoma and augments the tumorigenicity.	Laboratory investigation; a journal of technical methods and pathology	2011	48
22248732	bisbenzimide ethoxide trihydrochloride	Natarajan K	Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.	Biochemical pharmacology	2012	80
22284662	bisbenzimide ethoxide trihydrochloride	López J	Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance.	BMC cancer	2012	44
23009336	bisbenzimide ethoxide trihydrochloride	Singh S	EGFR/Src/Akt signaling modulates Sox2 expression and self-renewal of stem-like side-population cells in non-small cell lung cancer.	Molecular cancer	2012	69
26752044	bisbenzimide ethoxide trihydrochloride	Morata-Tarifa C	Low adherent cancer cell subpopulations are enriched in tumorigenic and metastatic epithelial-to-mesenchymal transition-induced cancer stem-like cells.	Scientific reports	2016	10
15896706	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Cao Y	Human adipose tissue-derived stem cells differentiate into endothelial cells in vitro and improve postnatal neovascularization in vivo.	Biochemical and biophysical research communications	2005	129
17135412	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Yasuhara T	Transplantation of human neural stem cells exerts neuroprotection in a rat model of Parkinson's disease.	The Journal of neuroscience 	2006	67
17204604	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	McLean AB	Activin a efficiently specifies definitive endoderm from human embryonic stem cells only when phosphatidylinositol 3-kinase signaling is suppressed.	Stem cells	2007	128
17234779	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Tabe Y	Activation of integrin-linked kinase is a critical prosurvival pathway induced in leukemic cells by bone marrow-derived stromal cells.	Cancer research	2007	61
19642865	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Lee KW	Rapamycin promotes the osteoblastic differentiation of human embryonic stem cells by blocking the mTOR pathway and stimulating the BMP/Smad pathway.	Stem cells and development	2010	46
20499340	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Chen L	Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation.	Journal of bone and mineral research 	2010	69
22761812	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Han M	Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN.	PloS one	2012	68
23869765	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Luo X	Enrichment of ovarian cancer stem-like cells is associated with epithelial to mesenchymal transition through an miRNA-activated AKT pathway.	Cell proliferation	2013	26
23951091	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Bronckaers A	Angiogenic properties of human dental pulp stem cells.	PloS one	2013	31
26568302	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	Yang CF	EB-virus latent membrane protein 1 potentiates the stemness of nasopharyngeal carcinoma via preferential activation of PI3K/AKT pathway by a positive feedback loop.	Oncogene	2016	13
19500472	PKH 26	Chang YS	Human umbilical cord blood-derived mesenchymal stem cells attenuate hyperoxia-induced lung injury in neonatal rats.	Cell transplantation	2009	55
23269272	PKH 26	Wang WJ	MYC regulation of CHK1 and CHK2 promotes radioresistance in a stem cell-like population of nasopharyngeal carcinoma cells.	Cancer research	2013	49
16405512	temozolomide	Hermisson M	O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.	Journal of neurochemistry	2006	70
17140455	temozolomide	Liu G	Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.	Molecular cancer	2006	509
17196391	temozolomide	Clement V	HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity.	Current biology 	2007	303
18565887	temozolomide	Murat A	Stem cell-related "self-renewal" signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma.	Journal of clinical oncology 	2008	233
18632623	temozolomide	Beier D	Temozolomide preferentially depletes cancer stem cells in glioblastoma.	Cancer research	2008	83
19265662	temozolomide	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	239
20388803	temozolomide	Hattermann K	The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects.	Cancer research	2010	81
20935218	temozolomide	Gaspar N	MGMT-independent temozolomide resistance in pediatric glioblastoma cells associated with a PI3-kinase-mediated HOX/stem cell gene signature.	Cancer research	2010	44
20957337	temozolomide	Ulasov IV	Inhibition of Sonic hedgehog and Notch pathways enhances sensitivity of CD133(+) glioma stem cells to temozolomide therapy.	Molecular medicine	2011	46
21988793	temozolomide	Beier D	Chemoresistance of glioblastoma cancer stem cells--much more complex than expected.	Molecular cancer	2011	80
23183822	temozolomide	Asuthkar S	Epigenetic regulation of miRNA-211 by MMP-9 governs glioma cell apoptosis, chemosensitivity and radiosensitivity.	Oncotarget	2012	49
23818228	temozolomide	Siebzehnrubl FA	The ZEB1 pathway links glioblastoma initiation, invasion and chemoresistance.	EMBO molecular medicine	2013	76
24608791	temozolomide	Auffinger B	Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy.	Cell death and differentiation	2014	58
24675463	temozolomide	Munoz JL	Temozolomide resistance in glioblastoma cells occurs partly through epidermal growth factor receptor-mediated induction of connexin 43.	Cell death & disease	2014	25
25105369	temozolomide	Adair JE	Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients.	The Journal of clinical investigation	2014	20
25364264	temozolomide	Lee JK	Targeting the epithelial to mesenchymal transition in glioblastoma: the emerging role of MET signaling.	OncoTargets and therapy	2014	23
25605243	temozolomide	Wang Z	Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.	Oncotarget	2015	18
26431379	temozolomide	Yu Z	Metformin and temozolomide act synergistically to inhibit growth of glioma cells and glioma stem cells in vitro and in vivo.	Oncotarget	2015	22
26542214	temozolomide	Murphy SF	Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide.	Cancer research	2016	12
26878385	temozolomide	Garros-Regulez L	mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance.	Expert opinion on therapeutic targets	2016	14
28233083	temozolomide	Ludwig K	Molecular markers in glioma.	Journal of neuro-oncology	2017	9
20851890	resveratrol	Liu M	Resveratrol inhibits mTOR signaling by promoting the interaction between mTOR and DEPTOR.	The Journal of biological chemistry	2010	59
21304978	resveratrol	Shankar S	Resveratrol inhibits pancreatic cancer stem cell characteristics in human and KrasG12D transgenic mice by inhibiting pluripotency maintaining factors and epithelial-mesenchymal transition.	PloS one	2011	79
21695150	resveratrol	Filippi-Chiela EC	Autophagy interplay with apoptosis and cell cycle regulation in the growth inhibiting effect of resveratrol in glioma cells.	PloS one	2011	44
21713995	resveratrol	Tseng PC	Resveratrol promotes osteogenesis of human mesenchymal stem cells by upregulating RUNX2 gene expression via the SIRT1/FOXO3A axis.	Journal of bone and mineral research 	2011	52
21857907	resveratrol	Aranha MM	miR-34a regulates mouse neural stem cell differentiation.	PloS one	2011	68
22052357	resveratrol	Menendez JA	mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.	Cell cycle	2011	58
22539994	resveratrol	Shakibaei M	Resveratrol mediated modulation of Sirt-1/Runx2 promotes osteogenic differentiation of mesenchymal stem cells: potential role of Runx2 deacetylation.	PloS one	2012	32
23897750	resveratrol	Paschalaki KE	Dysfunction of endothelial progenitor cells from smokers and chronic obstructive pulmonary disease patients due to increased DNA damage and senescence.	Stem cells	2013	29
26310874	resveratrol	Buhrmann C	Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, Epithelial-to-mesenchymal transition and apoptosis in colorectal cancer.	Biochemical pharmacology	2015	17
28611316	resveratrol	McCubrey JA	Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.	Aging	2017	6
17158356	sphingosine 1-phosphate	Walter DH	Sphingosine-1-phosphate stimulates the functional capacity of progenitor cells by activation of the CXCR4-dependent signaling pathway via the S1P3 receptor.	Arteriosclerosis, thrombosis, and vascular biology	2007	57
17918267	sphingosine 1-phosphate	Miron VE	FTY720 modulates human oligodendrocyte progenitor process extension and survival.	Annals of neurology	2008	55
19075223	sphingosine 1-phosphate	Pederson L	Regulation of bone formation by osteoclasts involves Wnt/BMP signaling and the chemokine sphingosine-1-phosphate.	Proceedings of the National Academy of Sciences of the United States of America	2008	101
20508253	sphingosine 1-phosphate	Pereira JP	Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses.	International immunology	2010	58
23615526	sphingosine 1-phosphate	Schneider G	Bioactive lipids S1P and C1P are prometastatic factors in human rhabdomyosarcoma, and their tissue levels increase in response to radio/chemotherapy.	Molecular cancer research 	2013	25
23861887	sphingosine 1-phosphate	Rex K	Sphingosine kinase activity is not required for tumor cell viability.	PloS one	2013	26
26400757	sphingosine 1-phosphate	Ratajczak MZ	Emerging Strategies to Enhance Homing and Engraftment of Hematopoietic Stem Cells.	Stem cell reviews	2016	11
27956387	sphingosine 1-phosphate	Powell JA	Targeting sphingosine kinase 1 induces MCL1-dependent cell death in acute myeloid leukemia.	Blood	2017	5
28144028	sphingosine 1-phosphate	Neurath MF	Current and emerging therapeutic targets for IBD.	Nature reviews. Gastroenterology & hepatology	2017	17
21193839	Curcumin	Lim KJ	A polymeric nanoparticle formulation of curcumin inhibits growth, clonogenicity and stem-like fraction in malignant brain tumors.	Cancer biology & therapy	2011	41
22108826	Curcumin	Bao B	Curcumin analogue CDF inhibits pancreatic tumor growth by switching on suppressor microRNAs and attenuating EZH2 expression.	Cancer research	2012	95
22952749	Curcumin	Bao B	Hypoxia induced aggressiveness of prostate cancer cells is linked with deregulated expression of VEGF, IL-6 and miRNAs that are attenuated by CDF.	PloS one	2012	43
23548270	Curcumin	Yu CC	miR145 targets the SOX9/ADAM17 axis to inhibit tumor-initiating cells and IL-6-mediated paracrine effects in head and neck cancer.	Cancer research	2013	40
23894315	Curcumin	Roy S	Difluorinated-curcumin (CDF) restores PTEN expression in colon cancer cells by down-regulating miR-21.	PloS one	2013	27
24371229	Curcumin	Charpentier MS	Curcumin targets breast cancer stem-like cells with microtentacles that persist in mammospheres and promote reattachment.	Cancer research	2014	27
24626093	Curcumin	Kantara C	Curcumin promotes autophagic survival of a subset of colon cancer stem cells, which are ablated by DCLK1-siRNA.	Cancer research	2014	26
26703799	Curcumin	Suresh R	The Role of Cancer Stem Cells in Recurrent and Drug-Resistant Lung Cancer.	Advances in experimental medicine and biology	2016	14
14561891	polylactic acid-polyglycolic acid copolymer	Levenberg S	Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds.	Proceedings of the National Academy of Sciences of the United States of America	2003	123
25453953	polylactic acid-polyglycolic acid copolymer	Pati F	Ornamenting 3D printed scaffolds with cell-laid extracellular matrix for bone tissue regeneration.	Biomaterials	2015	18
9027589	ascorbate-2-phosphate	Jaiswal N	Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro.	Journal of cellular biochemistry	1997	295
24930130	ascorbate-2-phosphate	Burridge PW	Chemically defined generation of human cardiomyocytes.	Nature methods	2014	181
17654479	alizarin	Zannettino AC	Multipotential human adipose-derived stromal stem cells exhibit a perivascular phenotype in vitro and in vivo.	Journal of cellular physiology	2008	154
20572012	alizarin	Battula VL	Epithelial-mesenchymal transition-derived cells exhibit multilineage differentiation potential similar to mesenchymal stem cells.	Stem cells	2010	87
20857424	alizarin	Pachón-Peña G	Stromal stem cells from adipose tissue and bone marrow of age-matched female donors display distinct immunophenotypic profiles.	Journal of cellular physiology	2011	46
20939067	alizarin	Shih YR	Matrix stiffness regulation of integrin-mediated mechanotransduction during osteogenic differentiation of human mesenchymal stem cells.	Journal of bone and mineral research 	2011	59
21732486	alizarin	Behr B	Locally applied vascular endothelial growth factor A increases the osteogenic healing capacity of human adipose-derived stem cells by promoting osteogenic and endothelial differentiation.	Stem cells	2011	37
23216074	alizarin	Chung MT	CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells.	Tissue engineering. Part A	2013	35
21618587	U 0126	Latifi A	Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.	Journal of cellular biochemistry	2011	70
20133333	hydrogen sulfite	Laurent L	Dynamic changes in the human methylome during differentiation.	Genome research	2010	371
21538319	hydrogen sulfite	Zhao S	MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1.	Arthritis and rheumatism	2011	83
21989055	hydrogen sulfite	Wissing S	Reprogramming somatic cells into iPS cells activates LINE-1 retroelement mobility.	Human molecular genetics	2012	55
23325432	hydrogen sulfite	Varley KE	Dynamic DNA methylation across diverse human cell lines and tissues.	Genome research	2013	214
24490752	hydrogen sulfite	Weidner CI	Aging of blood can be tracked by DNA methylation changes at just three CpG sites.	Genome biology	2014	126
25822089	hydrogen sulfite	Liao J	Targeted disruption of DNMT1, DNMT3A and DNMT3B in human embryonic stem cells.	Nature genetics	2015	71
26012557	hydrogen sulfite	Andoh-Noda T	Differentiation of multipotent neural stem cells derived from Rett syndrome patients is biased toward the astrocytic lineage.	Molecular brain	2015	18
28215704	hydrogen sulfite	Spencer DH	CpG Island Hypermethylation Mediated by DNMT3A Is a Consequence of AML Progression.	Cell	2017	12
19835841	salinomycin	Fuchs D	Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells.	Biochemical and biophysical research communications	2009	50
20350531	salinomycin	Fuchs D	Salinomycin overcomes ABC transporter-mediated multidrug and apoptosis resistance in human leukemia stem cell-like KG-1a cells.	Biochemical and biophysical research communications	2010	49
20973777	salinomycin	Kim JH	Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein.	British journal of pharmacology	2011	40
21267784	salinomycin	Dong TT	Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines.	Annals of surgical oncology	2011	35
21788521	salinomycin	Lu D	Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells.	Proceedings of the National Academy of Sciences of the United States of America	2011	92
21835542	salinomycin	Tang QL	Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.	Cancer letters	2011	45
21871443	salinomycin	Kim KY	Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization.	Biochemical and biophysical research communications	2011	41
21898546	salinomycin	King TD	The Wnt/β-catenin signaling pathway: a potential therapeutic target in the treatment of triple negative breast cancer.	Journal of cellular biochemistry	2012	61
22019123	salinomycin	Zhang Y	The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.	Biomaterials	2012	36
23251084	salinomycin	Naujokat C	Salinomycin as a drug for targeting human cancer stem cells.	Journal of biomedicine & biotechnology	2012	64
23639289	salinomycin	Jangamreddy JR	Salinomycin induces activation of autophagy, mitophagy and affects mitochondrial polarity: differences between primary and cancer cells.	Biochimica et biophysica acta	2013	28
23670030	salinomycin	Li T	Salinomycin induces cell death with autophagy through activation of endoplasmic reticulum stress in human cancer cells.	Autophagy	2013	31
25871400	salinomycin	Zhou Y	Salinomycin decreases doxorubicin resistance in hepatocellular carcinoma cells by inhibiting the β-catenin/TCF complex association via FOXO3a activation.	Oncotarget	2015	21
2070060	Glycophorin	Simmons PJ	Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO-1.	Blood	1991	205
18755895	Glycophorin	Ma F	Generation of functional erythrocytes from human embryonic stem cell-derived definitive hematopoiesis.	Proceedings of the National Academy of Sciences of the United States of America	2008	57
22498306	thiazolyl blue	Cheng W	MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells.	The FEBS journal	2012	64
23342249	thiazolyl blue	Fan F	Overexpression of snail induces epithelial-mesenchymal transition and a cancer stem cell-like phenotype in human colorectal cancer cells.	Cancer medicine	2012	58
24365767	thiazolyl blue	Gilpin SE	Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale.	The Journal of heart and lung transplantation 	2014	44
15549107	8-(3-chlorostyryl)caffeine	Singh SK	Identification of human brain tumour initiating cells.	Nature	2004	1948
16024622	8-(3-chlorostyryl)caffeine	Patrawala L	Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic.	Cancer research	2005	281
18593985	8-(3-chlorostyryl)caffeine	Chiou SH	Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.	Clinical cancer research 	2008	180
19190339	8-(3-chlorostyryl)caffeine	Charafe-Jauffret E	Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature.	Cancer research	2009	397
19806016	8-(3-chlorostyryl)caffeine	Ginestier C	Retinoid signaling regulates breast cancer stem cell differentiation.	Cell cycle	2009	56
20028757	8-(3-chlorostyryl)caffeine	Charafe-Jauffret E	Aldehyde dehydrogenase 1-positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer.	Clinical cancer research 	2010	238
21098716	8-(3-chlorostyryl)caffeine	Krishnamurthy S	Endothelial cell-initiated signaling promotes the survival and self-renewal of cancer stem cells.	Cancer research	2010	78
21224357	8-(3-chlorostyryl)caffeine	Liu S	Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks.	Cancer research	2011	167
21242971	8-(3-chlorostyryl)caffeine	Yu F	Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion.	Oncogene	2011	120
21498635	8-(3-chlorostyryl)caffeine	Silva IA	Aldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.	Cancer research	2011	133
21685475	8-(3-chlorostyryl)caffeine	Biddle A	Cancer stem cells in squamous cell carcinoma switch between two distinct phenotypes that are preferentially migratory or proliferative.	Cancer research	2011	68
21917736	8-(3-chlorostyryl)caffeine	Liu C	MicroRNA regulation of cancer stem cells.	Cancer research	2011	89
22096026	8-(3-chlorostyryl)caffeine	Cioffi M	EpCAM/CD3-Bispecific T-cell engaging antibody MT110 eliminates primary human pancreatic cancer stem cells.	Clinical cancer research 	2012	30
17651131	oil red O	Gay IC	Isolation and characterization of multipotent human periodontal ligament stem cells.	Orthodontics & craniofacial research	2007	65
17765303	oil red O	Mauney JR	Engineering adipose-like tissue in vitro and in vivo utilizing human bone marrow and adipose-derived mesenchymal stem cells with silk fibroin 3D scaffolds.	Biomaterials	2007	81
23497794	oil red O	Vanella L	Increased heme-oxygenase 1 expression in mesenchymal stem cell-derived adipocytes decreases differentiation and lipid accumulation via upregulation of the canonical Wnt signaling cascade.	Stem cell research & therapy	2013	28
26631736	oil red O	Boyle KE	Mesenchymal Stem Cells From Infants Born to Obese Mothers Exhibit Greater Potential for Adipogenesis: The Healthy Start BabyBUMP Project.	Diabetes	2016	15
15781101	2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile	Baxter EJ	Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.	Lancet	2005	672
16772604	2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile	Scott LM	Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia.	Blood	2006	67
18334677	2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile	Xing S	Transgenic expression of JAK2V617F causes myeloproliferative disorders in mice.	Blood	2008	75
20489053	2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile	Li J	JAK2 V617F impairs hematopoietic stem cell function in a conditional knock-in mouse model of JAK2 V617F-positive essential thrombocythemia.	Blood	2010	69
20541703	2-(3,4-dimethoxyphenyl)-5-amino-2-isopropylvaleronitrile	Mullally A	Physiological Jak2V617F expression causes a lethal myeloproliferative neoplasm with differential effects on hematopoietic stem and progenitor cells.	Cancer cell	2010	101
12855591	JM 3100	Liles WC	Mobilization of hematopoietic progenitor cells in healthy volunteers by AMD3100, a CXCR4 antagonist.	Blood	2003	145
15020611	JM 3100	Devine SM	Rapid mobilization of CD34+ cells following administration of the CXCR4 antagonist AMD3100 to patients with multiple myeloma and non-Hodgkin's lymphoma.	Journal of clinical oncology 	2004	89
15087398	JM 3100	Tavor S	CXCR4 regulates migration and development of human acute myelogenous leukemia stem cells in transplanted NOD/SCID mice.	Cancer research	2004	78
15837815	JM 3100	Broxmeyer HE	Rapid mobilization of murine and human hematopoietic stem and progenitor cells with AMD3100, a CXCR4 antagonist.	The Journal of experimental medicine	2005	322
15890685	JM 3100	Flomenberg N	The use of AMD3100 plus G-CSF for autologous hematopoietic progenitor cell mobilization is superior to G-CSF alone.	Blood	2005	88
18043246	JM 3100	Broxmeyer HE	Chemokines in hematopoiesis.	Current opinion in hematology	2008	52
18426988	JM 3100	Devine SM	Rapid mobilization of functional donor hematopoietic cells without G-CSF using AMD3100, an antagonist of the CXCR4/SDF-1 interaction.	Blood	2008	74
18987663	JM 3100	Burger JA	CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers.	Leukemia	2009	116
19139079	JM 3100	Azab AK	CXCR4 inhibitor AMD3100 disrupts the interaction of multiple myeloma cells with the bone marrow microenvironment and enhances their sensitivity to therapy.	Blood	2009	144
19161986	JM 3100	De Clercq E	The AMD3100 story: the path to the discovery of a stem cell mobilizer (Mozobil).	Biochemical pharmacology	2009	58
19363221	JM 3100	DiPersio JF	Plerixafor and G-CSF versus placebo and G-CSF to mobilize hematopoietic stem cells for autologous stem cell transplantation in patients with multiple myeloma.	Blood	2009	114
19720922	JM 3100	DiPersio JF	Phase III prospective randomized double-blind placebo-controlled trial of plerixafor plus granulocyte colony-stimulating factor compared with placebo plus granulocyte colony-stimulating factor for autologous stem-cell mobilization and transplantation for patients with non-Hodgkin's lymphoma.	Journal of clinical oncology 	2009	102
20460522	JM 3100	Nimmagadda S	Molecular imaging of CXCR4 receptor expression in human cancer xenografts with 64CuAMD3100 positron emission tomography.	Cancer research	2010	45
20631066	JM 3100	Kozin SV	Recruitment of myeloid but not endothelial precursor cells facilitates tumor regrowth after local irradiation.	Cancer research	2010	82
21349998	JM 3100	Duda DG	CXCL12 (SDF1alpha)-CXCR4/CXCR7 pathway inhibition: an emerging sensitizer for anticancer therapies?	Clinical cancer research 	2011	124
21494253	JM 3100	Dar A	Rapid mobilization of hematopoietic progenitors by AMD3100 and catecholamines is mediated by CXCR4-dependent SDF-1 release from bone marrow stromal cells.	Leukemia	2011	62
21618540	JM 3100	Ping YF	The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.	The Journal of pathology	2011	52
21998408	JM 3100	Ferraro F	Diabetes impairs hematopoietic stem cell mobilization by altering niche function.	Science translational medicine	2011	70
22370645	JM 3100	Jung MJ	Upregulation of CXCR4 is functionally crucial for maintenance of stemness in drug-resistant non-small cell lung cancer cells.	Oncogene	2013	54
22871210	JM 3100	Zhang SS	CD133(+)CXCR4(+) colon cancer cells exhibit metastatic potential and predict poor prognosis of patients.	BMC medicine	2012	46
23630186	JM 3100	Gassenmaier M	CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.	Stem cells	2013	27
24157575	JM 3100	Gatti M	Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity.	Toxicology	2013	27
26199389	JM 3100	Scala S	Molecular Pathways: Targeting the CXCR4-CXCL12 Axis--Untapped Potential in the Tumor Microenvironment.	Clinical cancer research 	2015	19
26347749	JM 3100	Pawig L	Diversity and Inter-Connections in the CXCR4 Chemokine Receptor/Ligand Family: Molecular Perspectives.	Frontiers in immunology	2015	17
26414794	JM 3100	Izumi D	CXCL12/CXCR4 activation by cancer-associated fibroblasts promotes integrin β1 clustering and invasiveness in gastric cancer.	International journal of cancer	2016	11
26517945	JM 3100	Fontanella R	A novel antagonist of CXCR4 prevents bone marrow-derived mesenchymal stem cell-mediated osteosarcoma and hepatocellular carcinoma cell migration and invasion.	Cancer letters	2016	10
21130701	alpha-hydroxyglutarate	Figueroa ME	Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation.	Cancer cell	2010	641
22166263	alpha-hydroxyglutarate	Luchman HA	An in vivo patient-derived model of endogenous IDH1-mutant glioma.	Neuro-oncology	2012	47
22343901	alpha-hydroxyglutarate	Lu C	IDH mutation impairs histone demethylation and results in a block to cell differentiation.	Nature	2012	439
23954893	alpha-hydroxyglutarate	Chaturvedi A	Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML.	Blood	2013	51
24065766	alpha-hydroxyglutarate	Lu C	Induction of sarcomas by mutant IDH2.	Genes & development	2013	40
24366912	alpha-hydroxyglutarate	Chesnelong C	Lactate dehydrogenase A silencing in IDH mutant gliomas.	Neuro-oncology	2014	32
25043045	alpha-hydroxyglutarate	Saha SK	Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer.	Nature	2014	66
25599133	alpha-hydroxyglutarate	Chan SM	Isocitrate dehydrogenase 1 and 2 mutations induce BCL-2 dependence in acute myeloid leukemia.	Nature medicine	2015	55
10851053	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Hirano T	Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors.	Oncogene	2000	254
15110706	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Ginis I	Differences between human and mouse embryonic stem cells.	Developmental biology	2004	143
15342941	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Dahéron L	LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells.	Stem cells	2004	96
17204602	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Assou S	A meta-analysis of human embryonic stem cells transcriptome integrated into a web-based expression atlas.	Stem cells	2007	128
20713517	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Inda MM	Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma.	Genes & development	2010	172
21408055	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Toth KG	IL-6 induced STAT3 signalling is associated with the proliferation of human muscle satellite cells following acute muscle damage.	PloS one	2011	38
22267310	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Guihard P	Induction of osteogenesis in mesenchymal stem cells by activated monocytes/macrophages depends on oncostatin M signaling.	Stem cells	2012	51
25966666	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Hossain A	Mesenchymal Stem Cells Isolated From Human Gliomas Increase Proliferation and Maintain Stemness of Glioma Stem Cells Through the IL-6/gp130/STAT3 Pathway.	Stem cells	2015	24
26945971	2-phenyl-5,5-dimethyltetrahydro-1,4-oxazine	Bharti R	Cancer development, chemoresistance, epithelial to mesenchymal transition and stem cells: A snapshot of IL-6 mediated involvement.	Cancer letters	2016	29
17440163	gefitinib	Farnie G	Novel cell culture technique for primary ductal carcinoma in situ: role of Notch and epidermal growth factor receptor signaling pathways.	Journal of the National Cancer Institute	2007	101
19147502	gefitinib	Griffero F	Different response of human glioma tumor-initiating cells to epidermal growth factor receptor kinase inhibitors.	The Journal of biological chemistry	2009	52
22173954	gefitinib	Xie M	Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells.	Journal of cellular biochemistry	2012	45
22935675	gefitinib	Huang CP	ALDH-positive lung cancer stem cells confer resistance to epidermal growth factor receptor tyrosine kinase inhibitors.	Cancer letters	2013	28
23461856	gefitinib	Ma L	Cancer stem-like cell properties are regulated by EGFR/AKT/β-catenin signaling and preferentially inhibited by gefitinib in nasopharyngeal carcinoma.	The FEBS journal	2013	26
23542356	gefitinib	Shien K	Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells.	Cancer research	2013	72
23695170	gefitinib	Morgillo F	Synergistic effects of metformin treatment in combination with gefitinib, a selective EGFR tyrosine kinase inhibitor, in LKB1 wild-type NSCLC cell lines.	Clinical cancer research 	2013	32
24489728	gefitinib	Murakami A	Hypoxia increases gefitinib-resistant lung cancer stem cells through the activation of insulin-like growth factor 1 receptor.	PloS one	2014	28
26943330	gefitinib	Bai XY	Blockade of Hedgehog Signaling Synergistically Increases Sensitivity to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer Cell Lines.	PloS one	2016	11
24394384	N(6)-methyladenosine	Wang Y	N6-methyladenosine modification destabilizes developmental regulators in embryonic stem cells.	Nature cell biology	2014	144
24981863	N(6)-methyladenosine	Schwartz S	Perturbation of m6A writers reveals two distinct classes of mRNA methylation at internal and 5' sites.	Cell reports	2014	95
25456834	N(6)-methyladenosine	Batista PJ	m(6)A RNA modification controls cell fate transition in mammalian embryonic stem cells.	Cell stem cell	2014	107
25799998	N(6)-methyladenosine	Alarcón CR	N6-methyladenosine marks primary microRNAs for processing.	Nature	2015	79
27117702	N(6)-methyladenosine	Lin S	The m(6)A Methyltransferase METTL3 Promotes Translation in Human Cancer Cells.	Molecular cell	2016	41
27590511	N(6)-methyladenosine	Zhang C	Hypoxia-inducible factors regulate pluripotency factor expression by ZNF217- and ALKBH5-mediated modulation of RNA methylation in breast cancer cells.	Oncotarget	2016	15
27602518	N(6)-methyladenosine	Patil DP	m(6)A RNA methylation promotes XIST-mediated transcriptional repression.	Nature	2016	52
28281539	N(6)-methyladenosine	Yang Y	Extensive translation of circular RNAs driven by N6-methyladenosine.	Cell research	2017	38
28297667	N(6)-methyladenosine	Cui Q	m6A RNA Methylation Regulates the Self-Renewal and Tumorigenesis of Glioblastoma Stem Cells.	Cell reports	2017	18
28344040	N(6)-methyladenosine	Zhang S	m6A Demethylase ALKBH5 Maintains Tumorigenicity of Glioblastoma Stem-like Cells by Sustaining FOXM1 Expression and Cell Proliferation Program.	Cancer cell	2017	22
28398475	N(6)-methyladenosine	Li L	Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis.	Human molecular genetics	2017	9
28637692	N(6)-methyladenosine	Ke S	m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover.	Genes & development	2017	19
28965759	N(6)-methyladenosine	Yoon KJ	Temporal Control of Mammalian Cortical Neurogenesis by m6A Methylation.	Cell	2017	12
17097560	BH 3	Konopleva M	Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.	Cancer cell	2006	331
20023629	BH 3	Schwickart M	Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.	Nature	2010	209
23063124	BH 3	Vo TT	Relative mitochondrial priming of myeloblasts and normal HSCs determines chemotherapeutic success in AML.	Cell	2012	91
24682005	BH 3	Colak S	Decreased mitochondrial priming determines chemoresistance of colon cancer stem cells.	Cell death and differentiation	2014	22
16179608	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Vallier L	Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells.	Journal of cell science	2005	244
20376579	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Kim DS	Robust enhancement of neural differentiation from human ES and iPS cells regardless of their innate difference in differentiation propensity.	Stem cell reviews	2010	68
21162120	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Morizane A	Small-molecule inhibitors of bone morphogenic protein and activin/nodal signals promote highly efficient neural induction from human pluripotent stem cells.	Journal of neuroscience research	2011	47
21525408	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Li W	Rapid induction and long-term self-renewal of primitive neural precursors from human embryonic stem cells by small molecule inhibitors.	Proceedings of the National Academy of Sciences of the United States of America	2011	103
21904773	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Cho JA	Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells.	International journal of oncology	2012	81
23197756	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Chen YS	Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells.	Stem cells translational medicine	2012	43
27320862	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Park NR	Synergistic effects of CD44 and TGF-β1 through AKT/GSK-3β/β-catenin signaling during epithelial-mesenchymal transition in liver cancer cells.	Biochemical and biophysical research communications	2016	10
27834668	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	Mohamed TM	Chemical Enhancement of In Vitro and In Vivo Direct Cardiac Reprogramming.	Circulation	2017	16
15720724	Amino Acids	Itoh K	Nuclear localization is required for Dishevelled function in Wnt/beta-catenin signaling.	Journal of biology	2005	78
19302039	Amino Acids	Conley ME	Primary B cell immunodeficiencies: comparisons and contrasts.	Annual review of immunology	2009	85
19713214	Amino Acids	Kim KK	Identification of neuronal nuclei (NeuN) as Fox-3, a new member of the Fox-1 gene family of splicing factors.	The Journal of biological chemistry	2009	115
22734070	Amino Acids	Payne EM	L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.	Blood	2012	45
24239963	Amino Acids	Granéli C	Novel markers of osteogenic and adipogenic differentiation of human bone marrow stromal cells identified using a quantitative proteomics approach.	Stem cell research	2014	23
25233904	Amino Acids	Kocak H	Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1.	Genes & development	2014	29
25581430	Amino Acids	Zhang MY	Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy.	Nature genetics	2015	44
25707267	Amino Acids	Collin M	Haematopoietic and immune defects associated with GATA2 mutation.	British journal of haematology	2015	24
26742086	Amino Acids	Carroll B	Control of TSC2-Rheb signaling axis by arginine regulates mTORC1 activity.	eLife	2016	22
28026090	Amino Acids	Fitter S	The Mesenchymal Precursor Cell Marker Antibody STRO-1 Binds to Cell Surface Heat Shock Cognate 70.	Stem cells	2017	5
28148781	Amino Acids	Khayati K	The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice.	FASEB journal 	2017	6
28279189	Amino Acids	Yoshida GJ	Therapeutic strategies of drug repositioning targeting autophagy to induce cancer cell death: from pathophysiology to treatment.	Journal of hematology & oncology	2017	11
28333144	Amino Acids	Jones VC	Aberrant iPSC-derived human astrocytes in Alzheimer's disease.	Cell death & disease	2017	8
12384400	lenalidomide	Richardson PG	Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.	Blood	2002	116
17576924	lenalidomide	Pellagatti A	Lenalidomide inhibits the malignant clone and up-regulates the SPARC gene mapping to the commonly deleted region in 5q- syndrome patients.	Proceedings of the National Academy of Sciences of the United States of America	2007	58
20825315	lenalidomide	Tehranchi R	Persistent malignant stem cells in del(5q) myelodysplasia in remission.	The New England journal of medicine	2010	68
21321360	lenalidomide	Jakubikova J	Lenalidomide targets clonogenic side population in multiple myeloma: pathophysiologic and clinical implications.	Blood	2011	61
24253022	lenalidomide	Ocio EM	New drugs and novel mechanisms of action in multiple myeloma in 2013: a report from the International Myeloma Working Group (IMWG).	Leukemia	2014	58
26308596	lenalidomide	Lokhorst HM	Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma.	The New England journal of medicine	2015	110
28295190	lenalidomide	Shah N	Phase I study of cord blood-derived natural killer cells combined with autologous stem cell transplantation in multiple myeloma.	British journal of haematology	2017	5
18200035	sorafenib	Zhang W	Sorafenib induces apoptosis of AML cells via Bim-mediated activation of the intrinsic apoptotic pathway.	Leukemia	2008	61
18230792	sorafenib	Zhang W	Mutant FLT3: a direct target of sorafenib in acute myelogenous leukemia.	Journal of the National Cancer Institute	2008	109
19844230	sorafenib	Kumar R	Myelosuppression and kinase selectivity of multikinase angiogenesis inhibitors.	British journal of cancer	2009	60
20495567	sorafenib	Sheng Z	A genome-wide RNA interference screen reveals an essential CREB3L2-ATF5-MCL1 survival pathway in malignant glioma with therapeutic implications.	Nature medicine	2010	53
21334406	sorafenib	Chen X	Epithelial mesenchymal transition and hedgehog signaling activation are associated with chemoresistance and invasion of hepatoma subpopulations.	Journal of hepatology	2011	38
21352471	sorafenib	Meng F	Functional analysis of microRNAs in human hepatocellular cancer stem cells.	Journal of cellular and molecular medicine	2012	41
22473773	sorafenib	Shan J	Nanog regulates self-renewal of cancer stem cells through the insulin-like growth factor pathway in human hepatocellular carcinoma.	Hepatology	2012	74
23471579	sorafenib	Xia H	MicroRNA-216a/217-induced epithelial-mesenchymal transition targets PTEN and SMAD7 to promote drug resistance and recurrence of liver cancer.	Hepatology	2013	89
23835194	sorafenib	Pez F	Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs.	Journal of hepatology	2013	56
25053293	sorafenib	Fernando J	A mesenchymal-like phenotype and expression of CD44 predict lack of apoptotic response to sorafenib in liver tumor cells.	International journal of cancer	2015	23
26514126	sorafenib	Lou G	Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma.	Journal of hematology & oncology	2015	38
26592953	sorafenib	Govaere O	Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche.	Journal of hepatology	2016	13
26655273	sorafenib	Xu Y	MicroRNA-122 confers sorafenib resistance to hepatocellular carcinoma cells by targeting IGF-1R to regulate RAS/RAF/ERK signaling pathways.	Cancer letters	2016	17
18238853	purmorphamine	Li XJ	Directed differentiation of ventral spinal progenitors and motor neurons from human embryonic stem cells by small molecules.	Stem cells	2008	98
19696748	purmorphamine	Hu BY	Differentiation of spinal motor neurons from pluripotent human stem cells.	Nature protocols	2009	89
25116795	purmorphamine	Chen HM	Transcripts involved in calcium signaling and telencephalic neuronal fate are altered in induced pluripotent stem cells from bipolar disorder patients.	Translational psychiatry	2014	35
12748309	sunitinib	Abrams TJ	SU11248 inhibits KIT and platelet-derived growth factor receptor beta in preclinical models of human small cell lung cancer.	Molecular cancer therapeutics	2003	147
17367763	sunitinib	Roskoski R Jr	Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor.	Biochemical and biophysical research communications	2007	73
19470923	sunitinib	Zhu AX	Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.	Journal of clinical oncology 	2009	143
21315783	sunitinib	Finke J	MDSC as a mechanism of tumor escape from sunitinib mediated anti-angiogenic therapy.	International immunopharmacology	2011	73
22308314	sunitinib	Conley SJ	Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia.	Proceedings of the National Academy of Sciences of the United States of America	2012	160
23378344	sunitinib	Hollier BG	FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.	Cancer research	2013	75
25123505	sunitinib	Mikami S	Expression of TNF-α and CD44 is implicated in poor prognosis, cancer cell invasion, metastasis and resistance to the sunitinib treatment in clear cell renal cell carcinomas.	International journal of cancer	2015	22
25200065	sunitinib	Zhang D	Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer.	Molecular cancer	2014	25
19372391	5-hydroxymethylcytosine	Tahiliani M	Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.	Science	2009	1432
20639862	5-hydroxymethylcytosine	Ito S	Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.	Nature	2010	727
21610077	5-hydroxymethylcytosine	Kinney SM	Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes.	The Journal of biological chemistry	2011	49
21689397	5-hydroxymethylcytosine	Stroud H	5-Hydroxymethylcytosine is associated with enhancers and gene bodies in human embryonic stem cells.	Genome biology	2011	157
21734233	5-hydroxymethylcytosine	Pronier E	Inhibition of TET2-mediated conversion of 5-methylcytosine to 5-hydroxymethylcytosine disturbs erythroid and granulomonocytic differentiation of human hematopoietic progenitors.	Blood	2011	51
21817016	5-hydroxymethylcytosine	He YF	Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA.	Science	2011	696
22083101	5-hydroxymethylcytosine	Branco MR	Uncovering the role of 5-hydroxymethylcytosine in the epigenome.	Nature reviews. Genetics	2011	208
22157888	5-hydroxymethylcytosine	Williams K	DNA methylation: TET proteins-guardians of CpG islands?	EMBO reports	2011	101
22196727	5-hydroxymethylcytosine	Yildirim O	Mbd3/NURD complex regulates expression of 5-hydroxymethylcytosine marked genes in embryonic stem cells.	Cell	2011	172
22829908	5-hydroxymethylcytosine	Orr BA	Decreased 5-hydroxymethylcytosine is associated with neural progenitor phenotype in normal brain and shorter survival in malignant glioma.	PloS one	2012	44
22902501	5-hydroxymethylcytosine	Doege CA	Early-stage epigenetic modification during somatic cell reprogramming by Parp1 and Tet2.	Nature	2012	110
23260135	5-hydroxymethylcytosine	Mellén M	MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system.	Cell	2012	283
23453809	5-hydroxymethylcytosine	Piccolo FM	Different roles for Tet1 and Tet2 proteins in reprogramming-mediated erasure of imprints induced by EGC fusion.	Molecular cell	2013	41
23671639	5-hydroxymethylcytosine	Liu C	Decrease of 5-hydroxymethylcytosine is associated with progression of hepatocellular carcinoma through downregulation of TET1.	PloS one	2013	45
23685628	5-hydroxymethylcytosine	Wang T	Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency.	Nature cell biology	2013	35
23827711	5-hydroxymethylcytosine	Song SJ	The oncogenic microRNA miR-22 targets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.	Cell stem cell	2013	95
24087792	5-hydroxymethylcytosine	Kim M	Dynamic changes in DNA methylation and hydroxymethylation when hES cells undergo differentiation toward a neuronal lineage.	Human molecular genetics	2014	28
24270360	5-hydroxymethylcytosine	Jeong M	Large conserved domains of low DNA methylation maintained by Dnmt3a.	Nature genetics	2014	88
24373966	5-hydroxymethylcytosine	Madzo J	Hydroxymethylation at gene regulatory regions directs stem/early progenitor cell commitment during erythropoiesis.	Cell reports	2014	30
25073028	5-hydroxymethylcytosine	Fu L	Tet-mediated formation of 5-hydroxymethylcytosine in RNA.	Journal of the American Chemical Society	2014	41
25362856	5-hydroxymethylcytosine	Neri F	TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway.	Oncogene	2015	40
25922306	5-hydroxymethylcytosine	Yang Q	The Mechanism and Function of Epigenetics in Uterine Leiomyoma Development.	Reproductive sciences	2016	15
26854228	5-hydroxymethylcytosine	Kafer GR	5-Hydroxymethylcytosine Marks Sites of DNA Damage and Promotes Genome Stability.	Cell reports	2016	18
28823558	5-hydroxymethylcytosine	Cimmino L	Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia Progression.	Cell	2017	14
28826859	5-hydroxymethylcytosine	Cull AH	Tet2 restrains inflammatory gene expression in macrophages.	Experimental hematology	2017	6
14702635	6-bromoindirubin-3'-oxime	Sato N	Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor.	Nature medicine	2004	556
24200905	6-bromoindirubin-3'-oxime	Caspi O	Modeling of arrhythmogenic right ventricular cardiomyopathy with human induced pluripotent stem cells.	Circulation. Cardiovascular genetics	2013	35
17213283	4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide	Jørgensen HG	Nilotinib exerts equipotent antiproliferative effects to imatinib and does not induce apoptosis in CD34+ CML cells.	Blood	2007	84
17519960	4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide	Brendel C	Imatinib mesylate and nilotinib (AMN107) exhibit high-affinity interaction with ABCG2 on primitive hematopoietic stem cells.	Leukemia	2007	55
19363292	4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide	Bellodi C	Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cells.	The Journal of clinical investigation	2009	156
20423956	4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide	Dohse M	Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.	Drug metabolism and disposition	2010	44
24957147	4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide	Gallipoli P	JAK2/STAT5 inhibition by nilotinib with ruxolitinib contributes to the elimination of CML CD34+ cells in vitro and in vivo.	Blood	2014	24
20130243	INCB018424	Quintás-Cardama A	Preclinical characterization of the selective JAK1/2 inhibitor INCB018424: therapeutic implications for the treatment of myeloproliferative neoplasms.	Blood	2010	164
24711661	INCB018424	Spoerl S	Activity of therapeutic JAK 1/2 blockade in graft-versus-host disease.	Blood	2014	37
25207766	INCB018424	Roberts KG	Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia.	The New England journal of medicine	2014	178
25671252	INCB018424	Ortmann CA	Effect of mutation order on myeloproliferative neoplasms.	The New England journal of medicine	2015	70
25824483	INCB018424	Parampalli Yajnanarayana S	JAK1/2 inhibition impairs T cell function in vitro and in patients with myeloproliferative neoplasms.	British journal of haematology	2015	18
27677740	INCB018424	Saenz DT	BET protein bromodomain inhibitor-based combinations are highly active against post-myeloproliferative neoplasm secondary AML cells.	Leukemia	2017	7
28139313	INCB018424	Weinacht KG	Ruxolitinib reverses dysregulated T helper cell responses and controls autoimmunity caused by a novel signal transducer and activator of transcription 1 (STAT1) gain-of-function mutation.	The Journal of allergy and clinical immunology	2017	6
19839055	Chir 99021	Li W	Generation of human-induced pluripotent stem cells in the absence of exogenous Sox2.	Stem cells	2009	102
21390254	Chir 99021	Yu J	Efficient feeder-free episomal reprogramming with small molecules.	PloS one	2011	60
22696177	Chir 99021	Xi J	Specification of midbrain dopamine neurons from primate pluripotent stem cells.	Stem cells	2012	44
23644405	Chir 99021	Wang F	Isolation and characterization of intestinal stem cells based on surface marker combinations and colony-formation assay.	Gastroenterology	2013	55
23896987	Chir 99021	Cao N	Highly efficient induction and long-term maintenance of multipotent cardiovascular progenitors from human pluripotent stem cells under defined conditions.	Cell research	2013	36
24357672	Chir 99021	Lam AQ	Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers.	Journal of the American Society of Nephrology 	2014	51
25241748	Chir 99021	Shelton M	Derivation and expansion of PAX7-positive muscle progenitors from human and mouse embryonic stem cells.	Stem cell reports	2014	30
25454631	Chir 99021	Kempf H	Controlling expansion and cardiomyogenic differentiation of human pluripotent stem cells in scalable suspension culture.	Stem cell reports	2014	25
24336571	vemurafenib	Shalem O	Genome-scale CRISPR-Cas9 knockout screening in human cells.	Science	2014	744
24871132	vemurafenib	Chung SS	Hematopoietic stem cell origin of BRAFV600E mutations in hairy cell leukemia.	Science translational medicine	2014	20
24879157	vemurafenib	Goodall ML	Development of potent autophagy inhibitors that sensitize oncogenic BRAF V600E mutant melanoma tumor cells to vemurafenib.	Autophagy	2014	20
12089448	2,3-anthracenedicarboxaldehyde	Aiuti A	Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning.	Science	2002	226
17671653	2,3-anthracenedicarboxaldehyde	Aiuti A	Multilineage hematopoietic reconstitution without clonal selection in ADA-SCID patients treated with stem cell gene therapy.	The Journal of clinical investigation	2007	82
19179314	2,3-anthracenedicarboxaldehyde	Aiuti A	Gene therapy for immunodeficiency due to adenosine deaminase deficiency.	The New England journal of medicine	2009	246
21865538	2,3-anthracenedicarboxaldehyde	Gaspar HB	Hematopoietic stem cell gene therapy for adenosine deaminase-deficient severe combined immunodeficiency leads to long-term immunological recovery and metabolic correction.	Science translational medicine	2011	72
23566838	2,3-anthracenedicarboxaldehyde	Mukherjee S	Gene therapy for PIDs: progress, pitfalls and prospects.	Gene	2013	41
